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Abstract 
Background: Pneumonia is a disease of the lungs that is caused by a number of 
pathogens including Gram-negative Pseudomonas aeruginosa and Gram-positive 
Streptococcus pneumoniae [1]. These pathogens are prevalent causes of 
hospital-acquired pneumonia, and P. aeruginosa is particularly problematic with 
regards to chronic pulmonary infection in patients with Cystic Fibrosis (CF) [2]. 
Antibodies are known to provide a component of host-defence against this 
microbe, but recent evidence suggests that cells secreting the pro-inflammatory 
cytokine interleukin-17 (IL-17) [3, 4], namely T helper 17 (Th17) cells, are also 
significant in these responses [3, 5].  
Aim: To investigate the sources of IL-17 and related cytokines during P. 
aeruginosa and S. pneumoniae infection, and to investigate if IL-1β has a role in 
Th17 formation during infection with these pathogens. Furthermore, to 
investigate the cytokine secretion of dendritic cells (DCs) derived from different 
sources following infection with these pathogens, and their roles at inducing Th-
17 secretion from naive CD4+ T cells.  
Methods & Results:  Dendritic cells from mucosal sites were found to be better 
than GM-CSF derived bone marrow dendritic cells (BMDCs) at inducing Th17 cells 
from naive T cells. Th17 cells were derived in response to both P. aeruginosa 
and S. pneumoniae, with the role of IL-1β seeming to be negligible for P. 
aeruginosa. However, the role of IL-1β during Th17 cell induction during S. 
pneumoniae is unclear and needs further investigation. γδ T cells were found to 
be a source of IL-17 during P. aeruginosa infection in a IL-23 dependent manner. 
Furthermore, γδ T cells were also found to be a source of IL-22, yet the majority 
of cells were either IL-17 or IL-22 producing, not double producers as expected.  
In vivo infection with these pathogens identifed γδ T cells to be a main source of 
IL-17 during P. aeruginosa infection, with Th17 cells having more of a role during 
S. pneumoniae infection, yet the main sources of IL-17 still need to be 
identified. Preliminary infections with S. pneumoniae in IL-17RKO mice 
identified IL-17 as a key mediator in downstream inflammatory responses in the 
lung during infection. 
3 
Conclusions: This study demonstrates that IL-17 responses are induced in 
response to infection with the respiratory pathogens P. aeruginosa and S. 
pneumoniae. Ex vivo, mucosal DCs were found to induce more robust Th17 cell 
responses compared to GM-CSF derived BMDCS. In vivo, Th17 cells appear to 
have a role in S. pneumoniae infection, with γδ T cells appearing to be the 
dominant source of IL-17 during P. aeruginosa infection. Furthermore, in vitro 
investigations of γδ T cells found them to be differentially IL-17 and IL-22 
producing in response to P. aeruginosa infection, in a DC contact independent 
manner. 
 
4 
Table of Contents 
Abstract ..................................................................................... 2 
Table of Contents ......................................................................... 4 
List of Tables ............................................................................... 9 
List of Figures ............................................................................ 10 
Acknowledgements ..................................................................... 14 
Abbreviations ............................................................................ 16 
1 Introduction......................................................................... 19 
1.1 Introduction .................................................................... 20 
1.2 Pneumonia...................................................................... 20 
1.3 Pseudomonas aeruginosa ..................................................... 21 
1.3.1 P. aeruginosa pneumonia and hospital acquired infections ........ 22 
1.3.2 P. aeruginosa infection in individuals with CF ....................... 23 
1.4 Streptococcus pneumoniae................................................... 24 
1.4.1 Pneumolysin (PLY) ....................................................... 24 
1.5 Defences to lung infection ................................................... 25 
1.5.1 Barrier defences .......................................................... 25 
1.5.2 Innate immunity .......................................................... 25 
1.5.2.1 TLRs................................................................... 26 
1.5.2.2 NLRs .................................................................. 27 
1.5.2.3 Neutrophils .......................................................... 27 
1.5.2.4 Epithelial cells ...................................................... 28 
1.5.2.5 Macrophages ......................................................... 28 
1.5.3 Adaptive immunity ....................................................... 29 
1.5.3.1 Antibodies............................................................ 29 
1.5.3.2 T cells ................................................................ 29 
1.6 Interleukin 17 (IL-17) ......................................................... 30 
1.6.1 IL-17 receptors ........................................................... 32 
1.6.2 IL-17 in infection and disease .......................................... 33 
1.6.3 Cellular sources of IL-17................................................. 33 
1.6.3.1 Th17 cells ............................................................ 33 
1.6.3.1.1 Development of Th17 cells ...................................... 34 
1.6.3.2 γδ T cells............................................................. 36 
1.6.3.3 Other sources of IL-17 .............................................. 38 
1.7 IL-23 ............................................................................. 39 
1.8 IL-1β ............................................................................. 40 
1.8.1 Inflammasome and IL-1β secretion .................................... 41 
1.8.1.1 The inflammasome ................................................. 41 
1.8.2 Type III secretion system (T3SS) ....................................... 43 
1.9 IL-22 ............................................................................. 44 
1.9.1 IL-22 Functions ........................................................... 44 
1.9.2 Cellular sources .......................................................... 45 
1.9.2.1 Th17 .................................................................. 45 
1.9.2.2 Th22 .................................................................. 45 
1.9.2.3 γδ T cells............................................................. 46 
1.9.2.4 Other sources of IL-22 .............................................. 46 
1.10 Hypothesis and aims .......................................................... 46 
2 Materials and methods ............................................................ 48 
2.1 Mouse strains ................................................................... 49 
2.1.1 C57BL/6 ................................................................... 49 
2.1.2 IL-17R KO .................................................................. 49 
5 
2.2 Cell culture ..................................................................... 49 
2.2.1 Cell lines .................................................................. 49 
2.2.1.1 X63 cells for GM-CSF................................................ 49 
2.2.2 Bone-marrow derived DCs............................................... 50 
2.2.3 Primary cell isolation .................................................... 50 
2.2.3.1 Splenocyte isolation ................................................ 50 
2.2.3.2 T Cell isolation using Magnetic-Activated Cell Sorting (MACS) 51 
2.2.3.2.1 Naive T cell isolation ............................................. 51 
2.2.3.2.2 γδ T cell isolation................................................. 51 
2.2.3.3 Nasal associated lymphoid tissue (NALT) isolation ............. 51 
2.2.3.4 Lung cell isolation .................................................. 52 
2.2.3.4.1 NALT and lung DC isolation ...................................... 52 
2.2.3.4.2 Density centrifugation ........................................... 52 
2.2.4 DC infection ............................................................... 53 
2.2.5 Co-culture set up ......................................................... 53 
2.3 Bacterial strains ............................................................... 54 
2.3.1 P. aeruginosa ............................................................. 54 
2.3.1.1 PA103 ................................................................. 54 
2.3.1.1.1 PA103 ΔUΔT ....................................................... 54 
2.3.1.1.2 PA103 ΔpcrV ....................................................... 54 
2.3.1.2 PAO1 .................................................................. 55 
2.3.2 S. pneumoniae ............................................................ 55 
2.3.2.1 D39.................................................................... 55 
2.3.2.1.1 D39 ΔPLY ........................................................... 55 
2.3.2.2 TIGR4 ................................................................. 55 
2.4 Bacterial cultures.............................................................. 55 
2.4.1 P. aeruginosa ............................................................. 55 
2.4.2 S. pneumoniae ............................................................ 56 
2.4.3 Pathogen minimum inhibitory concentration (MIC) assay........... 56 
2.5 Flow cytometry ................................................................ 57 
2.5.1 7AAD ....................................................................... 59 
2.5.2 CFSE ........................................................................ 59 
2.6 Enzyme-linked immunosorbant assay (ELISA) .............................. 59 
2.7 In vivo experiments ........................................................... 61 
2.7.1 Intranasal lung infections of mice with bacteria to induce 
pneumonia ........................................................................... 61 
2.7.2 Measuring bacteria for intranasal infection .......................... 62 
2.7.3 In vivo sample harvest ................................................... 63 
2.7.3.1 BAL collection for bacteriology and cytospin ................... 63 
2.7.3.2 Pleural wash collection for bacteriology and cytospin......... 63 
2.7.3.3 Lung tissue ........................................................... 64 
2.7.3.3.1 Lung section for Flow cytometry ............................... 64 
2.7.3.3.2 Lung section for histology ....................................... 64 
2.7.3.3.3 Lung Homogenate for bacterial load measurements......... 64 
2.7.3.4 Blood collection for bacteriology ................................. 64 
2.7.3.5 Nasal wash collection for bacteriology .......................... 65 
2.7.4 Bacterial culture ......................................................... 65 
2.7.5 Cytospin ................................................................... 65 
2.7.5.1 Rapid romanowsky staining of cytospins ......................... 65 
2.7.6 Histology .................................................................. 66 
2.7.6.1 Hematoxylin&eosin staining of lung tissue ...................... 66 
2.8 Reagents ........................................................................ 67 
2.9 Statistical analysis ............................................................. 67 
6 
3 Methods developed ................................................................ 68 
3.1 Isolation of single cell suspension from lung ............................... 69 
3.2 Lung DC isolation .............................................................. 70 
3.2.1 Density centrifugation ................................................... 74 
3.3 Conclusion ...................................................................... 77 
4 Dendritic cell activation by Pseudomonas aeruginosa and Streptococcus 
pneumoniae .............................................................................. 78 
4.1 Introduction .................................................................... 79 
4.2 BMDC induction by Granulocyte macrophage colony stimulating factor 
(GM-CSF) ................................................................................ 80 
4.2.1 Recombinant GM-CSF induces more CD11c+ cells from bone marrow 
progenitors than X63 media ....................................................... 80 
4.2.2 Recombinant GM-CSF induces functional CD11c+ cells from bone 
marrow progenitors based on CD40 and CD86 up-regulation ................. 81 
4.2.3 X63 and GM-CSF induced DCs do not differ in IL-1β secretion ..... 82 
4.2.4 Functional CD11c+ cell generation using Flt3 ligand ................ 83 
4.3 DCs from frozen bone marrow ............................................... 87 
4.4 P. aeruginosa activates BMDCs .............................................. 89 
4.5 Initial IL-1β production from DCs upon P. aeruginosa infection is T3SS 
dependent .............................................................................. 91 
4.6 DC activation by P. aeruginosa occurs early with few bacteria, and 
increases over time and MOI ......................................................... 94 
4.7 IL-23 output from P. aeruginosa infected DCs ............................. 95 
4.8 Streptococcus pneumoniae activates BMDCs .............................. 96 
4.8.1 S. pneumoniae activation of DCs requires overnight incubation... 98 
4.9 IL-1β output from S. pneumoniae infected DCs .......................... 100 
4.10 IL-23 from S. pneumoniae infected DCs ................................... 101 
4.11 DCs do not produce IL-17 in response to P. aeruginosa ................. 102 
4.12 Isolation of mucosal tissue DCs ............................................. 103 
4.12.1 Immune cells in NALT................................................... 104 
4.12.2 Isolation of mucosal DCs ............................................... 106 
4.12.3 Activation of lung DCs with P. aeruginosa infection................ 107 
4.13 Discussion ...................................................................... 108 
5 In vitro IL-17 responses induced by the mucosal pathogens Pseudomonas 
aeruginosa and Streptococcus pneumoniae  .......................................116 
5.1 Introduction ................................................................... 117 
5.2 Co-culture of CD4+ T cells with P. aeruginosa infected DCs allows         
T cell proliferation ................................................................... 118 
5.3 Co-culture of CD4+ T cells with P. aeruginosa infected DCs allows        
IL-17 production ...................................................................... 119 
5.4 IL-2 diminishes the IL-17 producing population observed upon              
P. aeruginosa infection .............................................................. 120 
5.5 IL-17 producing cells observed during co-culture of CD4 MACS sorted 
cells with P. aeruginosa infected DCs are CD4- .................................. 122 
5.6 γδ T cells are prolific producers of IL-17 and do so in an antigen 
independent manner ................................................................. 124 
5.7 CD44 and CD62L are interchangeable markers of T cell memory status 
and naive CD44- T cells become CD44+ memory T cells upon activation. .... 125 
5.8 γδ T cells are memory like with regards to CD62L expression ......... 127 
5.9 Naive CD4+ T cells become Th17 cells upon co-culture with                  
P. aeruginosa infected DCs.......................................................... 128 
5.10 IL-17 secretion from naive CD4+ T cells is DC dependent............... 130 
5.11 Role of IL-1β contribution in Th17 cell development .................... 132 
7 
5.12 IL-17 secreting cells induced from co-culture with P. aeruginosa do not 
co-express IL-22 ...................................................................... 133 
5.13 CD4+ naive T cells can be induced to secrete IL-17 when cultured with 
S. pneumoniae infected DCS ........................................................ 136 
5.14 Naive CD4+ T cells become Th17 cells upon co-culture with                    
S. pneumoniae infected DCs, and require DC-T cell contact for optimal IL-17 
production ............................................................................. 139 
5.15 IL-17 may be induced from naive CD4+ T cells when cultured with         
P. aeruginosa infected mucosal DCs. .............................................. 141 
5.15.1 P. aeruginosa infected NALT DCs induce IL-17 responses from    
naive CD4+ T cells ................................................................. 141 
5.15.2 P. aeruginosa infected lung DCs induce IL-17 responses from    
naive CD4+ T cells ................................................................. 144 
5.15.3 IL-22 responses from naive CD4+ T cells co-cultured with               
P. aeruginosa infected mucosal DCs............................................. 146 
5.16 Discussion ...................................................................... 148 
6 IL-17 secretion from γδ T cells following P. aeruginosa infection .......157 
6.1 Introduction ................................................................... 158 
6.2 γδ T cells are contained in the CD62L- memory preparation of CD4+ 
negatively selected cells by MACS, and proliferate upon stimulation ......... 159 
6.3 γδ isolation using MACS  ...................................................... 160 
6.4 γδ T cells are IL-17 producing upon co-culture with P. aeruginosa 
infected DC conditioned media in a DC contact independent manner.  ....... 162 
6.5 γδ T cells do not directly recognise P. aeruginosa....................... 166 
6.6 γδ T cells produce IL-17 in an IL-23 dependent manner ................ 169 
6.7 γδ T cells are IL-22 producing upon co-culture with P. aeruginosa 
infected DC conditioned media in a DC contact independent and IL-23 
dependent manner. .................................................................. 170 
6.8 The majority of IL-17 secreting cells induced from co-culture with       
P. aeruginosa do not co-express IL-22 ............................................. 172 
6.9 Discussion ...................................................................... 174 
7 In vivo responses to Pseudomonas aeruginosa and Streptococcus 
pneumoniae .............................................................................178 
7.1 Introduction ................................................................... 179 
7.2 Establishment of pneumoniae infection using P. aeruginosa ........... 180 
7.3 P. aeruginosa and S. pneumoniae intranasal infection induces lung 
disease ................................................................................. 181 
7.3.1 P. aeruginosa and S. pneumoniae infection induce hematomas in 
the lung. ............................................................................ 181 
7.3.2 P. aeruginosa and S. pneumoniae both induce severe lung 
inflammation indicative of acute pneumonia.  ................................. 182 
7.4 Neutrophils dominate the cellular population in the BAL of infected 
animals................................................................................. 187 
7.5 IL-17 concentrations in the BAL ............................................ 189 
7.6 S. pneumoniae infection induces inflammation at the pleural edge     
that is not observed in P. aeruginosa infection .................................. 190 
7.7 Immune cells migrate into the pleural space during S. pneumoniae 
infection ............................................................................... 192 
7.7.1 More cells are found in the pleural space of infected mice than 
control animals..................................................................... 192 
7.7.2 Upon infection there is a cellular infiltrate of neutrophils into     
the pleural space .................................................................. 193 
7.7.3 IL-17 in the pleural space .............................................. 196 
8 
7.7.4 Sources of IL-17 in pleural space ...................................... 196 
7.7.5 Immune cells are increased in the pleural space upon infection . 197 
7.8 Immune cell populations in the lung increase during bacterial 
pneumonia............................................................................. 200 
7.9 Sources of IL-17 in the lung during bacterial pneumonia ............... 202 
7.10 Effects of IL-17 signalling via its receptor IL-17R on the immune 
responses in the lung during S. pneumoniae pneumonia ........................ 207 
7.11 IL-17RKO mice are larger, heavier and have more subcutaneous fat   
that WT mice.......................................................................... 207 
7.12 IL-17 signalling via IL-17R may induce inflammation in the lung during  
S. pneumoniae infection............................................................. 209 
7.13 IL-17 and neutrophil recruitment in BAL in IL-17RKO animals .......... 210 
7.14 IL-17 signalling via IL-17R may regulate immune cells in the pleural 
space during S. pneumoniae infection ............................................. 213 
7.14.1 Increased cells in the pleural space of IL-17RKO mice during          
S. pneumoniae infection .......................................................... 213 
7.14.2 IL-17R may regulate IL-17 concentrations in pleural space ....... 215 
7.14.3 IL-17R regulation of immune cells in pleural space  ................ 216 
7.15 IL-17 signalling via IL-17R may regulate immune cells in the lung      
during S. pneumoniae infection .................................................... 219 
7.15.1 IL-17R negatively regulates IL-17+ cells in the lung during              
S. pneumoniae infection .......................................................... 221 
7.16 Discussion ...................................................................... 223 
8 General Discussion ................................................................232 
References ..............................................................................237 
 
 
9 
List of Tables 
Table 1-1 TLRs and examples of ligands .............................................. 26 
Table 1-2 NLRs and examples of ligands .............................................. 27 
Table 1-3 IL-17 family members and their sources .................................. 30 
Table 1-4 Targets of IL-17, and their effects on immune responses .............. 31 
Table 1-5 IL-17 Receptor family members and their cells of expression ......... 32 
Table 2-1 Antibodies for flow cytometry.............................................. 57 
Table 2-2 R&D Duoset antibody and standard concentrations ..................... 61 
10 
List of Figures 
Figure 1-1 Helper T cell paradigm ..................................................... 36 
Figure 1-2 The inflammasome. ......................................................... 42 
Figure 1-3 IL-1β processing by the inflammasome ................................... 42 
Figure 1-4 Schematic representation of the type III secretion system ............ 43 
Figure 2-1 Illustration of density centrifugation of lung tissue .................... 52 
Figure 2-2 MIC assay of gentamicin killing of P. aeruginosa ........................ 57 
Figure 2-3 Example of standard gating for flow cytometry analysis. .............. 58 
Figure 3-1 CD11c+ isolation using liberase to isolate lung cells is more effective 
than use of Collagenase D............................................................... 70 
Figure 3-2 CD11c+ cells are not only contained in the adherent cell population  
as others have claimed .................................................................. 72 
Figure 3-3 CD11c+ cells from different treatments of lung DC isolation ......... 74 
Figure 3-4 Diagram of density centrifugation of lung tissue homogenate  ........ 75 
Figure 3-5 Density centrifugation treatment of lung tissue increases the CD11c+ 
populations isolated from the lung by CD11c+ MACS treatment ................... 76 
Figure 4-1 Recombinant GM-CSF induces higher numbers of CD11c+ populations 
from bone marrow than X63 media .................................................... 81 
Figure 4-2 Recombinant GM-CSF induced DCs up-regulate more CD40 than X63 
media induced DCs ....................................................................... 82 
Figure 4-3 IL-1β output from recombinant GM-CSF and X63 induced DCs does   
not differ .................................................................................. 83 
Figure 4-4 CD11c expression by DCs derived using Flt3l is lower than CD11c 
expression of DCs derived by recombinant GM-CSF ................................. 84 
Figure 4-5 Activation of Flt3l derived DCs using LPS ................................ 85 
Figure 4-6 Cell death with day 14 Flt3l derived DCs ................................ 86 
Figure 4-7 DCs from frozen bone marrow progenitors .............................. 87 
Figure 4-8 Lack of activation from DCs from frozen bone marrow progenitors .. 88 
Figure 4-9 P. aeruginosa infection activates DCs to up-regulate co-stimulatory 
markers CD40 and CD86 ................................................................. 90 
Figure 4-10 IL-1β is secreted from DCs infected with T3SS competent PA103 
ΔUΔT but not T3SS deficient PA103 ΔpcrV ............................................ 92 
Figure 4-11 IL-1β is secreted from DCs infected with both PA103 strains after 
overnight incubation, regardless of T3SS contribution .............................. 93 
Figure 4-12 P. aeruginosa infection of DCs over time at various MOIs ............ 95 
Figure 4-13 IL-23 secretion from PA103 ΔUΔT and ΔpcrV infected DCs does not 
differ ....................................................................................... 96 
Figure 4-14 DC activation with S. pneumoniae occurs at low MOIs................ 97 
Figure 4-15 DC activation with S. pneumoniae harvested after 2 hours after      
90 minute infection and addition of antibiotics...................................... 99 
Figure 4-16 S. pneumoniae D39 WT allows IL-1β secretion from DCs whereas the 
PLY deficient mutant D39 ΔPLY does not ............................................ 100 
Figure 4-17 Infection with S. pneumoniae strains D39 WT and D39 ΔPLY does    
not lead to IL-23 release from DCs.................................................... 101 
Figure 4-18 DCs do not secrete IL-17 during P. aeruginosa infection ............ 102 
Figure 4-19 Cell populations from NALT ............................................. 104 
Figure 4-20 CD4 population of naive NALT........................................... 105 
Figure 4-21 CD11c+ NALT cells ........................................................ 106 
Figure 4-22 DC isolation from lung using positive selection MACS ................ 107 
Figure 4-23 Lung DCs are activated by P. aeruginosa infection................... 108 
11 
Figure 5-1 T cells co-cultured with P. aeruginosa infected DCs are induced to 
proliferate................................................................................ 119 
Figure 5-2 Culture with P. aeruginosa infected DCs induces IL-17+ populations 
from MACS isolated CD4+ T cells ...................................................... 120 
Figure 5-3 IL-2 reduces IL-17 production from MACS isolated CD4+ T cells ..... 121 
Figure 5-4 IL-2 reduces IL-17+ populations .......................................... 122 
Figure 5-5 IL-17+ populations during co-culture with P. aeruginosa infected     
DCs are CD4- ............................................................................. 123 
Figure 5-6 IL-17 observed upon co-culture with P. aeruginosa infected DCs is 
from γδ T cells .......................................................................... 124 
Figure 5-7 IL-17 from CD4+ γδ + cells co-cultured with P. aeruginosa infected 
DCs stimulated with anti-CD3 ......................................................... 125 
Figure 5-8 CD62L- cells are CD44+ .................................................... 126 
Figure 5-9 Naive CD44- cells become CD44+ upon activation ..................... 127 
Figure 5-10 γδ T cells are CD62L- ‘memory like’ cells ............................. 128 
Figure 5-11 Co-culture with P. aeruginosa infected DCs induces naive CD4+         
T cells to become Th17 cells .......................................................... 129 
Figure 5-12 IL-17 producing populations upon co-culture with P. aeruginosa 
infected DCs ............................................................................. 130 
Figure 5-13 IL-17 secretion from naive T cells requires DC presence ............ 131 
Figure 5-14 IL-17 production from naive T cells is IL-1β independent ........... 133 
Figure 5-15 IL-22 secretion from naive T cells culture with P. aeruginosa  
infected DCs is low ...................................................................... 134 
Figure 5-16 IL-22+ cells are not induced from naive CD4+ T cells co-cultured  
with P. aeruginosa infected DCs ...................................................... 135 
Figure 5-17 Cytokine induced Th17 cells are IL-17+ and IL-22- ................... 136 
Figure 5-18 Co-culture with PLY deficient S. pneumoniae infected DCs induces 
naive CD4+ T cells to become Th17 cells ............................................ 137 
Figure 5-19 Th17 cell populations are induced from naive T cells co-cultured  
with S. pneumoniae infected DCs ..................................................... 138 
Figure 5-20 IL-17 secretion from naive T cells co-cultured with S. pneumoniae 
infected DCs is DC contact dependent.  .............................................. 139 
Figure 5-21 Production of IL-17+ populations from naive T cells co-cultured    
with S. pneumoniae infected DCs is DC contact dependent....................... 140 
Figure 5-22 Naive T cells co-cultured with P. aeruginosa infected NALT DCs 
become IL-17+ ........................................................................... 141 
Figure 5-23 IL-17 production from co-culture of naive T cells with P. aeruginosa 
infected NALT DCs. ..................................................................... 142 
Figure 5-24 Stimulated whole NALT does not contain an innate IL-17 producing 
population................................................................................ 143 
Figure 5-25 A new ‘activated’ population of T cells is observed when naive         
T cells are co-cultured with P. aeruginosa infected lung DCs..................... 144 
Figure 5-26 'Live' and 'activated' T cell populations from co-culture with lung   
DCs contain IL-17+ populations ........................................................ 145 
Figure 5-27 Naive T cells co-cultures with P. aeruginosa infected lung DCs are  
IL-17 secreting. .......................................................................... 146 
Figure 5-28 IL-22 secretion from naive T cells co-cultured with P. aeruginosa 
infected lung DCs is low ................................................................ 147 
Figure 5-29 Naive T cells co-cultured with P. aeruginosa infected NALT DCs do 
not secrete IL-22 ........................................................................ 148 
Figure 6-1 γδ T cells proliferate upon stimulation ................................. 160 
Figure 6-2 γδ T cells isolated using positive selection MACS ...................... 161 
12 
Figure 6-3 γδ T cells cultured in P. aeruginosa infected DC conditioned media   
in the absence of DCs secrete IL-17 .................................................. 163 
Figure 6-4 IL-17 cells observed during γδ T cell cultured in P. aeruginosa 
infected DC conditioned media are γδ+.............................................. 164 
Figure 6-5 Secreted factors from activated DCs are more important than DC 
contact at inducing production of IL-17 from γδ T cells ........................... 165 
Figure 6-6 Production of IL-17 from γδ T cells requires conditioned media from 
stimulated DCs........................................................................... 166 
Figure 6-7 Direct infection of γδ T cells with P. aeruginosa does not induce      
IL-17+ γδ+ T cell populations .......................................................... 167 
Figure 6-8 Direct infection of γδ T cells with P. aeruginosa does not lead to      
IL-17 secretion ........................................................................... 168 
Figure 6-9 IL-17 secretion from γδ T cells is IL-23 dependent .................... 170 
Figure 6-10 γδ T cells cultured in P. aeruginosa infected DC conditioned       
media in the absence of DCs secrete IL-22 .......................................... 171 
Figure 6-11 IL-22 secretion from γδ T cells is partly IL-23 dependent ........... 172 
Figure 6-12 IL-17+ and IL-22+ γδ populations are distinct ......................... 173 
Figure 7-1 Dissected lungs from in vivo model ...................................... 182 
Figure 7-2 Section of healthy control lung stained with H&E ..................... 183 
Figure 7-3 Section of P. aeruginosa infected lung stained with H&E............. 184 
Figure 7-4 Section of S. pneumoniae infected lung stained with H&E ........... 185 
Figure 7-5 Inflammation in the lung during bacterial pneumonia is due to 
neutrophils ............................................................................... 186 
Figure 7-6 Examples of a macrophage and neutrophil identified by rapid 
Romanowsky staining ................................................................... 187 
Figure 7-7 Cytospin of cells from BAL of control lung, P. aeruginosa infected  
lung and S. pneumoniae infected lung stained with rapid Romanowsky......... 188 
Figure 7-8 Counts of neutrophil populations in BAL ................................ 189 
Figure 7-9 IL-17 concentrations in the BAL during P. aeruginosa and                    
S. pneumoniae infection ............................................................... 190 
Figure 7-10 Pleural edge of S. pneumoniae mice is inflamed compared to   
control and P. aeruginosa infected animal .......................................... 191 
Figure 7-11 Total cell numbers in pleural space of uninfected and infected 
animals ................................................................................... 193 
Figure 7-12 Cytospins of lung pleural washes stained with H&E .................. 194 
Figure 7-13 Neutrophils dominate the pleural space during S. pneumoniae 
infection .................................................................................. 195 
Figure 7-14 Concentrations of IL-17 are found in the pleural space during 
bacterial infection ...................................................................... 196 
Figure 7-15 Immune cells in the pleural space during infection .................. 199 
Figure 7-16 Immune cells in the lung during pneumonia .......................... 201 
Figure 7-17 IL-17 cells are increased during S. pneumoniae but not                    
P. aeruginosa infection ................................................................. 203 
Figure 7-18 IL-17+ γδ T cells in the lung during P. aeruginosa and                      
S. pneumoniae infection ............................................................... 204 
Figure 7-19 Th17 cells in the lung increase during S. pneumoniae bacterial 
pneumonia, yet decrease during infection with P. aeruginosa ................... 205 
Figure 7-20 IL-17+ Gr-1+ cells in the lung during bacterial pneumonia .......... 206 
Figure 7-21 IL-17RKO animals are significantly heavier than their WT 
counterparts ............................................................................. 208 
Figure 7-22 Histology of WT lung during S. pneumoniae infection is grossly 
inflamed whereas histology of IL-17RKO lung during the same infection is not.210 
Figure 7-23 IL-17R does not regulate IL-17 concentrations in the BAL ........... 211 
13 
Figure 7-24 Cytospin of cells from BAL of WT and IL-17RKO lung during              
S. pneumoniae infection stained with rapid Romanowsky ......................... 212 
Figure 7-25 Cell numbers are increased in pleural space during S. pneumoniae 
infection in IL-17RKO animals ......................................................... 213 
Figure 7-26 The pleural space of IL-17RKO animals is dominated by neutrophils 
during S. pneumoniae infection ....................................................... 214 
Figure 7-27 Neutrophils are increased in the pleural space during S. pneumoniae 
infection in IL-17RKO animals ......................................................... 215 
Figure 7-28 IL-17 is increased during S. pneumoniae infection in IL-17RKO 
animals ................................................................................... 216 
Figure 7-29 Immune populations in the pleural space of WT and IL-17RKO mice 
during S. pneumoniae infection ....................................................... 218 
Figure 7-30 CD4 and γδ populations in WT and IL-17RKO mice during                  
S. pneumoniae infection ............................................................... 220 
Figure 7-31 IL-17 producing populations are increased in S. pneumoniae  
infection in the absence of IL-17R .................................................... 221 
Figure 7-32 Sources of IL-17 during S. pneumoniae infection in WT and             
IL-17RKO mice ........................................................................... 222 
 
14 
Acknowledgements 
Firstly I must thank my supervisor Tom Evans for taking a chance on me and for 
his help and encouragement over my PhD. Especially his insistence that it would 
all be ok when I was panicking about having no results and it all going wrong-you 
were right, it has turned out ok. I must mention his catchphrase for whenever I 
was in doubt of my results: ‘it is what it is’. This became my motto. I even have 
a keyring of this given to me by my special and daft friend Jen. Thanks Jen, for 
this and for being generally daft with me and helping me let off steam, for your 
understanding when I became a hermit and the worst friend ever while writing, 
and for listening to all my rants and placating me. You have been a real support.  
Thanks to my wonderful Swedish meatball, Cecilia for teaching me everything I 
know, for her patience in teaching me and for a fantastic friendship! I miss you 
and hope to visit you in California soon. Thanks to many others in the GBRC for 
their help over the years, Jim and Shauna, Ashley G, Hannah, all of the Harnetts 
and Mowlings-far too many to mention individually, though I must mention my 
petite chou-fleur Aude and give a mega thank you to ex-mowling Ellie! Thanks to 
Ananda for being optimistic (even when she’s so pessimistic about her own work-
unnecessarily) and to Bob for being realistic! Thanks for being my ‘bench 
buddies’, and for making work a fun place to be. Thanks to Lucy, and Carole 
‘Roseyposey’ for this also- Rosey, I can’t wait to meet your little rose bud!  
 A special mention must go to Ryan for without his help I wouldn’t have my last 
chapter and a possibility of a future publication. Thanks for putting up with me 
Ryan and for all your help, even when you had so much on your plate already.  
I must also mention my little nephew Harry, seeing you every Friday made the 
weeks of writing bearable. You are such an amazing wee guy and you make me 
so happy. x 
Finally a massive thank you to Sean for all his love and support, for his 
encouragement and persistence (which wasn’t always graciously accepted, 
sorry). For putting up with my late nights, early mornings, bad moods, bad 
meals, and for being MIA for a few months.  I know everyone says this about 
someone but I really couldn’t have got through the last few years, and especially 
the last few months, without you! I love you and our new home! This is for you 
xxx 
15 
Author’s Declaration  
I declare that, except where explicit reference is made to the contribution of 
others, that this thesis is the result of my own work and has not been submitted for 
any other degree at the University of Glasgow or any other institution.  
Signature…………………………………………………………  
Printed name……………………………………………………  
16 
Abbreviations  
2-ME  2-mercaptoethanol 
Ab  Antibody 
Abx  Antibiotics 
AhR  Aryl hydrocarbon receptor 
AM  Alveolar macrophage 
APC  Allophycocyanin 
APCs  Antigen presenting cells 
BAL  Bronchoalveolar lavage 
Bcl  B cell lymphoma   
BHI  Brain heart infusion 
BIR  Baculovirus inhibitor of apoptosis protein repeat 
BLP  Bacterial lipo-protein 
BMDC  Bone marrow derived dendritic cells 
BSA  Bovine serum albumin 
CARD  Caspase activating and recruitment domain 
CCL  CC chemokine ligand 
CCR  CC chemokine receptor 
CD  Cluster of differentiation 
CF  Cystic Fibrosis 
CFTR  Cystic fibrosis transmembrane conductance regulator 
CFU  Colony forming units 
CXCL  CXC chemokine ligand 
CXCR  CXC chemokine receptor 
DC  Dendritic cell 
DMSO  Dimethyl sulfoxide 
DNA  Deoxyribonucleic acid 
EAE  Experimental autoimmune encephalomyelitis 
EDTA  Ethylenediaminetetraacetic acid 
ELISA  Enzyme-linked immunosorbent assay 
FACS   Fluorescence activated cell sorting 
FCS  Fetal calf serum 
FITC  Fluorescein isothiocyanate 
FSC  Forward scatter 
17 
G-CSF  Granulocyte colony stimulating factor 
GM-CSF Granulocyte macrophage colony stimulating factor 
H&E  Hematoxylin and eosin stain 
HBSS  Hank’s buffered salt solution 
HRP  Horseradish peroxidise 
IFN  Interferon 
IL  Interleukin 
iNKT cells Invariant Natural Killer T cell 
IVIS  In vivo imaging system 
KO  Knock-out 
LB  Luria Bertani 
LPS   Lipopolysaccharide 
LRR  Leucine rich repeats 
LTi cell Lymphoid tissue inducer cell 
MACS  Magnetic-Activated Cell Sorting 
MHC  Major histocompatability complex 
MIC  Minimum inhibitory concentration 
MOI   Multiplicity of infection 
MS  Multiple sclerosis 
NALT  Nasal associated lymphoid tissue 
NK cell Natural Killer cell 
NKT cell Natural Killer T cell 
NLR Nucleotide oligomerization domain and leucine rich repeat 
containing proteins 
PAMP  Pathogen associated molecular pattern 
PBMC  Peripheral blood mononuclear cells 
PBS  Phosphate buffered saline 
PE   Phycoerythrin  
Percp  Peridinin Chlorophyll Protein Complex 
PFA  Paraformaldehyde 
P.I  Post infection 
PLY  Pneumolysin 
PMA  Phorbol 12-myristate 13-acetate 
PRR  Pattern recognition receptor 
PYD  Pyrin domain 
18 
RA  Rheumatoid arthritis 
RBC  Red blood cell 
RNA  Ribonucleic acid 
RT  Room temperature 
SSC  Side scatter 
TC  Tissue culture 
TCR  T cell receptor 
TGFβ  Transforming growth factor beta 
Th  Helper T cell 
TIR   Toll-like Interleukin-1 receptor like 
TLR  Toll like receptor 
TMB  Tetramethylbenzidine 
TNFα  Tumor necrosis factor alpha 
WT  Wild type 
 
19 
1 Introduction 
  20 
1.1 Introduction 
Pneumonia is a disease of the lungs that is caused by a number of pathogens 
including Gram-negative Pseudomonas aeruginosa and Gram-positive 
Streptococcus pneumoniae [1]. These pathogens are prevalent causes of 
hospital-acquired pneumonia and P. aeruginosa is particularly problematic with 
regards to chronic pulmonary infection in patients with Cystic Fibrosis (CF) [2]. 
Antibodies (Abs) are known to provide a component of host-defence against this 
microbe, but recent evidence suggests that cells secreting pro-inflammatory 
cytokine interleukin-17 (IL-17) [3, 4], namely T helper 17 (Th17) cells, are also 
significant in these responses [3, 5], and we wished to investigate this. 
The work presented in this thesis explores the production of IL-17 secreting cells 
in response to the pneumonia causing Gram-negative pathogen P. aeruginosa and 
to a lesser extent, the Gram-positive pneumonia causing pathogen S. 
pneumoniae.  This chapter provides an overview of these respiratory pathogens, 
of immune defences in the lung, and of IL-17 and its functions with emphasis on 
the cells known to produce IL-17 and the importance of IL-17 in other infections.  
The aim of this chapter is to highlight the importance of IL-17 in inflammatory 
responses to bacterial infection, and to place in context the importance of the 
results presented in this thesis in the fight against common bacterial infections 
that are causative agents of pneumonia.  
1.2 Pneumonia 
Pneumonia is an inflammatory condition of the lungs, which leads to respiratory 
problems such as difficulty breathing, severe coughing, chest pain and fever. It 
is usually caused by an infection, such as bacterial or viral infection, but fungi 
and parasites can also be responsible for the inflammation that leads to 
pneumonia [6].  
Immunocompetent individuals who suffer from a mild pneumonia with no other 
complications normally recover well, but to those with co-morbidities such as 
Chronic obstructive pulmonary disease (COPD), pneumonia can be deadly [7]. 
Pneumonia can lead to certain complications such as respiratory failure due the 
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inflamed tissue not being able to absorb enough oxygen. Pneumonia appears to 
be responsible for nearly half of intensive care unit infections in Europe [8], 
illustrating its magnitude. 
Two causative agents of bacterial pneumonia are P. aeruginosa and S. 
pneumoniae and it is these respiratory pathogens that are the focus of this 
thesis. 
1.3 Pseudomonas aeruginosa 
P. aeruginosa is a Gram-negative rod shaped flagellated opportunistic bacteria 
that is a common cause of respiratory infections in immunocompromised and 
hospitalised individuals [9].  
An environmental pathogen commonly found in soil and water, P. aeruginosa is 
highly resistant to antibiotics. Perhaps this is, in part, due to the fact that it can 
be found in areas where antibiotic sources also grow, such as the soil, and so has 
developed factors to survive alongside these antibiotics. It can infect a number 
of life forms including amoebas [10], nematodes [11], insects [12, 13], plants 
[14] and mammals and is thus extremely adaptable to endure in these various 
environments where all of these organisms exist. It is a robust pathogen that has 
been shown to survive virtually oxygen free environments, even though it is 
classified as an aerobic bacterium [15], and so is known as a facultative 
anaerobe. This adaptability and potential to survive extremes of environment 
contribute to its resilient nature making it a very difficult pathogen not only to 
avoid, but to eradicate once it has been encountered.  
P. aeruginosa is not detrimental to those who have a fully competent immune 
system, and may be found in the throat and nasal mucosa of these individuals 
[16], making them carriers. In these individuals, barrier functions of the lung 
(discussed in section 1.5 of this chapter) appear to be enough to ensure 
effective removal of the pathogen from the airways, and disruption of 
colonization.  It is however a major source of infection in immunocompromised 
individuals such as patients undergoing chemotherapy and patients with 
compromised defences for instance burns patients, and CF sufferers [2]. In these 
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individuals it can cause a myriad of complications which will be discussed in the 
following sections. 
1.3.1 P. aeruginosa pneumonia and hospital acquired infections 
Hospital acquired infections (HAIs) or nosocomial infections (NIs) are infections 
acquired by individuals upon admission to hospital. P. aeruginosa is an important 
cause of HAIs as it is an opportunistic pathogen that seems to readily colonise 
those with other co-morbidities, worsening prognosis. It has been found that, of 
all HAIs, P. aeruginosa is responsible for 1 in 10 [17, 18], and is a leading cause 
of NIs worldwide.  
P. aeruginosa is a major cause of urinary tract infections [19]; eye infections- it 
is the main cause of bacterial keratitis, an inflammation of the cornea [20]; 
wound infections [21], in addition to respiratory infections which are the main 
focus of this thesis. Generally P. aeruginosa can infect any mucosal surface or 
any instance where physical barriers have been breached such as wounds and 
burns.  
As P. aeruginosa is an environmental pathogen, entry to the lungs is not 
particularly difficult. For example it colonizes the throat and nasal mucosa of 
carriers [16], and may be made airborne upon coughing and sneezing. Equally, if 
a source of P. aeruginosa infected water becomes disturbed and water particles 
become airborne, it allows the organism to be inhaled readily, leading to entry 
into the lung and possible colonisation. 
In the lungs of immunocompromised individuals P. aeruginosa may colonize and 
form biofilms in the airway, reducing the conduction of oxygen in these 
airspaces. Biofilms are aggregates of the pathogen contained in a sticky matrix 
[22], which aid in the pathogens adherence to surfaces and survival as the sticky 
matrix is virtually impermeable to the hosts immune response [22]. The 
pathogen may also release pathogenic components leading to cellular 
destruction [23] and inflammation in the tissue. This may further impede oxygen 
diffusion in the lung, making the patient breathless and causing weakness in the 
individual due to lack of sufficient oxygen consumption.  
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P. aeruginosa can colonise plastics where it forms these biofilms, which is why it 
can be a problematic organism in the hospital environment where patients have 
indwelling urinary catheters or are intubated to aid with their breathing, 
thereby allowing P. aeruginosa to readily colonize the urinary tract or the 
airways. Intubation also inhibits normal clearance of respiratory secretions [24, 
25], increasing the likelihood of respiratory infections.  
1.3.2 P. aeruginosa infection in individuals with CF 
CF is a recessive genetic disorder that results from a mutation in a protein called 
the cystic fibrosis transmembrane conductance regulator (CFTR) which is 
responsible for regulation of components of mucus, sweat and other body 
secretions [26]. It affects many body organs but is most well known for the 
difficulties it causes in respiratory function of sufferers.  
CF patients have over production of mucus in the lung and reduced mucociliary 
function, meaning that this excess mucus cannot be removed from the lung 
effectively. As the mucus produced cannot be effectively removed, it becomes a 
breeding ground for pathogens, as it is a perfect moist warm environment and 
multiple infections can ensue, a primary source being P. aeruginosa [2], known 
to be a colonizer of structurally abnormal lung tissue. In CF individuals P. 
aeruginosa  will eventually colonize 80% of adult patients [27, 28]. There is great 
inflammation in the lungs of these individuals, characterized by neutrophil 
infiltration [5], which can lead to fibrosis and result in further decline of lung 
function. 
An additional complication of lack of functional CFTR, is that is has been shown 
to be a receptor for lipopolysaccharide (LPS) [29], a conserved component of 
bacterial cell walls and strong immunogenic factor. Functional CFTR may bind to 
LPS on pathogens and allow recognition and downstream immune responses to 
the pathogen [29]. In CF patients where this receptor is disrupted, this immune 
component is lacking and therefore the bacteria may thrive, as they are not 
recognised and eliminated.  
Studies have shown elevated IL-17 in sputum samples of CF patients colonized 
with P. aeruginosa [3, 5] indicating that IL-17 is produced in response to P. 
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aeruginosa infection in CF patients. IL-17 may contribute to host defence but 
this immune response is also potentially pathological in CF individuals, as IL-17 is 
known to aid in recruitment of neutrophils [3, 30] which cause inflammation and 
fibrosis in the lung to the detriment of the host. Conceivably IL-17 may 
responsible for the persistent neutrophilia in the airways of CF patients [5] and 
consequently inflammation. One study showed that IL-17 in CF lungs may prime 
airway epithelial cells to up-regulate pattern recognition receptors [30], thus 
increasing bacterial recognition and enhancing the inflammatory response. 
Therefore attenuation of IL-17 responses in CF individuals may be beneficial.  
1.4 Streptococcus pneumoniae 
S. pneumoniae is a Gram-positive pathogen, commonly referred to as the 
pneumococcus. It is a commensal pathogen of humans, usually found in the 
nasopharynx. It may spread from the nasopharynx and cause a variety of 
infections including meningitis and pneumonia, and is thought to be responsible 
for 20-60% of bacterial cases of community acquired pneumonias [31, 32]. The 
pneumonia suffered by S. pneumoniae infection is clinically not that much 
different from that of the pneumonia induced by P. aeruginosa infection, 
discussed earlier, though one key difference between S. pneumoniae and P. 
aeruginosa is that S. pneumoniae can infect healthy individuals. A further pitfall 
of S. pneumoniae infection is, like P. aeruginosa, strains of S. pneumoniae exist 
that are resistant to common antibiotics [32], making it a difficult pathogen to 
control. Due to its antibiotic resistance S. pneumoniae is also a prominent source 
of HAIs, and is thought to responsible for early onset infections as opposed to P. 
aeruginosa which is a caustive agent of late onset pneumonia [33]. 
1.4.1 Pneumolysin (PLY)  
Pneumolysin (PLY) is a toxin in S. pneumoniae that is very toxic to cells. It is a 
haemolysin, meaning it lyses red blood cells (RBCs), and is probably the most 
well studied of the pneumococcus virulence factors and is produced by a 
majority clinical isolates of S. pneumoniae [34]. PLY has been shown to induce 
CXCL8, a well known neutrophil attractant [35], from nasopharyngeal epithelia 
cells [36] and thus may play a role in neutrophil recruitment during S. 
pneumoniae infection in the lung. It has also been shown to be vital for 
  25 
secretion of cytokines dependent on caspase-1 activation such as IL-18 and IL-1β 
[37, 38], which is discussed in section 1.6.5 of this introduction. Infection of 
macrophages with PLY deficient S. pneumoniae mutants had significantly 
reduced secretion of these pro-inflammatory cytokines indicating importance of 
PLY in production of caspase-1 dependent cytokines [37]. Recognition of PLY is 
considered to be via an innate pattern recognition receptor (PRR) named Toll-
like receptor 4 (TLR4) [39], and this interaction is thought to be critical for 
immune responses to S. pneumoniae [39]. (TLRs and PRRs are described in 
greater depth later in the chapter). However recent studies have found that PLY 
is able to stimulate downstream production of pro-inflammatory cytokines in a 
TLR4 independent manner [40] and that the role of TLR4 in immune resistance 
to S. pneumoniae may be dose dependent [41]. Thus the roles of TLR4 and PLY 
interaction in S. pneumoniae infection remain to be fully elucidated.  
1.5 Defences to lung infection 
1.5.1 Barrier defences 
The lungs are organised in such a way to protect them from an invading 
pathogens. Such defensive features of the lung include mucus, and mucus 
clearance by the cilia of the lungs [42]. If these are impaired or the pathogen 
manages to overcome them, then the very make up of the cells in the 
conducting zone, the area of the respiratory system that is in contact with the 
outside world, acts as barrier. The epithelia of the lung are stratified and 
connected by tight junctions that are somewhat impermeable to pathogens [43]. 
Colonizing P. aeruginosa may overcome this however by secretion of toxins that 
break down plasma membranes in cells [44], leading to cell death. 
If in the instance that P. aeruginosa has colonised the lung by overcoming these 
defensive strategies then the innate, and eventually the adaptive, immune 
responses come into play.  
1.5.2 Innate immunity 
Innate immunity is the first arm of the immune system that a pathogen may 
encounter. It is broad and unspecific, acting against conserved pathogenic 
signals that can be found in many types of similar pathogens; for example 
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conserved components of cell walls in bacteria. These conserved components 
are called pathogen associated molecular patterns (PAMPs) and are recognised 
by PRRs, of which there are many types found on various cell types such as 
neutrophils, macrophages and epithelial cells. The most well-known of the PRRs 
are TLRs and NLRs (nucleotide oligomerization domain and leucine rich repeat 
containing proteins) discussed in more depth below.  
1.5.2.1 TLRs 
TLRs are the most ‘famous’, most studied and hence probably most well 
understood of the PRRs. TLRs are transmembrane spanning with an extracellular 
region of leucine rich repeats (LRR) which are used for recognition of PAMPs, and 
an intracellular TIR (Toll-like Interleukin-1 receptor like) domain, used for 
signalling and initiating of appropriate responses [45]. This intracellular toll-like 
region is also shared by IL-1R family, hence the name toll-like, interleukin-1-
receptor like domain. 
There are 10 TLRs in humans known to date, some extracellular, some 
intracellular, each with their own distinct ligand (see Table 1-1). 
Table 1-1 TLRs and examples of ligands 
TLR Ligand  
TLR1/2 Bacterial lipoprotein (BLP) from bacteria cell walls [46] 
TLR2/6 MALP-2 (macrophage activating lipopeptide) [46] 
TLR3 Double stranded RNA [46] 
TLR4  Lipopolysaccharide (LPS) [46] 
TLR5 Flagellin [46] 
TLR7/8 Single stranded RNA [46] 
TLR9 CpG DNA [46] 
TLR10 Unknown [46] 
With the exception of TLR3, all TLRs signal through the NFκB pathway [47] and 
thus may lead to induction of pro-inflammatory cytokines such as IL-6 [48]. 
Furthermore, TLR4 recognition of LPS by antigen presenting cells (APCs) such as 
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dendritic cells (DCs) leads to secretion of IL-23 [49], an important cytokine for 
maintenance of IL-17 secreting cells as discussed in section 1.6.4.  
1.5.2.2 NLRs 
NLRs are the main intracellular sensors of bacterial PAMPS and include 
Nucleotide-binding oligomerization domain-containing protein 1 (Nod1), Nod2 
and NLRC4, whose ligands are illustrated in Table 1-2. 
Table 1-2 NLRs and examples of ligands 
NLR Ligand  
NOD1 (NLRC1) γ-D-glutamyl-mesodiaminopimelic acid containing peptide from 
Gram-negative and some Gram-positive bacteria [50] 
NOD2 (NLRC2)  Muramyl dipeptide (MDP) [50] 
NLRC4 Flagellin [50] 
NLRP3 PLY [51] 
NLRs are composed of 3 structures, 2 of which are conserved among the NLRs- a 
C terminal LRR (like TLRs) for recognition of bacterial products, and a central 
NOD domain that mediates self-association. The NLRs vary in their N terminal 
structure which may be either a pyrin domain (PYD) and the subsequent NLR is 
named a NLRP; a caspase activating and recruitment domain (CARD) named 
NLRC; or a baculovirus inhibitor of apoptosis protein repeat (BIR), named NLRB 
[52], as well as others. 
1.5.2.3 Neutrophils 
Neutrophils are granular multi-lobed nucleated cells that are one of the first 
cells to be recruited to a site of infection. They are known to have a major role 
in bacterial pneumonia [53] and considered to be a hallmark indicator that the 
disease is present [54]. Neutrophils have been found to be indispensible in P. 
aeruginosa disease as it has been shown that in neutrophil depleted animals 
there is excessive mortality upon P. aeruginosa infection [55].  
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Neutrophils provide several bacteriocidal components to provide protection 
during bacterial infection such as proteinases [56] and defensins [57]. 
Neutrophils also provide lactoferrin, a bacteriocidal component that scavenges 
iron [58], thus depleting the pathogens source of this element, required for P. 
aeruginosa proliferation. Neutrophils are not the sole source of lactoferrin, as 
epithelia cells are known to secrete it also [59]. 
Neutrophils are recruited to the lung by chemokines, chemotactic cytokines 
which may be named CC or CXC depending on their spacing of cysteine residues. 
Chemokines act with adhesion molecule and intergrin interactions to allow the 
neutrophils to enter the airspace. Recognition of pathogens with PRRs such as 
TLRs lead to downstream production pro-inflammatory cytokines, which may 
include CXCL8 [59, 60], from cells in the bronchiole space and thus recruitment 
of neutrophils into the lung. It has recently been shown that IL-17 can also 
induce production of CXCL8 [61] and thus Th17 cells may be a candidate for 
upstream initiation of neutrophil recruitment in the lung.  
1.5.2.4 Epithelial cells 
As discussed epithelial cells are important at providing a tight barrier to lung 
invading pathogens, however epithelial cells are not just barrier cells but 
provide innate immune responses also. Epithelia cells express TLRs [59], and this 
leads to downstream activation of NFκβ pathway and production of various 
inflammatory cytokines such as TNFα, IL-1β, IL-6 [47] and chemokines such as 
CCL5 (RANTES) and CCL2 (MCP-1) [62].  TNFα, IL-1β, IL-6 are pro-inflammatory 
cytokines that play various role in infection and inflammatory responses, and 
CCL5 and CCL2 are known to recruit leukocytes to the site of inflammation. 
Essentially, engagement of TLRs on epithelia cells leads to robust localised 
inflammatory responses. Epithelial cells also secrete anti-microbial products 
such as β defensins and lactoferrin, which inhibit bacterial growth [59]. 
1.5.2.5 Macrophages 
Macrophages are the resident leukocyte of the lung alveoli as can be observed by 
histology of uninfected animals and are so named alveolar macrophages (AMs). 
They act as scavengers in the lung, patrolling the tissue and phagocytosing 
foreign material [63]. Macrophages are not only innate effector cells but APCs 
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[64], cells which collect ‘debris’ in the tissue and carry it to immune sites to 
present to T cells. If the T cells do not recognise and respond to the presented 
‘debris’ then the macrophage carries on its scavenging, however if the 
macrophage presents to a T cell something which it recognises, a cascade of 
responses are initiated inducing the adaptive immune response, making 
macrophages key to the branch of innate and adaptive immunity.  
The role of alveolar macrophages during P. aeruginosa pneumonia appears to 
differ upon time point during infection. Studies have shown that early on in 
infection, approximately 8 hours, AMs contribute to neutrophil recruitment and 
associated tissue destruction. Thus deletion of AMs abrogates this deleterious 
effect [65]. This would make blockade of AMs an attractive prospect in the first 
few hours of infection. However, it appears that lack of AMs in the long term 
reduces long term survival of P. aeruginosa infected animals [65]. These findings 
indicate the AMs play a key role in animal survival during P. aeruginosa induced 
pneumonia. 
1.5.3 Adaptive immunity 
1.5.3.1 Antibodies 
Antibodies (Abs) have been shown to be made in response to P. aeruginosa  
infection [66] but it appears that these Abs alone are not enough to allow 
bacterial clearance [66]. It has in fact been suggested that the humoral response 
to P. aeruginosa  in CF individuals could have adverse effects and actually be 
detrimental to lung function and therefore worsen clinical outcome [67]. 
However, it is also thought that anti-pseudomonal Abs play a role in prevention 
of systemic spread of P. aeruginosa impeding bacteraemia and sepsis [54]. 
1.5.3.2 T cells 
The role of T cells in P. aeruginosa infection is at present unclear though many 
are attempting to elucidate the roles of various T cells during this infection[68-
70]. It is the purpose of our study to look at T cells during P. aeruginosa 
infection, specifically IL-17 producing T cells, both conventional αβ T cells and 
‘unconventional’ γδ T cells, investigating if they do in fact have a role in P. 
aeruginosa infection and if so is that role indispensible. 
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1.6 Interleukin 17 (IL-17) 
IL-17 is a pro-inflammatory cytokine of which there are several family members, 
named IL-17A-F, with varying sources listed in Table 1-3. 
Table 1-3 IL-17 family members and their sources 
IL-17 family member 
Homology 
between murine 
and human 
Secreted by 
IL-17A (IL-17) 62% 
Th17 cells [71] 
γδ T cells [72] 
Neutrophils [73, 74] 
CD8 cells [49, 75] 
iNKT cells [76, 77] 
mast cells [73] 
LTi-like cells [78] 
IL-17B 88% 
Chondrocytes [79] 
Neurons [80] 
IL-17C 83% Epithelial cells in psoriasis [81] 
IL-17D 78% Unknown 
IL-17E (IL-25) 81% 
Th2 cells [82] 
 Mast cells [83]                     
Eosinophils and Basophils [84]    
IL-17F 77% As IL-17A [85] 
IL-17A is simply referred to as IL-17, and was the founding member of the family 
and probably the best understood. IL-17F is the closest family member to IL-17A, 
sharing 50% identity [86]. They are thought to have similar functions, but to bind 
with different affinity to their receptor, as discussed in the next section. IL-17 
presence is observed in many extra-cellular bacterial infections [87, 88], 
autoimmune diseases [81, 89, 90], and is associated with inflammation. Some of 
the downstream targets of IL-17 are up-regulation of pro-inflammatory 
chemokines such as CXCL1 and CXCL8 [3, 61]; up-regulation of pro-inflammatory 
cytokines such as IL-1β and IL-6, and the colony stimulating cytokines G-CSF and 
GM-CSF [91], and up-regulation of anti-microbial peptides such as β defensins 
and mucins [92, 93]. These all contribute to the attraction and generation of 
immune cells and aid in inflammation. The role and source of each element up-
regulated by IL-17 during lung infection is described more thoroughly in Table 
1-4. 
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Table 1-4 Targets of IL-17, and their effects on immune response s 
Downstream IL-17 target 
(and aliases) 
Effect on immune response during lung infection 
CXCL1 (melanoma growth 
stimulating activity, alpha 
(MSGA-α)) 
Chemokine with neutrophil attracting and 
activating properties [35] 
CXCL8 (IL-8, Monocyte-
derived neutrophil 
chemotactic factor (MDNCF)) 
(Mouse functional homolog MIP2) 
Chemokine that is a potent neutrophil 
chemoattractant [94] 
IL-1β Pro-inflammatory cytokine with roles in cell 
migration, cell differentiation and fever [95] 
IL-6 Involved in acute phase response [96] and Th17 
differentiation [97] 
Granulocyte colony 
stimulating factor (GCSF) 
Regulates neutrophil release from the bone marrow 
[98], enhances cytotoxicity of neutrophils[99] 
Granulocyte-macrophage 
colony stimulating factor  
(GM-CSF) 
Neutrophil activating factor [100], enhances 
cytotoxicity of neutrophils [99] 
α-defensins Peptides from neutrophils with microbicidal 
properties [101] 
Mucins Component of mucus and mucus secretion and 
therefore physical trapping and eradication of 
pathogen [93] 
The family member IL-17E, also known as IL-25, actually acts to inhibit IL-17 
production from IL-17 producing cells and so is a negative regulator. It does via 
downstream blocking of the cytokine IL-23 [102] which is known to be important 
for IL-17 producing cell maintenance and is discussed in section 1.6.4 of this 
chapter. IL-17E treatment is linked to expression of IL-13, an anti-inflammatory 
Th2 cytokine, which in turn blocks DC secretion of IL-23, therefore hindering IL-
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17 producing cell population survival [102, 103]. IL-17E has Th2 associations, 
perhaps further evidence of its IL-17/Th17 cell negative regulation properties as 
Th2 cells are known to compete with and negatively regulate Th1 and Th17 cells 
as they originate from the same precursors.  The main sources of IL-17E 
considered to be memory Th2 cells [104], mast cells [83], eosinophils and 
basophils [84]. 
Recent studies have identified IL-17C as having a role in innate immune 
functions of epithelial cells [86] and regulation of Th17 cells in the auto-immune 
disease experimental autoimmune encephalomyelitis (EAE) [77] a mouse model 
of multiple sclerosis (MS). 
Far less is known about the remaining IL-17 family members IL-17B and D. These 
molecules are much less studied and at present their functions are unknown. 
1.6.1 IL-17 receptors 
IL-17 signals through the IL-17 receptor (IL-17R). Although the term IL-17R is 
commonly used this is not just one structure, but a dimer composed of 2 units 
from a possible family of 5 subunits name IL-17RA-E, which are listed with the 
cells that they are expressed on in Table 1-5. 
Table 1-5 IL-17 Receptor family members and their cells of expression  
IL-17 receptor unit Found on Binds to 
IL-17RA Most cell types studied to 
date [105] 
IL-17A 
IL-17RB (IL-25R) Th9 cells [106] 
Th2 cells [84] 
iNKT cells [107] 
basophils [108] 
IL-17E (IL-25) 
IL-17RC Adipocytes [105] 
Chondrocytes [105] 
Epithelial cells [105] 
IL-17A, IL-17F 
IL-17RD Epithelial and endothelial 
cells [109] 
unknown 
IL-17RE Epithelial cells [86] IL-17C 
IL-17A signals through a heterodimeric complex of IL-17RA and IL-17RC. IL-17F 
also signals through this receptor complex, but IL-17A is known to respond more 
vigorously than IL-17F [110]. This IL-17RA/RC dimer is commonly referred to as 
IL-17R. It can be found on epithelial cells and fibroblasts [105] and so is an ideal 
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candidate for immune responses in the lung. In fact IL-17RA is claimed to be on 
all cells [105] so the potential for IL-17 signalling on all cells exists. Mice lacking 
in IL-17R have reduced G-CSF, reduced neutrophil recruitment, greater bacterial 
burden and thus a higher rate of fatalities following infection [61] indicating that 
IL-17 signalling is vital during infection. 
IL-17E signals via a complex of IL-17RA and IL-17RB, also known as IL-25R. IL-
17RB can be found on Th2 cells [84] and basophils [108] and so IL-17E appears to 
act on the cells it secretes, possibly indicative of a positive feedback loop.  
1.6.2 IL-17 in infection and disease 
IL-17 has major roles in infection and disease and seems to be a key player in 
many autoimmune diseases that were once considered to be Th1 dominated, 
such as rheumatoid arthritis (RA) [89]. Studies have shown IL-17 to be very 
important in anti-microbial responses such as Staphylococcus aerus [111] and 
Klebsiella pneumoniae [87, 112]. It was the role of IL-17 in these bacterial 
responses which has led us to investigate the role of IL-17 in P. aeruginosa 
infection, for if there is a similar IL-17 requirement for host survival and 
bacterial clearance, this quality could be utilized with administration of IL-17, or 
IL-23 to bolster IL-17 responses, during infection. 
1.6.3 Cellular sources of IL-17 
There are both innate and adaptive cellular sources of IL-17 which respond in 
different manners to different stimuli. Innate IL-17 secreting cells such as γδ T 
cells produce IL-17 in a fast non-specific manner with no specific antigen 
recognition. They respond to cytokines produced by activated DCs, or ligation of 
PRRs on their surface. Adaptive responses are pathogen specific, require 
presentation and co-stimulation by APCs and initially take longer to develop, but 
respond rapidly upon re-infection with the specific pathogen. Both the innate 
and adaptive IL-17 sources are discussed below. 
1.6.3.1 Th17 cells 
Th17 cells are CD4+ helper T cells that characteristically secrete IL-17 and IL-22 
[71]. They are adaptive immune response cells identified as being IL-17 and IL-22 
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secreting, CD4+, CD3+ IL-23R+, positive for the transcription factor RORγt [113], 
and aryl hydrocarbon receptor (AhR) [114]. AhR is a cytosolic transcription factor 
that has been shown to be involved in Th17 cell development [115]. Th17 cells 
are thought to have many roles in disease such as RA [89] and are appearing 
evidently more important in bacterial infections [111]. As the name suggests, 
they can ‘help’ other immune cells and responses. Th17 cells have been shown 
to aid B cell responses aiding in B cell proliferation and antibody class switching 
[116]. However, their main role is in IL-17 secretion, which is the focus of this 
thesis. 
1.6.3.1.1 Development of Th17 cells 
Th17 cells are thought to be induced from the same Th0 CD4+ helper T cell 
precursor as that of the better known Th1 and Th2 cells. Induction of these cells 
to their helper class is under the influence of various cytokines. IL-12 and IFNγ 
induce Th1 cells [117], IL-4 induces Th2 cells [118]. The process of Th17 
induction is only somewhat understood with differing roles for different 
cytokines found in humans and mice. Typically 3 cytokines are regarded to be 
inducers of Th17 cells; TGFβ, IL-6 and IL-1β. In mice TGFβ and IL-6 are thought 
to have the main roles in Th17 cell induction [97, 119, 120] with IL-1β believed 
to enhance the Th17 development from naive CD4+ precursors [121]. However 
there is now evidence that all 3 cytokines are not necessary, as Ghoreschi et al 
show that Th17 cells can be induced in the absence of TGFβ signalling [122]. In 
humans the process is less well understood with suggestions that Th17 
development in humans is donor dependent [123]. IL-17 has been observed from 
naive CD4+ cells under the influence of IL-1β and IL-6 but not TGFβ [124]. 
However studies in humans show that TGFβ contribution to Th17 induction may 
be dose dependent with doses of approximately 10ng/ml allowing Th17 induction 
in combination with pro-inflammatory cytokines, but doses such as 50ng/ml 
inhibiting Th17 [125] and allowing for regulatory T cells (Tregs) instead. Other 
studies show that other pro-inflammatory cytokines such as IL-21 may play a role 
in Th17 cell generation in humans [125]. It is clear from previous studies that 
there are differences in Th17 development in humans and mice with IL-1β 
looking to play an important role in humans but less so in mice.  
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A key difference in Th17 cell induction compared to that of Th1 and Th2 is that 
it appears to be plastic. Once Th1 and Th2 cells are committed they remain that 
class of cell even upon exposure to cytokines that induce other helper T cell 
phenotypes such as TGFβ and IL-6 that induce Th17 cells [126]. However, Th17 
cells can be switched, in vitro, to become Th1 cells upon exposure to Th1 
inducing cytokines such as IL-12 [127], though this may be an artefact of in vitro 
culture where all biological IL-17 cell inducing and maintenance factors are not 
present. There is evidence that Th17 cells have the capacity to remain plastic in 
vivo under certain conditions [126, 128] and that the capacity for a Th17 cell to 
change its fate depends on the type of infection, whether it is acute or chronic, 
and the speed of resolution of infection [128]. In a study of EAE, it was shown 
that Th17 cells down-regulate their IL-17A production and up-regulate 
production of IFNγ, in what appears to be an IL-23 dependent manner [128]. It 
was shown that IL-23p19 deficient mice lacked IFNγ+ cells and displayed reduced 
T-bet [128], a transcription factor considered necessary for Th1 induction. This 
indicates that Th1 cell formation may be IL-23 dependent in this circumstance. 
This IL-23 dependent switch to a Th1 like cell is interesting as IL-23 is thought to 
enhance Th17 responses and has been shown to allow IL-17 secretion from γδ T 
cells in combination with IL-1β [129] (discussed in section 1.6.4). Thus it is 
remarkable that IL-23 may have such a role in IL-17 secreting cell maintenance 
but may also switch its phenotype to IFNγ producing under certain conditions.  
Another interesting difference is that the signature cytokines that Th1 and Th2 
cells secrete, IFNγ and IL-4 respectively, directly have positive feedback on 
themselves and limit the induction of the other phenotypes, whereas IL-17 
production from Th17 cells is not known as yet to amplify Th17 cells directly, or 
to limit Th1, Th2 or Tregs. However, IL-21 secreted from Th17 cells acts in an 
autocrine manner to amplify Th17 cells [130]. This paradigm is illustrated below 
in Figure 1-1. 
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Figure 1-1 Helper T cell paradigm 
Signature cytokines of Th1 and Th2 feedback directly on themselves to amplify their own cell type 
and block formation of other helper T cell. IL-17 has not as yet been shown to have similar direct 
abilities. 
Another factor that distinguishes Th17 cells from other CD4+ T helper subsets is 
the expression of transcription factor RORγt. Transcription factors T-bet and 
GATA3 are expressed in Th1 [131] and Th2 [132] cells respectively, whereas 
RORγt  is expressed in Th17 cells. Expression of RORγt is said to be essential for 
production of Th17 cytokines IL-17A, IL-17F, IL-21 and IL-22, and RORγt 
expression is adequate to induce expression of these cytokines from the cells 
[133].  
1.6.3.2 γδ T cells 
γδ T cells are ‘innate like’ T cells found mainly at mucosal sites. They have been 
mostly studied in the gut but they are important in the lung also having been 
found to reside in the subepithelium of the alveolar and non-alveolar regions of 
the lung [134]. Th17 cells have previously been considered to be the trademark 
IL-17 producing cell, yet it has been shown that there are instances where γδ T 
cells are the main source of IL-17, for example in Mycobacterium tuberculosis 
[135], Staphylococcus aureus [111] and E.coli [136]. Thus γδ T cells must be 
considered as an important source of IL-17. γδ T cells have been described as 
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either IL-17A alone expressing or dual expressers of IL-17A and IL-22 [72] akin to 
Th17 cells. Further to this, γδ T cells that produce IL-17 bear other similarities 
to Th17 cells; they are both positive for the transcription factor RORγt and have 
IL-23R on their surface along with AhR [72]. What sets γδ T cells apart from 
conventional αβ T cells is that they have PRRs on their surface and thus do not 
need antigen presentation from another cell, allowing responses to be faster. 
TLR2, a receptor for BLP, which is a component of Gram-positive bacteria cell 
walls, has been found on the surface of γδ T cells, as has dectin-1 [72], a 
receptor for β glucans, molecules found in plants, yeast and fungi. IL-17+ γδ T 
cells can also produce IL-17 in a fast antigen independent manner, with CD3 
ligation of the T cell receptor (TCR) being enough stimuli for a γδ T cell to 
secrete IL-17 [137]. Furthermore IL-1β and  IL-23 binding to their receptors on 
these cells is enough to allow IL-17 secretion in the absence of any engagement 
of CD3 [129]. 
αβ T cells have CD markers on their surface which identify them as CD4+ helper 
T cells or CD8+ cytotoxic T cells, and these CD markers ligate respectively to 
major histocompatability complex II (MHCII) and MHCI [138] on APCs when they 
recognise specific antigen presented via these MHC molecules. This process is 
vital for naive T cell induction of an immune response and occurs in an antigen 
specific manner. γδ T cells are mainly CD4- and CD8- [139] and thus do not 
recognise antigen in the typical way via MHC and APCs. As discussed they have 
PRRs on their surface and so may recognise antigen directly [72], eliminating the 
need for APCs. This saves time during the immune response as they can respond 
a lot faster than other T cells and are therefore thought to be more of an innate 
like cell. However, γδ T cells express CD62L (L-selectin) on their surface when 
they are inactivated which is down-modulated upon detection of certain stimuli 
[140, 141]. CD62L is an adhesion molecule found on naive lymphocytes which 
acts as a lymphoid homing receptor, responding to various ligands such as 
GlyCAM-1 [142], allowing naive lymphocytes to home to secondary lymphoid 
structures such as the lymph nodes. In these secondary lymphoid structures the 
naive lymphocyte may meet its corresponding antigen and become an effector 
cell, down-regulating its CD62L expression, as it no longer needs to home to 
these sites. Thus presence of CD62L is generally regarded as a marker of naive T 
cells, and consequently cells that lack CD62L are memory T cells. Due to the 
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presence and down-modulation of this molecule it could be suggested that γδ T 
cells are an adaptive cell type. CD44 is another cell marker commonly used to 
identify naive and memory cells. It is a cell surface glycoprotein that is known to 
be involved in cell to cell interactions and participating in lymphocyte activation 
and so is regarded as a marker for memory cells [143]. IL-17 producing γδ T cells 
have been shown to be CD44+ [144] further classifying them as a memory cells 
and therefore an adaptive cell as opposed to an innate cell. Thus it is difficult to 
categorize γδ T cells fully, though due to their ability to recognise antigen 
directly and respond in a fast non-specific manner, they behave more like an 
innate like T cell. 
In αβ T cells the T cell receptor (TCR) is important during development of 
functional T cells in the thymus, but the γδ TCR may not play such a role in 
functional γδ T cell development. Developing  αβ T cells in the thymus that 
recognise self antigen via their TCR and MHC molecules with high affinity are 
deleted as they would be self-reactive, a process known as negative selection 
[145, 146]. T cells that recognise antigen with moderate avidity are rescued 
from this deletion in a process known as positive selection, and proceed into the 
periphery [145-147]. The role of the γδ TCR and antigen recognition in 
development appears to differ however. γδ T cells are created regardless of 
whether they recognise antigen or not, but it appears those that do recognise 
antigen in the thymus are IFNγ producing γδ T cells, and those that are antigen 
naive are IL-17 producing γδ T cells [137]. Unlike αβ T cells that have TCRs with 
a vast repertoire of recognition, γδ TCR range of recognition is more reduced 
and scarcely understood [148] and this limited scope of recognition further 
likens them to innate cells. 
1.6.3.3 Other sources of IL-17 
There are many other cells that secrete IL-17 under different conditions 
including CD8 T cells [49, 75], neutrophils [73, 74], NKT cells [77, 149], mast 
cells [73, 150] and LTi-like cells [78]. LTi cells are lymphoid tissue inducer cells 
that are important in lymphoid organogenesis during foetal development. They 
express the transcription factor RORγt [151, 152], which made them subject of 
investigation in relation to IL-17, yet are negative for CD3 [153] and hence are 
not T cells. In adults cells exist that are phenotypically similar to LTi cells and 
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are termed LTi-like cells. LTi-like cells exist in the spleen that bear a similar 
profile Th17 cells. They produce IL-17 and IL-22, express RORγt, and have IL-23R 
and AhR on their surface [78]. LTi-like cells have been shown to secrete IL-17 
when exposed to IL-23 [78] further confirming the role of IL-23 in stimulation of 
IL-17 secreting cells which is discussed in more depth below. Invariant NKT cells 
(iNKT) cells have been shown to be a source of IL-17 in neutrophillic 
inflammation [76, 77] and may have thus may have roles during P. aeruginosa  
and S. pneumoniae lung infections, though these cells are not investigated in 
this thesis. 
1.7 IL-23 
IL-23 is a pro-inflammatory cytokine that is known to amplify IL-17 responses in 
both αβ [154] and γδ [129] T cells. Amplification of CD4+ Th17 cells in response 
to IL-23 requires engagement of their TCR [129]. γδ T cells however, produce  
IL-17 in response to IL-23 in combination with IL-1β, in the absence of  TCR 
engagement [129], further confirming γδ T cells ability to secrete IL-17 in a non-
specific manner. Additionally, IL-23 also aids in γδ T cell survival [72, 155]. 
Although IL-23 is classically known to enhance Th17 responses, there is evidence 
that IL-23 may also have roles in driving Th17 cells to be IFNγ secreting under 
certain conditions [128], and therefore the role of IL-23 during Th17 responses 
requires further study. 
IL-23 is composed of two subunits, IL-23p19 and IL-12p40 [156]. As the name 
suggests, IL-12p40 is a subunit of the Th1 inducing cytokine IL-12, along with IL-
12 subunit IL-12p35 [157]. It is this sharing of the IL-12p40 subunit that caused 
confusion of IL-12 and thus Th1 cells role in disease where IL-23 and Th17 cells 
were responsible. For years studies suggested that IL-23 was necessary for Th17 
cell induction, but this is not the case. IL-23 is essential for Th17 cell population 
maintenance, but not its induction [154]. Thus the importance of IL-23 in 
maintaining a functional Th17 cell population makes presence of IL-23R on their 
cell surface another characteristic of Th17 cells. 
In P. aeruginosa lung infection, IL-23 has been shown to regulate airway 
inflammation but it appears it is not required for control of bacterial infection 
[158]. This was demonstrated using IL-23p19-/- mice where lack of IL-23 reduces 
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pro-inflammatory cytokines and chemokines in the airspace, but shows no 
difference in bacterial dissemination [158]. The source of IL-23 in infection is 
mainly thought to be macrophages and DCs, with IL-23 production from DCs 
shown to be TLR dependent, shown using mice with dysfunctional TLR4 signalling 
[49]. 
In the lung, AMs have been shown to be a source of IL-23 [159] and so these cells 
may be of great importance at inducing IL-17 responses to P. aeruginosa in the 
lung. 
1.8 IL-1β  
IL-1β is a pro-inflammatory cytokine produced by macrophages and DCs, and is 
considered the hallmark cytokine of inflammation. It is a member of the IL-1 
superfamily which includes the members IL-1α, IL-18, IL-33 and IL-36. These 
other members will not be discussed further.  
IL-1β has been suggested to contribute to the induction of IL-17 response in 
humans [124] and enhancement of IL-17 responses in mice [121]. IL-1β exerts its 
effects through binding to its receptors, IL-1R, of which there are 2, named type 
I and type II. IL-1RI is a functional receptor, whereas IL-1RII is non-functional 
and thus acts as a decoy receptor [160]. Upon ligation of IL-1β and IL-1RI, a 
further molecule is recruited to site, known as IL-1RAcP. Together these 3 
molecules make a functional signalling complex that recruits MyD88 and 
downstream phosphorylation of NFκβ, leading to transcription of pro-
inflammatory cytokines [47]. Thus IL-1β is just the first cytokine in a cascade of 
inflammation. 
As IL-1β is so inflammatory there are natural measures in check to prevent its 
constant assault. One is the 2 step process of its release, as discussed in the next 
sub-section detailing inflammasome activation. This is a failsafe method to make 
sure IL-1β is only released when there are both extra and intracellular signals 
indicating a real threat, and therefore signifies an actual assault on the host 
cell. A further method is the expression of IL-1RII on cells, mentioned briefly 
previously. This receptor lacks the TIR signalling domain and therefore lacks any 
downstream signalling of the IL-1β molecule [160]. It acts as a decoy receptor 
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and essentially ‘mops up’ any left-over cytokine. A third measure is the presence 
of further IL-1 superfamily member that is a naturally occurring IL-1β receptor 
antagonist (IL-1Ra). IL-1Ra binds to IL-1R, preventing binding of IL-1β to its 
functional receptor and thus abrogating any signalling [161, 162]. These 
measures have all been put in place naturally by the immune system and thus 
demonstrate the robust and inflammatory nature of an IL-1β response if it must 
so be kept in check.  
1.8.1 Inflammasome and IL-1β secretion 
The processing and secretion of IL-1β is a complex process that involves 2 
necessary steps: the production of the pro-form of IL-1β and then the cleavage 
and activation of pro-IL-1β into mature IL-1β. 
The first step involves ligation of a PRR such as a TLR, which leads to production 
of pro-IL-1β in the cell [163]. As illustrated previously in Table 1-1 there are 
many different TLRs that recognise different pathogenic components, allowing 
formation of pro-IL-1β to a multitude of pathogens. This accumulates in the cell 
waiting to be cleaved by active caspase-1, when a true threat is encountered. 
The second step involves caspase-1 activation from pro-caspase-1, by a complex 
called the inflammasome. The inflammasome is activated by an intracellular PRR 
such as an NLR [164]. There are many types of inflammasome, reflected by their 
differing NLRs, thus allowing many bacteria types to activate the inflammasome, 
activating IL-1β and initiating inflammatory responses when needed [165]. Thus 
both extracellular and intracellular PRRs are important for IL-1β secretion. 
Furthermore, the inflammasome can be activated by endogenous factors such as 
ATP binding to the P2X7 receptor [166]. 
1.8.1.1 The inflammasome 
The inflammasome is an intracellular complex composed of several proteins that 
leads to the eventual release of active IL-1β via activation of casapse-1. The 
inflammasome is complied of various proteins such as a protein called ASC 
(apoptosis-associated speck like protein containing a CARD (caspase recruitment 
domain)), the pro-form of caspase-1, and an intracellular PRR for example an 
NLR. This is illustrated below in Figure 1-2. 
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Figure 1-2 The inflammasome.   
A complex of proteins composed of pro-caspase-1, an NLR and ASC 
Together this complex acts as an intracellular sensor of bacterial invasion, and a 
response unit. Essentially a bacterial component is recognised intracellularly by 
an NLR in the inflammasome complex, and this leads to cleavage of pro-caspase-
1 into its active form caspase-1. Caspase-1 is then able to cleave the pro-form of 
IL-1β that exists in the cell, produced upon TLR stimulation, into active IL-1β 
and allow its secretion from the cell. This full process is diagrammed below 
(Figure 1-3). 
 
Figure 1-3 IL-1β processing by the inflammasome  
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1.8.2 Type III secretion system (T3SS) 
Gram-negative bacterial strains have a number of systems in place to aid them 
with secretion of their toxins and virulence, named secretion systems of which 
there are 6 [167], numbered by roman numerals. P. aeruginosa has a type III 
secretion system (T3SS) that allows attachment of the bacteria to host cells and 
injection of toxins such as ExoU and ExoT [168]. The T3SS is a needle like 
complex, called the injectisome, that is composed of an extracellular needle 
and a base of circular rings that spans the bacterial membrane [169]. This is 
illustrated in Figure 1-4 
 
Figure 1-4 Schematic representation of the type III secretion system 
The injectisome is said to have evolutionary similarities to the flagella of 
pathogens [170], a external tail like structure that allows motility [171]. The 
T3SS is one of the ways P. aeruginosa exerts its pathogenic effects by allowing 
attachment of the pathogen to host cells and passing effector toxins through 
three membranes, two of the bacteria and one of the host. Passage of these 
toxins into the host allows them to take effect within the host cells destroying 
host cell membranes [44], while subverting host responses such as phagocytosis 
[23]. Phagocytosis of bacteria by host cells, although an immune response 
protective mechanism, also allows entry of the effector toxins into host cells 
where they may exert pathogenic effects, yet this would not occur in non-
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phagocytic cells. Thus the T3SS is an important virulence factor for bacteria as it 
allows pathogens to get into these non-phagocytic host cells and exert their 
harmful effects [170]. However, during this process the pathogen unknowingly 
allows passage of conserved proteins that are not harmful to the host such as 
flagellin, the protein component of flagella. These conserved proteins are 
recognised by intracellular PRRS in the host, for instance flagellin is recognised 
by NLRC4 [50], thus allowing the host to respond to the pathogen assault. This 
then may lead to inflammasome activation.  
1.9 IL-22 
IL-22 is a cytokine that is a member of the IL-10 family [172] that is also thought 
to be characteristically secreted by Th17 cells and thus is associated with IL-17 
secretion. IL-22 is helical in structure and binds to a receptor composed of 2 
subunits, IL-22R1 and IL-10R2, a IL-10 receptor subunit [173]. Human and mouse 
IL-22 share 79% homology [174]. A soluble receptor for IL-22 also exists, named 
IL-22 binding protein (IL-22BP) [175, 176]. As it is soluble it does not lead to any 
downstream IL-22 effects and thus is an antagonist to IL-22 signalling. IL-22R1 is 
found on non-lymphoid tissues such as the skin, small intestine, colon, liver and 
kidneys, but is absent on lymphoid tissues such as the thymus and spleen [177]. 
Furthermore IL-22R expression is not be found on of peripheral blood 
mononuclear cells (PBMCs), the pool of cells in the blood where immune cells 
reside [177], indicating that IL-22 does not exert effects on immune cells.  
1.9.1 IL-22 Functions 
IL-22 is thought to be a tissue protective cytokine, aiding in regeneration of 
epithelia [178] and has been shown to protective roles during a model of 
hypersensitivity pneumonitis by inhibiting excessive lung fibrosis [179]. IL-22 is 
thought to exert these tissue repair effects via increased expression of pro-
survival molecules Bcl-2 and Bcl-xl, increased production of genes muc1 and 
muc3 that contribute to mucus production, and increased production of matrix 
metalloproteinases, enzymes that break down the extracellular matrix and have 
roles in tissue remodelling [180]. 
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Evidence does exist however for a pro-inflammatory role for IL-22. For example 
it has been shown to increase transcription of inflammatory genes in 
hepatocytes (liver cells) during hepatitis B virus infection [181]. High IL-22 is 
seen in those with psoriasis and it is IL-22 that is thought to be responsible for 
the pathological inflammation in the skin of these individuals [182]. IL-22 also 
been shown to be the driving cytokine in bleomycin induced lung injury as 
blockade of this cytokine prevents further injury, indicating another pro-
inflammatory role for IL-22. This study proposes that the pro-inflammatory 
activities of IL-22 are regulated by IL-17 and in the absence of IL-17, IL-22 
promotes tissue repair [183]. Thus the role of IL-22 as a tissue repair or 
inflammatory cytokine appears to be dictated by the surrounding cytokine 
milieu. Its role in bacterial infection seems to be that of protective function, 
with IL-22 being responsible in host defense during, Klebsiella pneumoniae 
infection [112]. It may possibly have a similar function in P. aeruginosa 
infections, and it has been shown that there is increased IL-22 from T cells found 
in lung draining lymph nodes in CF patients with P. aeruginosa infection [112]. 
1.9.2 Cellular sources 
As with IL-17 it appears there are several sources of IL-22, albeit perhaps not as 
many as IL-17. The main regarded source of IL-22 has traditionally been Th17 
cells but there has been evidence in recent years to shed light on other cells 
that have IL-22 producing capabilities. 
1.9.2.1 Th17 
As stated Th17 cells are a widely known source of IL-22, with Th17 cells 
regarded as both IL-17 and IL-22 producing [71]. However there is evidence of a 
CD4+ helper T cell subset that produces IL-22 but is IL-17 negative. These cells 
have been aptly named Th22 cells and are discussed below. 
1.9.2.2 Th22 
10 years ago Th17 cells were discovered and proclaimed as a source of IL-22 
also, but recently papers have described a CD4+ cell that secretes IL-22 but not 
IL-17 [184, 185]. These cells have been identified in the skin of individuals with 
inflammatory skin disorders such a psoriasis [186]. It was already known that IL-
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22 played key role in such disorders but was assumed to be from Th17 cells. The 
emergence of this new subset identifies a cell type with the anti-inflammatory 
properties of a Th17 cell but lacking the pro-inflammatory properties of IL-17 
(although IL-22 can be pro-inflammatory also under certain circumstances 
discussed earlier). In Th17 cell dominated infection and disease this may be a 
cell that could regulate Th17 cell inflammatory responses.  
1.9.2.3 γδ T cells 
γδ T cells are also a source of IL-22, with evidence seen of IL-22+ IL-17+ γδ T 
cells [72]. It has been observed during infection with Bacillus subtilis, that in the 
absence of γδ T cells, IL-17A levels remain the same due to compensation of 
Th17 cells but IL-22 levels are reduced, indicating that γδ T cells are an 
important source of IL-22 [179]. 
1.9.2.4 Other sources of IL-22 
IL-22 can be made by other cells such as natural killer (NK) cells [187] and the 
afore mentioned LTi-like cells [78], but these are not investigated and thus not 
discussed further. 
1.10 Hypothesis and aims 
Hypotheses of the project are as follows:  
1. DCs are activated by P. aeruginosa and S. pneumoniae to secrete 
cytokines that may contribute to Th17 cell responses, and mucosal DCs 
may respond more genuinely in vitro than artificially derived DCs in 
response to mucosal pathogens P. aeruginosa and S. pneumoniae. 
2. P. aeruginosa and S. pneumoniae primed DCs that produce IL-1β and IL-23 
contribute to generation of Th17 responses from naive CD4+ T cells and ex 
vivo mucosal DCs may induce more long-lasting Th17 responses than 
artificially derived DCs from bone marrow progenitors 
3. γδ T cells produce IL-17 in response to DC derived cytokines in a DC 
independent manner. 
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4. IL-17+ cells may be pronounced in the lung and surrounding areas during 
P. aeruginosa and S. pneumoniae infection and that IL-17 may be 
responsible for neutrophil recruitment in these spaces.  
The overall objectives of this research will be to:  
1. Investigate the best method of DC induction from bone marrow 
progenitors, and use these DCs to investigate IL-1β and IL-23 production 
from the DCs during infection with P. aeruginosa and S. pneumoniae. 
Furthermore, to investigate the isolation of mucosal DCs from the lung 
and nasal associated lymphoid tissue (NALT) and investigate their 
responses to these pathogens. This will be addressed in Chapter 4. 
2. Use these pathogen primed DCs investigated in Chapter 4, to investigate 
the consequences of co-culture of pathogen primed DCs with naive CD4+ T 
cells to see if Th17 responses are formed in response to P. aeruginosa and 
S. pneumoniae. This will be addressed in Chapter 5. 
3.  Investigate the contribution of γδ T cells in IL-17 responses to P. 
aeruginosa primed DCs. This is the focus of Chapter 6. 
4. Investigate in vivo infections of P. aeruginosa and S. pneumoniae with 
focus on IL-17 producing cells in the lung and surrounding area. 
Preliminary investigations were also performed in IL-17RKO animals to see 
if IL-17 responses to the pathogens were beneficial or detrimental to the 
host. This is addressed in Chapter 7. 
The following chapters of this thesis will deal with each separate objective, with 
a brief introduction of the topic and full discussion of results in context with the 
literature. All chapters will be summarized and linked together in the general 
discussion, which will also suggest how this research can be further directed. 
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2 Materials and methods 
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2.1 Mouse strains 
2.1.1 C57BL/6 
C57BL/6 mice purchased from Harlan were housed in University of Glasgow 
Biological Services facilities. Mice were used aged 6-12 weeks. 
2.1.2 IL-17R KO 
IL-17R KO mice on a C57BL/6 background were obtained from Jay Kolls, 
Louisiana State University Health Sciences Centre and bred in house.  
2.2 Cell culture 
2.2.1 Cell lines 
2.2.1.1 X63 cells for GM-CSF 
X63 cells are a murine cell line derived from a mouse myeloma that produces 
Granulocyte macrophage colony stimulating factor (GM-CSF) in culture [188]. 
Cells were obtained from Prof Maggie Harnett, University of Glasgow, and 
cultured in order to obtain GM-CSF for culturing of bone marrow derived 
dendritic cells (BMDCs). The cells were cultured in RPMI 1640 supplemented with 
10% FCS, 100μg/ml Streptomycin, 100 U/ml Penicillin and 2mM L-glutamine (all 
Invitrogen). For the first week cells were also cultured in 0.5mg/ml Geneticin 
(G418)(Invitrogen). After this time cells were cultured in large volumes of G418 
free media in large tissue culture (TC) flasks and cultured over a period of 2 
weeks, closely monitored and being split when cells looked too dense or media 
became yellow. After a 2 week period the supernatant was removed by 
centrifugation to pellet cells and leave supernatant cell free. This was sterile 
filtered and stored at -20˚C until required. Batches of X63 media were tested by 
flow cytometry, staining for CD11c, a dendritic cell (DC) marker. Typically 
results were 50-70% CD11c+ cells cultured by this means from bone marrow 
derived progenitors (data not shown). These cells were also shown to be MHCII 
high and are not autofluorescent, a characteristic of macrophages [189, 190], 
(data not shown) thus we are confident we have culture DCs.  
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2.2.2  Bone-marrow derived DCs 
C57BL/6 mice were scarified aged 6-12 weeks by cervical dislocation or by CO2 
gas, and femurs and tibias were dissected. Bone marrow progenitors were 
isolated similarly to previously described by others [191]. Briefly the ends of the 
bones were cut off using dissection scissors and the bone marrow was flushed 
into fresh media using a 21g needle and 5ml syringe. The bone marrow was then 
broken up by suction up and down the needle and then passed through sterile 
nitex mesh to remove any debris. 
Culture media used was IMDM+glutamax supplemented with 10% heat inactivated 
FCS, 100μg/ml Streptomycin, 100 U/ml Penicillin, 2.5μg/ml Fungizone 
(amphotericin B) (all Invitrogen). Bone marrow mononuclear phagocytic 
precursors were plated into 9cm low adherence petri dishes (Sterlin) at a 
concentration of between 3-4x106 cells/plate. Media was additionally 
supplemented with 20% X63 media or 10ng/ml recombinant GM-CSF (Peprotech). 
Cells were cultured for 7 days with feeds of 7ml complete media supplemented 
with X63 media or GM-CSF after days 3 and 6. Mature DCs were used between 
days 7-10. Mature DCs were scraped off plates using ice cold phosphate buffered 
saline (PBS) and harvested into 50ml tubes (Invitrogen). Cells were counted, 
washed in PBS and resuspended at desired concentrations for experiments.  
2.2.3 Primary cell isolation 
2.2.3.1 Splenocyte isolation 
Spleens were dissected and mashed through 40um nitex into sterile media to 
obtain single cell suspensions. Cells were spun down at 300g for 10 minutes and 
pellet was resuspended in 5ml of red cell lysis buffer per spleen and left to 
incubate at room temperature (RT) for 10 minutes after which time cells were 
drenched with PBS and spun down again at 300g. Cells were resuspended in PBS, 
a sample was taken for counting and cells were spun down again giving them a 
final wash. Cells were then treated for specific isolation depending on 
experiment. 
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2.2.3.2 T Cell isolation using Magnetic-Activated Cell Sorting (MACS) 
2.2.3.2.1 Naive T cell isolation  
Naive Cells were sorted on the basis of CD4 and CD62L to isolate CD4+, CD62L+ 
naive populations and CD4+, CD62L- memory populations using antibody 
conjugated magnetic beads from Miltenyi and following manufacturer’s 
instructions. 
CD4 cells were negatively selected, whereby every other cell in the preparation 
was labelled and retained in the magnetic column allowing untouched CD4 cells 
to pass through. It is important to note that γδ T cells are not retained by this 
kit, and therefore come through in the flow through. Removal can be achieved 
by adding γδ beads, from a γδ positive selection kit, at time of bead incubation. 
CD62L cells were positively selected, with the naive CD4+ cells being in the 
CD62L+ prep retained on the column. 
2.2.3.2.2 γδ T cell isolation 
An enriched but not completely pure population of γδ T cells could be observed 
in the CD4+ preparation of splenocytes treated with the CD4 MACS negative 
selection kit. This was due to the kit not retaining γδ T cells as mentioned 
previously. This preparation was used for a majority of the γδ T cell work as γδ 
T cells make up such a small percentage of splenocytes that pure γδ T cell 
isolation allowed for very few conditions. However to test our hypothesis with γδ 
T cells some experiments were performed with a purified γδ T cells population, 
isolated using a γδ positive selection MACS kit and following manufacturer’s 
instructions. 
2.2.3.3 Nasal associated lymphoid tissue (NALT) isolation 
NALT is a small tertiary lymphoid structure in mice above the hard palate. This 
tissue is so small it is difficult to identify by eye, so it is best just to remove the 
hard palate and isolate any cells associated with it. NALT was dissected by 
removing the head and jaw and using fine sharp scissors or a scalpel to cut 
around the hard palate, on the inside of the teeth. The hard palate was then 
removed very gently using a pair of tweezers and was agitated in a vial of sterile 
PBS to allow the cells of the tissue to become free. The hard palate can further 
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be mashed through nitex but it is recommended doing so after agitation as there 
are very few cells and some may get lost on the nitex.  
2.2.3.4 Lung cell isolation 
Lungs were digested using 50μl/ml of 26units/ml stock liberase (Roche) and 
10μg/ml DNase (Roche) in RPMI. Lungs were chopped into small pieces in a 
bijoux and then 2ml of liberase/DNase digestion mix was added to each tube. 
Tissues were incubated at 37°C with gentle agitation for 1 hour before being 
passed through nitex to obtain a single cell suspension.  
2.2.3.4.1 NALT and lung DC isolation 
NALT or lung cells were isolated as stated, and DCs were removed using CD11c 
positive selection MACS beads (Miltenyi) following manufacturer’s instructions, 
with the additional step of density centrifugation required for lung cells before 
CD11c MACS treatment.  
2.2.3.4.2 Density centrifugation 
After digestion of lung tissue the cells were spun down at 300g for 10 minutes to 
obtain a cell pellet. The ‘volume’ of cell pellet was estimated and an equal 
measure of Hanks buffered salt solution (HBSS) was added and mixed well. On 
top of this 2ml of ficoll-paque (GE healthcare) was gently laid and preparations 
were spun at 300g for 30 minutes with the brake off. This allows the distribution 
of cell populations as can be observed in the diagram below (Figure 2-1). 
 
 
Figure 2-1 Illustration of density centrifugation of lung tissue  
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The interface, which contains immune cells, was isolated by gently pippeting 
without disturbing the other layers, before being washed twice and treated for 
DC isolation using MACS as previously described. 
2.2.4 DC infection 
2.5x105 DCs were set up in 48 well plates, in 500μl at a concentration of 5x105 
cells/ml and infected with the pathogens at various multiplicity of infections 
(MOIs) depending on pathogen, for various times depending on experiment. 
Antibiotics were added to cultures after desired time to kill pathogen: 10ng/ml 
gentamicin (Invitrogen) was added to P. aeruginosa infected cultures and 
100μg/ml Streptomycin, 100 U/ml Penicillin was added to S. pneumoniae 
infected cultures. DCs were then incubated at 37°C overnight before being 
harvested for co-culture. 
2.2.5 Co-culture set up 
1x105 T cells were set up with 1x104 DCs in their respective medias in 96 well 
round bottom plates. Wells were anti-CD3 coated (2.5μg/ml) (Ebioscience) for 
naive set up, but not memory. Where DCs alone in absence of conditioned media 
were cultured with T cells, the DCs were washed out of their conditioned media 
and resuspended in fresh media, before culturing with the T cells in fresh media. 
Where DC condition media was used alone in the absence of DCs, the DCs were 
spun out of the media, and the T cells spun down also, with the T cells 
resuspended in the DC condition media. Where both DCs and condition media 
were present, T cells were treated as above and DCs were just carried over from 
treated well in condition media in whatever volume contained 1x104 DCs. Naive 
T cell co-cultures were left for 6 days, γδ T cell co-cultures for 3 days, after 
which times supernatants were harvested for analysis with ELISA, and cells were 
stained for flow cytometry. 
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2.3 Bacterial strains 
2.3.1 P. aeruginosa  
2.3.1.1 PA103 
PA103 is a cytotoxic strain of P. aeruginosa commonly used in research [192]. It 
is non-flagellated, making it less motile, and has recently been found to activate 
the inflammasome, a platform that allows eventual IL-1β release (described in 
the introduction), via pilin [193]. Lack of flagellin may decrease bacterial 
recognition somewhat as flagellin is recognised by TLR5 [46], however there are 
other PRRs on DCs that detect P. aeruginosa, such as TLR4 recognition of LPS 
[46], and therefore lack of TLR5 is not a concern for our experimental set-up. 
Furthermore, in Chapter 4 we demonstrate that PA103 stimulates DCs 
effectively, measured by various outputs discussed in Chapter 4. PA103 possesses 
the toxins ExoU and ExoT and is very cytotoxic to cells upon infection. PA103 is 
the focus of our in vitro studies with P. aeruginosa, of which we use 2 strains 
PA103 ΔUΔT and PA103 ΔpcrV.  
2.3.1.1.1 PA103 ΔUΔT 
The symbol Δ denotes a lack of the following element. In this case this bacterial 
strain lacks the pseudomonal toxins ExoU and ExoT. Lack of these toxins, inhibits 
the cytotoxic properties of this pathogen, thus making it a useful model for 
investigation of immune recognition of the pathogen. Use of the wild type (WT) 
of this strain would simply kill the cells with which it was cultured making 
analysis challenging. Furthermore ExoU inhibits inflammasome activation [194] 
which is important for IL-1β secretion as discussed in the introduction. As IL-1β 
is of interest to our studies, ExoU deficient strains must be used in these 
experiments to allow inflammasome activation. 
2.3.1.1.2 PA103 ΔpcrV 
PcrV is an essential component of the Type III secretion system (T3SS) [169,195] 
and thus important for the pathogenic functions of P. aeruginosa. PA103 ΔpcrV 
lacks of this essential component resulting in lack of functional T3SS, and 
therefore obliterates any downstream effects such as inflammasome activation 
and IL-1β secretion. 
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2.3.1.2 PAO1 
P. aeruginosa strain PAO1 is an invasive strain that is commonly used in 
experiments studying P. aeruginosa and is fully sequenced [196]. 
PAO1 can be purchased from calliper with a bioluminescent label, named Xen41, 
and is the focus of our in vivo studies with P. aeruginosa, where we wish to 
visualise colonisation of the pathogen in the lung using an in vivo imaging system 
(IVIS). 
2.3.2 S. pneumoniae  
2.3.2.1 D39 
D39 is a capsulated virulent strain of S. pneumoniae, commonly used in 
laboratory experiments, whose genome has been mapped [197]. D39 is the focus 
of our in vitro studies with S. pneumoniae, of which we use 2 strains D39 WT and 
D39 ΔPLY. 
2.3.2.1.1 D39 ΔPLY  
D39 ΔPLY has an absent PLY toxin and is less virulent than its WT counterpart. 
2.3.2.2 TIGR4 
TIGR4 is a capsulated S. pneumoniae which can be purchased with a 
bioluminescent label from Calliper, named Xen35, and is the focus of our in vivo 
studies with S. pneumoniae, where we wish to visualise colonisation of the 
pathogen in the lung using an IVIS. 
2.4 Bacterial cultures 
2.4.1 P. aeruginosa  
A single colony or 50μl of a 25% glycerol stock was added to 10ml of Luria-
Bertani (LB) media (Invitrogen) and grown for 15 hours overnight at 225rpm at 
37˚C with caps loose to allow aeriation. After 15 hours, the overnight culture 
was diluted 1:30 in LB and grown for another 90 minutes or until the OD600 was 
between 0.4 and 0.6 for this is when they are in exponential growth phase. 
  56 
Bacteria were the centrifuged at 3000g for 10 minutes at 4˚C and washed twice 
in sterile PBS. Bacteria cell pellets were then resuspended in a volume of 
antibiotic free media to a concentration of approximately 1x106 cfu/μl. The 
volume was obtained using this formula:  
(OD600) / 0.4 x 1.8 = volume (ml) to resuspend pellet in, to obtain 1x106 cfu/μl. 
2.4.2 S. pneumoniae  
For S. pneumoniae, a scraping of 25% glycerol stock was plated on blood agar 
plates and incubated at 37°C overnight. A few colonies were selected and put 
into 5ml of brain heart infusion (BHI) broth under completely sterile conditions 
and grown in a 37˚C water bath for approx 8-12 hours or until 0D600 was 
between 0.3 and 0.5. Bacteria were the centrifuged at 3000g for 10 minutes at 
4˚C and washed twice in sterile PBS and finally resuspended in the initial volume 
of antibiotic free media. Number of bacteria in suspension was ascertained by: 
e (OD600x8.5) = cfu x107/ml 
2.4.3 Pathogen minimum inhibitory concentration (MIC) assay 
To test the lower limit of antibiotic needed to effectively kill pathogen a MIC 
assay was performed. A volume of pathogen at a known concentration was set 
up in wells in a 96 well plate. Antibiotics were added at doubling dilutions in 
duplicate and plates were incubating overnight.  MIC was measured by visualising 
wells that were clear and so antibiotic was effective at killing pathogen, and 
wells that were cloudy, where antibiotic had not been effective and pathogen 
had multiplied.  By this means a point of effectivity of antibiotic could be 
observed. An example of this is seen in Figure 2-2, a MIC assay of P. aeruginosa 
at an MOI of 10 testing the lower limit of gentamicin to use to effectively kill the 
pathogen. This figure shows an MIC of 12.5μg/ml gentamicin is effective at 
killing P. aeruginosa MOI 10.  
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Figure 2-2 MIC assay of gentamicin killing of P. aeruginosa 
2.5 Flow cytometry 
Flow cytometry, or Fluorescence-activated cell sorting (FACS), was performed 
using antibodies purchased from Biolegend. Cell marker fluorochromes, their 
appropriate isotypes and the concentration at which they were used are 
documented in Table 2-1. 
Table 2-1 Antibodies for flow cytometry 
Marker Clone Isotype Fluorescence 
label 
Concentration 
used 
CD4 RM4-5 Rat IgG2a, κ FITC 5 μg/ml 
CD8 53-6.7 Rat IgG2a, κ FITC 5 μg/ml 
γδ  GL3 Armenian 
Hamster IgG 
FITC 2 μg/ml 
γδ  GL3 Armenian 
Hamster IgG 
APC 2 μg/ml 
IL-22 poly5164 Polyclonal Goat 
IgG 
PE 100μl/ml 
Gr-1 RB6-8C5 Rat IgG2b, κ PE/Cy7 2 μg/ml 
IL-17A TC11-
18H10.1 
Rat IgG1, κ Alexafluor647 5 μg/ml 
CD11c N418 Armenian 
Hamster IgG 
APC 2 μg/ml 
CD40 HM40-3 Armenian 
Hamster IgM 
FITC 5 μg/ml 
CD86 GL-1 Rat IgG2a, κ FITC 5 μg/ml 
Extracellular staining was performed after cell harvest by washing cells twice in 
PBS at 300g to rinse off media. Cells were then incubated with appropriate 
dilutions of antibody, mentioned in Table 2-1, in 50μl FACS buffer for 30mins at 
4°C. After this time cells were washed and acquired or fixed for intracellular 
staining. 
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Intracellular staining for IL-17 and IL-22 was performed on the cultured T cells, 
and harvested in vivo infected lung cells. Cells were stimulated with phorbol 12-
myristate 13-acetate (PMA) (50ng/ml) and Ionomycin (500ng/ml) (both Sigma) in 
the presence of Brefeldin A (10μg/ml) (Sigma) for 5 hours, after which time cells 
were harvested and washed twice in PBS and extracellular staining was 
performed as described above. 
After extracellular staining, cells were washed 3 times in PBS before being fixed 
using 200μl fixation solution (Biolegend) for 20 minutes at RT in the dark. After 
fixation cells were washed 3 times with 1ml permeablising solution (Biolegend) 
and stained for intracellular markers at appropriate dilution mentioned in Table 
2-1  in the permeablising solution, and allowed to incubate at RT for 20 minutes 
in the dark. Cells were then washed 3 times in 1ml permeablising solution and 
resuspended in FACS buffer and kept on ice before being acquired on 
FACSCalibur (BD bioscience) where 20,000 gated events were recorded for each 
sample. Data was analysed using FlowJo software (Tree Star) comparing positive 
markers to negative isotypes. Cells were gated on forward scatter (FSC) and side 
scatter (SSC) to isolate the live population, regarded as cells not clustered on 
the axis. An example of this gating can be observed in Figure 2-3. The viability 
of these cells was verified using 7AAD (BD biosciences)(data not shown).  
 
Figure 2-3 Example of standard gating for flow cytometry analysis.  
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This gating strategy was used when investigating in vitro DC cultures, in vitro T 
cell-DC co-cultures and in vivo CD4, CD19, γδ and IL-17 cell populations. The 
only exception to this gating was when Gr-1 positive cells were investigated 
during the in vivo infection experiments where the gate was extended up the 
side axis to encompass more granular cells as this is where Gr-1 cells would be 
found but no the other cells of interest would be situated here. 
2.5.1 7AAD 
7-Aminoactinomycin D (7AAD) is a fluorescent compound that can be detected by 
flow cytometry in fluorescence channel 3. It strongly binds to DNA and cannot 
penetrate cell membranes and so only binds to the DNA of dead cells, making it 
a useful live/dead cell marker. Dead cells are identified as 7AAD high cells and 
live cells are 7AAD low.  7AAD is available to buy commercially from BD, and 3μl 
of this was added to samples right before they were analysed on the 
FACSCalibur. An unstained sample of cells and a 7AAD single stained sample 
were recorded also for gating and compensation purposes.  
2.5.2 CFSE 
Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a fluorescent dye that 
labels cells and is used as a measure of cell proliferation as it can be detected 
by flow cytometry. Cells take up CFSE and pass it on to daughter cells during cell 
division, thereby halving the concentration of CFSE present in each cell. This 
division can be observed by flow cytometry by decreasing peaks of CFSE shifting 
to the left. CFSE treatment of T cells was performed using a CellTrace™ CFSE 
Cell Proliferation Kit (Invitrogen), following manufacturer’s instructions.  
2.6 Enzyme-linked immunosorbant assay (ELISA) 
ELISA duosets from R&D were used to determine the concentration of cytokines 
in cell culture supernatants, following manufactures instructions with slight 
variations. Generally high affinity 96 well flat bottom plates (VWR) were coated 
with 50μl capture antibody at recommended concentration in PBS with no carrier 
protein, overnight at RT. They were then washed four times with wash buffer 
(PBS, 0.05% Tween 20), blocked using 300μl appropriate block buffer (see  Table 
2-2) and allowed to incubate at RT for one hour. The plates were washed before 
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applying the samples and standards, which were incubated for 2 hours at RT or 
overnight at 4°C.  Standards were provided by manufacturer and were 
performed in duplicate, with doubling dilutions. The plates were washed before 
the detection antibody conjugated to biotin was added and incubated for 2 hours 
at RT, or overnight at 4°C. Plates were washed again and then 50μl of 
streptavidin peroxidase dilution (1:200) in required reagent diluent (see Table 
2-2) was applied and plates were incubated at RT for 20 minutes in the dark. 
The plates were washed, and 50μl TMB (KPL) substrate added to each well. 
Cytokine presence was indicated by substrate turning blue. During this reaction 
the plates were incubated in the dark, time dependent on the assay as some 
turned blue faster than others. Plates were removed from dark and 50μl of stop 
solution (KPL) was added when standards appeared to be of a satisfactory colour 
of blue, usually until blue had slightly appeared in standard dilution 7. Plates 
were then measured at 570nm using a plate reader (Tecan, sunrise) running 
Magellan software, with values calculated by software using standard curve 
generated by software.  Table 2-2 illustrates the kits used, along with the 
concentrations of each antibody for each kit, the reagent diluents used and the 
standards measured. 
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 Table 2-2 R&D Duoset antibody and standard concentrations 
Cytokine 
Capture 
Antibody 
(g/ml) 
Detection 
Antibody 
(μg/ml) 
Reagent 
diluent 
Blocking 
buffer 
Top 
standard 
(pg/ml) 
Lower 
Limit of 
Detection 
(pg/ml) 
IL-1β 720 450 
0.1% BSA, 
0.05% 
Tween 20 
in Tris-
buffered 
Saline 
PBS,1% 
BSA 
1000 1.9 
IL-17 144 72 
PBS,1% 
BSA 
PBS,1% 
BSA 
1000 1.9 
IL-22 360 108 
PBS, 5% 
Tween 20 
PBS, 5% 
Tween 
20, 
0.05% 
NaN3 
2000 3.9 
IL-23 720 18 
PBS,1% 
BSA 
PBS,1% 
BSA 
1000 1.9 
Unless otherwise stated a volume of 50μl per well was used, and antibodies, 
standards and samples were diluted in appropriate reagent diluents dependent 
on kit and cytokine (Table 2-2). 
2.7 In vivo experiments 
2.7.1 Intranasal lung infections of mice with bacteria to induce 
pneumonia 
Pneumonia was induced in C57BL/6 mice using Gram-positive S. pneumoniae 
TIGR and Gram-negative P. aeruginosa PA01. Bioluminescent strains of these 
pathogens were purchased from calliper, named Xen35 and Xen41 respectively. 
Bioluminescent pathogens were observed using the IVIS, a spectrum imager that 
can be used for in vivo disease monitoring to see if pathogens had been inhaled 
and if they had proceeded to the lung. When using bioluminescent pathogens 
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and the IVIS, white BALB/c mice are usually used and the mice can be simply 
photographed, but the fur of black C57BL/6 mice disrupts with the images and 
so C57BL/6 mice must be shaved first to expose the skin so the bioluminescence 
can be viewed. 
Pathogens were given intranasally by anesthetising the mice using isoflurane and 
then gently pippeting 25μl of pathogen at desired concentration in PBS, 5x106 for 
Xen 35 and 2x107 for Xen 41, following methodology to induce acute pneumonia 
as developed by the group of TJ Mitchell, University of Glasgow  and as tested by 
us. This was pipetted into the nostrils of the animal where the animal will inhale 
it by reflex, hopefully bypassing the swallowing reflex and allowing it to reach 
the lung. Mice are photographed in the IVIS before and after infection to show 
that bacteria have in fact reached the lung and we are confident pneumonia will 
be induced. IVIS use requires a qualified technician. 
Animals were divided into 3 groups; control, P. aeruginosa infected and S. 
pneumoniae infected. Infected mice were treated as above and control mice 
were untreated completely. Mice were left until 48 hours and weight and health 
were monitored. 20μl of blood was taken by tail bleed after 24 hours to see if 
pathogen had become systemic as yet.  Mice were culled as near to 48 hours as 
possible within regulations of home office license.  
2.7.2 Measuring bacteria for intranasal infection 
Pathogen concentration for infection was measured by plating out stocks of 
pathogen in various dilutions on agar plates, LB agar for P. aeruginosa and blood 
agar for S. pneumoniae. Colonies were counted and multiplied by dilution factor 
to work out how many pathogens/ml a stock contained in order to calculate 
working concentrations of pathogen for infections. Stocks were washed twice in 
PBS, spun at 4000 rpm and resuspended finally in PBS. Aliquots of the infecting 
sample must be taken before and after animal infection, re-plated and counted, 
to ensure that the desired amount of pathogen was given. 
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2.7.3 In vivo sample harvest 
After cull, a bronchoalveolar lavage (BAL) was performed and was used for 
bacterial cultures, cytospin with Haemotoxylin&Eosin (H&E) staining and 
cytokine analysis by ELISA. 
Pleural washes were collected and treated the same as the BALs.  
Lungs were dissected and divided into 3 for 3 separate treatments. One section 
was placed in PBS for homogenising for plating for bacteriology; another was 
placed in PBS for digestion to obtain single cell suspensions for FACS staining to 
identify cell populations, and another placed in buffered formalin for fixation 
and histology. 
Blood was taken from chest cavity, nasal washes were performed and brain and 
lung were taken for homogenising, all for plating for bacteriology. 
2.7.3.1 BAL collection for bacteriology and cytospin  
Animals were culled using CO2 at 48 hours or when deemed too sick to continue 
according to home office regulations. Skin from around the throat was cut to 
expose the trachea, being careful not to disrupt the trachea or blood vessels. 
Holding the trachea slightly aloft, a small hole was cut at the front of the 
trachea and a pipette cut at an angle to create a bevelled tip, was inserted into 
this hole and 1ml PBS is flushed through the lungs twice.  
100μl of this is used for plating for bacteriology, the remaining sample is treated 
first for a cytospin and then the remaining liquid is harvested for ELISA. We 
recognise the limitations of a single time point with reference to our cytokine 
measurements as it may not accurately portray cytokine levels in this space as it 
would fluctuate during infection. However, the resources were not available to 
us to consider other time points.  
2.7.3.2 Pleural wash collection for bacteriology and cytospin  
The chest cavity was exposed by removing the skin around it, careful not to 
pierce the pleura. The liver was removed carefully to allow exposure of the 
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diaphragm, which must be released to allow full distension of the pleural space. 
This was done by gently snipping the flaciform ligament of the liver which is 
attached to the diaphragm. Pleural washes were taken using 5ml of calcium free 
PBS, by inserting 18g needle between the ribs, which was removed using a 23g 
needle inserted under the animals right side of the diaphragm. These washes 
were treated the same as the BALs. 
2.7.3.3 Lung tissue 
The lungs of each animal were divided into 3 equal parts for various treatments 
described below. 
2.7.3.3.1 Lung section for Flow cytometry 
A section of lung was placed in PBS and then treated with a digestion mix 
(described previously) and passed through nitex to obtain a single cell suspension 
as described previously in lung cell isolation section. Cells were then stimulated 
with 50μg/ml PMA and 500μg/ml ionomycin in the presence of brefeldin A for 5 
hours after which time they were harvested and stained for γδ, CD4, Gr-1, CD19 
and IL-17 and analysed by flow cytometry. 
2.7.3.3.2 Lung section for histology 
A section of lung was embedded in paraffin, sectioned and stained with H&E to 
stain for neutrophils and macrophages.  
2.7.3.3.3 Lung Homogenate for bacterial load measurements 
Sections of lung were rinsed in ethanol and PBS before being homogenized in 1ml 
sterile PBS. The homogenizer was disinfected between samples using 70% 
ethanol to prevent contamination of subsequent samples. After ethanol clean, 
homogenizer was rinsed with PBS to remove any remaining ethanol that could 
prevent inhibition of bacterial growth of subsequent samples.  
2.7.3.4 Blood collection for bacteriology 
Blood was collected from tail bleeds mid experiment at 24 hours and from the 
chest cavity after culling. 20μl was collected and diluted 1:10, 8 times and then 
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plated in triplicate on agar plates to allow them to grow to count bacteria in the 
blood to investigate if the infection was systemic. 
2.7.3.5 Nasal wash collection for bacteriology 
Nasal washes performed by removing the head and flushing 1ml PBS through the 
nasal cavity, using a pastette, and collecting the liquid via the nose into an 
eppendorf. 
2.7.4 Bacterial culture 
Homogenates and washes collected as described above for bacteriology were 
serially diluted in sterile PBS and cultured, 20μl in triplicate, on appropriate 
media plates, LB agar plates for P. aeruginosa infection and blood agar plates 
for S. pneumoniae infection and incubated overnight at appropriate conditions, 
37°C incubator for P. aeruginosa, and in an anaerobic cabinet at 37°C for S. 
pneumoniae. Bacterial colony counts from each animal were counted, averaged 
and compared between groups. Cfu/ml was calculated by average cfu, 
multiplied by the dilution, multiplied by 50 (as bacteria were plated in 20μl, 
20μlx50=1000μl=1ml). 
2.7.5 Cytospin 
Cytopsins were performed of the BAL and pleural washes. For each sample cells 
were counted and resuspended at a concentration of 1x106/ml in PBS so that a 
consistent 1x105 cells would be applied in 100μl to all slides.  Positively charged 
glass slides were labelled and placed into the metal holders of the cytospin 
apparatus, with cardboard filters and the cuvettes, to which an aliquot of 100μl 
of sample was added. Slides were then spun down at 400rpm for 6 minutes after 
which time cytospin apparatus was removed carefully as to not smudge the cell 
spot, and slides were allowed to air dry overnight. Once dry, cells were stained 
using rapid romanowsky and mounted using DPX and coverslips. 
2.7.5.1 Rapid romanowsky staining of cytospins 
Rapid romanowsky staining of cytospin slides was performed using a kit from 
Thermo scientific and following manufactures instructions.  
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2.7.6 Histology 
Tissues were harvested and fixed in buffered formalin for 48 hours after which 
time they were transferred to 70% ethanol until they were embedded in 
paraffin. Tissues were processed using a Shandon citadel 1000 tissue processor 
(Thermo scientific). After this, tissues were transferred to blocks and submerged 
in hot wax and left to cool. Wax embedded tissues were cut onto slides using a 
microtome, before being left to dry and then stained for H&E and histologically 
analysed and photographed. 
2.7.6.1  Hematoxylin&eosin staining of lung tissue 
To H&E stain paraffin wax sections, wax was softened in a 60°C for 35 minutes 
and the following protocol was followed: 
Dewax 
1. Submerged in Xylene for 3 minutes X 2 
2. 100% ethanol for 3 minutes X 2 
3. 90% ethanol 3 minutes x 2 
4. 70% ethanol 3 minutes x 2 
5. Running water 3 minutes 
Stain 
1. Harris Haematoxylin for 2 minutes 
2. Running water for 2 minutes 
Differentiation 
1. 1% Acid/Alcohol for a few seconds 
2. Quick rinse in running water 
3. Scotts Tap Water Substitute 
4. Quick rinse in running tap water 
Counter stain 
1. 1% Eosin for 2 minutes 
2. Running water 
 
Dehydrate sections 
1. 70% alcohol for 30 seconds 
2. 90% alcohol for 30 seconds 
3. 100% alcohol for 1 minute x 2 
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4. Xylene 3 minutes x 2 
Mount coverslip over tissue section from Xylene with DPX mountant (Sigma).  
2.8 Reagents 
T cell media - IMDM+glutamax supplemented with 10% heat inactivated FCS, 
100μg/ml Streptomycin, 100 U/ml Penicillin (all Invitrogen) 
DC media – as T cell media with 2.5μg/ml Fungizone (amphotericin B), 
supplemented with 10ng/ml GM-CSF  
PBS - 8g/L of NaCl, 0.2g/L of KCl, 1.44g/L of Na2HPO4, 0.24g/L of KH2PO4 (all 
Sigma) in distilled water. 
Wash buffer - PBS, 0.05% Tween20 
FACS buffer - 2% FCS in PBS, 0.09% NaN3 (Sigma) 
MACS buffer - PBS, pH 7.2, 0.5% BSA, and 2 mM EDTA (Sigma) 
Red cell lysis buffer - 0.15M NH4Cl, 10mM KHCO3, 0.1mM EDTA (all Sigma) in 
distilled water, pH 7.4 
2.9 Statistical analysis 
All ELISA results were analysed by paired T test, 1-way ANOVA or 2-way ANOVA 
using Graphpad Prism 4 software. Results were displayed as mean ± standard 
error of mean.  A p value of < 0.05 was considered statistically significant.  
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3 Methods developed 
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3.1 Isolation of single cell suspension from lung 
Several methods of obtaining single suspensions of lung cells have been 
described [198-200]. In general, cells are treated with digestive enzymes and 
then mashed through nitex to obtain single cell suspensions. Most protocols 
describe the use of DNase and collagenase D [200]. We initially used this 
combination for our digestion mix (both purchased from Roche) but we found 
that our single cell suspensions contained a lot of debris, and that further cell 
isolations using MACS isolation were less than 20% pure (data not shown). Others 
in the lab have used liberase (Roche) for lung tissue digestion instead of DNase 
and so this was tried also. We then compared to the quality of cell populations 
liberated by use of either collagenase D or liberase, both with DNase. 
Use of liberase allows a much cleaner population with less debris than when 
collagenase D is used, as can be identified when looking at cells on the 
haemocytometer on the microscope (data not shown). Furthermore, use of 
liberase in preparation for CD11c+ dendritic cell (DC) isolation with MACS gives a 
enhanced CD11c+ population (Figure 3-1) indicating that a better single cell 
suspension has been produced by this means.  
 
  70 
 
Figure 3-1 CD11c+ isolation using liberase to isolate lung cells is more effective than use of 
Collagenase D 
Lung cells were isolated using a digestion mix of DNase with liberase (blue line) or Collagenase D 
(red line) and then treated with CD11c+ MACS selection. Cells stained for CD11c and analysed by 
flow cytometry, compared to isotype (filled histogram). Cells were gated on live cells based on their 
forward scatter (FSC) and side scatter (SSC) as described in materials and methods. Data 
representative of 3 experiments.  
A 30% CD11c+ cell increase is evident with liberase preparation compared to 12% 
with collagenase D. Due to this, liberase was used for all experiments that 
required lung cell isolation. 
3.2 Lung DC isolation 
Isolation of lung DCs was performed by obtaining a single cell suspension of lung 
tissue and then using a CD11c+ positive selection MACS kit (Miltenyi).  
Some studies recommend that to increase CD11c+ cell acquisition from the lung, 
cells should be incubated on tissue culture (TC) plates for 1 hour at 37°C after 
lung cells have been liberated, after which time non-adherent cells should be 
removed by gently pipetting off half the volume. Cells should be further 
incubated on TC plates overnight, with loosely adherent cells harvested the next 
day as it is this population that is believed to contain the CD11c+ cells [201]. 
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This will be referred to therein as the adherent population, with removed cells 
referred to as the non-adherent population. The adherent cell preparation 
should then be harvested and treated with CD11c+ MACS kit to give a CD11c+ 
enriched population. 
To test this phenomenon, we also kept aside the non-adherent populations for 
isolation and staining also to confirm that this population of cells did not contain 
CD11c+ DCs. Using both the adherent and non-adherent cell preparation with the 
CD11c MACS positive selection kit and subsequent staining with CD11c antibodies 
to test purity of CD11c isolated populations, we observed that there were just as 
many CD11c+ cells in the non-adherent preparation as the adherent (Figure 3-2).  
 
  72 
 
Figure 3-2 CD11c+ cells are not only contained in the adherent cell population as others 
have claimed 
Lungs were digested and plated to obtain adherent and non -adherent cells as described. Both 
adherent and non-adherent cells were treated with CD11c MACS kit and both the positively 
retained cells and the flow through cells were stained for CD11c, compared to isotype, to test 
efficacy of kit and, and compared to cells before treatment. Cells were gated on live cells based on 
FSC and SSC as described in materials and methods. Data representative of 3 experiments. 
The lung homogenates were tested before CD11c positive selection MACS 
preparation to give an idea of how many CD11c+ cells reside in the lung before 
purification. We see approximately 14% and 18% of CD11c+ cells in both the 
adherent and non-adherent preparations respectively, indicating that the non-
adherent cell preparation not only contained CD11c+ cells but in fact marginally 
more than the adherent population (Figure 3-2). Both of these preparations were 
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then treated with CD11c+ MACS kit and both the positively selected cell 
preparation retained in the column and the CD11c negative preparation flow-
through were stained with CD11c antibodies and analysed by flow cytometry to 
ensure no CD11c+ cells are escaping into this CD11c- preparation. 
Upon CD11c positive selection we see 38% and 50% CD11c+ in the adherent and 
non-adherent cell preparations respectively, indicating that there are CD11c+ 
cells in the non-adherent cell preparation indeed and this should not be 
disregarded as others have suggested. Furthermore it is evidence that the CD11c 
positive selection kit is not highly pure as manufacturers claim. However, it 
appears that CD11c cells are not being lost in the flow-through, as the flow-
through preparations of both the adherent and non-adherent cells appear 
negative for CD11c+ cells (Figure 3-2). This indicates that the problem is 
retention of other cell types in the column and not just the CD11c cells as 
desired. We believe this is due to the ‘sticky’ nature of epithelial cells in the 
lung and devised strategies to omit these cells such as density centrifugation 
pre-treatment discussed in the next section.  
To further investigate if incubation of lung homogenates and selection of 
adherent cells increases CD11c+ cell isolation, we tested 3 methods of 
incubation on the same isolated lung homogenate preparations (Figure 3-3). 
Lung tissue was digested and passed through nitex to obtain a single cell 
suspension and then: 
A) Treated with CD11c positive selection MACS kit with no incubations or 
removal of cells 
B) Cells were incubated for 1 hour at 37°C on TC plates, with non-adherent 
cells removed and treatment of only the adherent cells with CD11c 
positive selection MACS kit 
C) Cells were incubated for 1 hour at 37°C, with non-adherent cells removed 
and adherent cells further incubated overnight as other protocols suggest 
with further removal of non-adherent cells the next day and treatment of 
only the adherent cells with CD11c positive selection MACS kit 
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Figure 3-3 CD11c+ cells from different treatments of lung DC isolation 
Lung DCs were isolated using CD11c+ MACS treatment after A) digestion and isolation by nitex ; B) 
as A but with prior incubation for 1 hour at 37°C and removal of non -adherent cells; C) as B but 
with a further overnight incubation and second removal of non-adherent cells before MACS 
treatment. Cells were stained for CD11c (black line) and analysed by flow cytometry compared to 
isotype (filled histogram). Cells were gated on live cells based on FSC and SSC as described in 
materials and methods. Data representative of 3 experiments. 
It appears that the recommended practice of 2 incubations and 2 steps of 
removal of non-adherent cell as described above, gives the worst CD11c+ cell 
population for the lung tissue of all 3 methods, with only 30% CD11c+ cells 
observed after positive selection (Figure 3-3C). 
The best CD11c+ population is observed where there is no prior treatment or 
removal of non-adherent cells (Figure 3-3A), further indicating that the non-
adherent preparation that others suggest we remove may contain CD11c cells 
and thus must be included. Due to this we performed all lung DC isolations on 
whole lung cell homogenates. 
3.2.1 Density centrifugation 
We have observed that upon isolation of CD11c+ positively selected lung DCs 
using MACS does not give rise to a highly pure population (Figure 3-2 and Figure 
3-3), indicating contamination with other cells. We believe this contamination is 
probably epithelial cells as they are plentiful in the lung and sticky and so may 
stick to the column and be retained along with the positively selected cells. Due 
to this we introduced a further step of density centrifugation, as some studies 
suggest [200], before MACS treatment to separate the DC containing interface 
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from other cells and tissue. This should allow a purer population not 
contaminated with epithelial cells, before MACS preparation, thus allowing 
better selection of CD11c+ cells.  
Ficoll-Paque (GE healthcare) is a density centrifugation medium commonly used 
for isolation of mononuclear cells from the blood, that allows all cells to be 
separated by density into layers [202, 203]. The technique of density 
centrifugation is normally used for blood and so is divided into plasma, 
peripheral blood mononuclear cells (PBMCs) and red blood cells (RBCs). We are 
not sure exactly how the cells in the lung would be separated, as there are more 
cells in lung tissue than in blood such as epithelial cells and connective tissue, 
and this has not been documented to present. When the lung homogenate was 
mixed with Hanks buffered saline solution (HBSS) and centrifuged over Ficoll-
Paque the cells in the tissue become layered as can be seen in Figure 3-4. 
 
Figure 3-4 Diagram of density centrifugation of lung tissue homogenate  
The very dense RBCs sink to the bottom and the ‘lighter’ interface, which 
contains immune cells such as lymphocytes, monocytes and macrophages sits 
nearer the top just under the buffer solution.  
We believe the epithelial cells to be in the debris layer as we have named it, as 
this layer looked very ‘tissue like’ and was very sticky and congealed. Upon 
insertion of a pipette into the tube to liberate the interface, this ‘debris’ layer 
wasn’t disturbed or dispersed as the interface would be, and appeared to stick 
to the plastic and moved as a whole. This indicates that this debris layer could 
be the ‘stickiness’ that we believe is preventing pure CD11c isolation with MACS. 
  76 
DNA is also regarded as ‘sticky’ and this layer is where we believe the disturbed 
DNA would reside, further confirming that removal of this layer may reduce the 
‘stickiness’ of the preparation thus allowing a purer CD11c population.  
The interface was removed as carefully as possible and once fully isolated this 
interface cell preparation was treated with CD11c positive selection MACS kit 
and the preparation was stained with CD11c antibodies and analysed by flow 
cytometry as before (Figure 3-5). 
 
Figure 3-5 Density centrifugation treatment of lung tissue increases the CD11c+ populations 
isolated from the lung by CD11c+ MACS treatment 
Lung tissue was digested and then separated using density centrifugation to isolate the CD11c+ 
cell containing interface which was then treated by CD11c+ MACS, and stained for CD11c for 
analysis by flow cytometry (blue line) compared to isotype (red line). Cells were gated on live cells 
based on FSC and SSC as described in materials and methods. Data representative of 2 
experiments. 
Pre-treatment with density centrifugation results in a CD11c+ cell population of 
57% after CD11c+ MACS treatment. This was the purest CD11c+ population we 
observed although it is still not near as highly pure as the providers of these 
positive selection kits claim. 
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3.3 Conclusion 
Liberation of a single cell suspension from lung tissue and further CD11c+ cell 
isolation proved difficult with no perfect technique found as yet. We found that 
use of liberase with DNase gives a much cleaner single cell suspension upon lung 
tissue digestion than that of Collagenase D with DNase, and so liberase is 
recommended when digesting lung tissue to obtain a single cell suspension for 
any purpose. CD11c+ isolation using CD11c positive selection MACS kit proved to 
be less than successful with many variations on how to best obtain maximum 
CD11c+ yield from the tissue tested, such as differing digestion enzymes, 
culturing of cells before treatments and density centrifugation. We found that 
incubation of the cells and CD11c+ treatment of the adherent cells only did not 
give a very pure CD11c+ population and furthermore was found to actually 
eliminate CD11c+ cells that could be found in the non-adherent cell preparation. 
Due to this, the whole lung homogenate was treated for CD11c+ cell isolation 
during our experiments to maximise CD11c+ DC number. CD11c+ populations 
were enhanced when the immune cells of the lung were separated by density 
gradient centrifugation prior to MACS selection, although this technique still did 
not give the highly pure CD11c+ population as we had hoped. We have exhausted 
all theories as how to increase this yield and thus decided that for our 
experiments where we wished to isolate lung CD11c+ DCs to use whole lung 
homogenates, prepared by density centrifugation before CD11c positive MACS 
selection and to take into account that the preparation may only be under 60% 
pure and that other cells may contribute to the responses. 
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4 Dendritic cell activation by Pseudomonas 
aeruginosa and Streptococcus pneumoniae 
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4.1  Introduction 
Antigen presenting cells (APCs) present antigen to other cells for recognition and 
induction of immune responses. These cells uptake antigen in the periphery and 
carry them to secondary lymphoid tissues where they present antigen to T cells 
for recognition. If the T cell recognises an antigen, it proliferates and secretes 
cytokines to co-ordinate an immune response to that antigen, in the presence of 
co-stimulation which is also provided by the APC [204]. There are 3 types of 
APC; Dendritic cells (DC), macrophages and B cells [205], with DCs being the 
only APC whose sole function is dedicated to antigen presenting. Macrophages 
are also involved in innate immunity and phagocytosis, and B cells are involved 
in humoral immunity and antibody production [205].  
DCs are commonly identified using the surface protein CD11c, with DCs being 
CD11c+. Though the use of the molecule solely as a DC marker is a subject of 
debate [206], it is a widely applied marker of murine DCs and is the DC marker 
of choice in our set up (these CD11c+ cells were verified to be DCs by other 
means as discussed in materials and methods which are not mentioned futher in 
this thesis). DCs can be activated by numerous stimuli which produces a range of 
phenotypic changes, such as up-regulation of co-stimulatory markers, major 
histocompatability complex (MHC) molecules and secretion of chemokines and 
cytokines [207]. In the work described in this thesis, we follow activation of DCs 
by measuring up-regulation of the co-stimulatory molecules CD40 and CD86, two 
molecules that would conjugate with receptors CD40L (CD154) and CD28 on T 
cells to allow T cell activation. We also follow production of the pro-
inflammatory cytokines IL-23 and IL-1β as evidence that the DC has recognised 
the pathogen and has been activated by it via direct infection. As discussed in 
the introduction, IL-1β secretion involves intracellular recognition of a pathogen 
to activate the inflammasome and allow IL-1β release, and thus production of IL-
1β may indicate that the pathogen has infected the cell. IL-23 secretion however 
just requires ligation of a TLR, most likely TLR4 [49], on the surface of the DC. 
DCs recognise pathogens by use of pathogen recognition receptors (PRRs) on 
their surface which recognise pathogen associated molecular patterns (PAMPs), 
on microorganisms. The most famous of the PRRs are the TLRs as discussed in 
the introduction. Recognition of bacterial components by the TLRs leads to DC 
activation [207], and thus we will use addition of recombinant 
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lipopolysaccharide (LPS) to cultures which is recognised by TLR4 [208] as a 
positive control to show DCs can be activated by TLR stimulation. 
This chapter investigates different methods of DC induction from bone marrow 
progenitor cells, activation of these DCs by the pathogens P. aeruginosa and S. 
pneumoniae and investigates the use of the bacterial strains of P. aeruginosa 
which activate and do not activate the inflammasome, to represent a model of 
IL-1β presence and absence respectively. It also investigates isolation of DCs 
from mucosal sites and looks at their activation upon stimulation and infection 
to see if they have the potential to be better T cells stimulators than bone 
marrow derived DCs (BMDCs), which may induce Th17 cells in response to these 
respiratory pathogens. 
4.2 BMDC induction by Granulocyte macrophage colony 
stimulating factor (GM-CSF)  
4.2.1  Recombinant GM-CSF induces more CD11c+ cells from 
bone marrow progenitors than X63 media 
GM-CSF is a cytokine known to induce bone marrow progenitor cells to become 
DCs under the correct culture conditions [209]. GM-CSF is available as a 
recombinant cytokine or can be found in the supernatant of cultures of the cell 
line X63, a mouse myeloma cell line that produces GM-CSF and secretes it into 
the supernatant [210, 211]. We sought to find out if recombinant GM-CSF or X63 
media is more effective at inducing DCs from bone marrow and the activation 
status of these DCs upon stimulation with LPS. 
Bone marrow was isolated as described in materials and methods and cultured 
with media supplemented with 10ng/ml recombinant GM-CSF or 20% X63 media. 
A larger yield of CD11c+ cells is observed when recombinant GM-CSF is used as 
opposed to media supplemented with X63 (Figure 4-1) represented by a higher 
peak on the % max axis; 80% compared to 40% of 20,000 events recorded. 
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Figure 4-1 Recombinant GM-CSF induces higher numbers of CD11c+ populations from bone 
marrow than X63 media 
Bone marrow was isolated from femurs of C57BL/6 mice and cells were cultured with recombinant 
GM-CSF (blue line) or X63 media (green line) for 7 days and compared to undifferentiated cells 
(red line) and CD11c isotype (filled histogram). Cells gated on live cells based on forward scatter 
(FSC) and side scatter (SSC) as described in material and methods. Histograms are representative 
of culture set up in triplicate. Data representative of 3 experiments.  
Using recombinant GM-CSF gives a more consistent population of CD11c+ cells, 
as a calculated concentration of GM-CSF is added to culture. 
4.2.2 Recombinant GM-CSF induces functional CD11c+ cells from 
bone marrow progenitors based on CD40 and CD86          
up-regulation 
Using up-regulation of co-stimulatory molecules CD40 and CD86, it is apparent 
that recombinant GM-CSF induced DCs are more readily activated on the basis of 
up regulation of their co-stimulatory molecules upon stimulation of LPS (Figure 
4-2). LPS is a component of Gram-negative bacterial cell walls that is a potent 
activator of DCs due to its ability to be recognised by TLR4 on the surface of DCs 
[208]. 
  82 
 
 
Figure 4-2 Recombinant GM-CSF induced DCs up-regulate more CD40 than X63 media 
induced DCs 
DCs differentiated by recombinant GM-CSF or X63 media were left unstimulated (red line) or 
stimulated with LPS for 90 minutes (blue line)  after which time cells were harvested, stained with 
CD40 and analysed by flow cytometry. Cells gated on live cells based on FSC and SSC as 
described in materials and methods, and positive gates for CD40 were set on isotypes on each cell 
type. Histograms are representative of culture set up in triplicate. Data representative of 3 
experiments. 
Use of recombinant GM-CSF to skew DCs from bone marrow progenitors, allows a 
higher yield of cells that up-regulate of CD40 than DCs initiated by X63 media, 
represented by a larger peak on the % max axis relative to 20,000 events 
recorded for each condition. This is also evident with the co-stimulatory marker 
CD86 (data not shown). These results indicate that recombinant GM-CSF is a 
better method of inducing DCs as it allows a more functional cell type that can 
be activated upon stimulation, and thus proceed to stimulate T cells for 
activation. Taken together these results indicate that recombinant GM-CSF not 
only generates a higher yield of CD11c+ cells(Figure 4-1) but also induces a 
better quality of DC gauged on activation capacity, compared to that of the X63 
supernatant (Figure 4-2).  
4.2.3 X63 and GM-CSF induced DCs do not differ in IL-1β 
secretion 
A higher number of cells that up-regulate CD40 and CD86 upon LPS stimulation 
indicates that recombinant GM-CSF derived DCs have a greater capacity to 
generate inflammatory activated DCs. To confirm this we measured the ability of 
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the two different DC populations to produce IL-1β following infection with P. 
aeruginosa. Both types of DC produced very similar levels of IL-1β with no 
significant difference observed (Figure 4-3). This indicates that DCs induced with 
X63 media are infected and respond in the same manner as GM-CSF derived DCs, 
with regards to IL-1β production. 
 
Figure 4-3 IL-1β output from recombinant GM-CSF and X63 induiced DCs does not differ 
DCs differentiated by recombinant GM-CSF or X63 media were left unstimulated, infected for 90 
minutes with P. aeruginosa ΔUΔT after which time antibiotics were added to kill the pathogen, or 
LPS stimulated. Cells were incubated overnight before supernatants were harvested and assayed 
for IL-1β by ELISA. All error bars represent mean ± standard error of the mean (SEM). Data are 
representative of 3 separate experiments of experimental triplicates. 
4.2.4 Functional CD11c+ cell generation using Flt3 ligand 
Fms-like tyrosine kinase 3 ligand (Flt3l) is a haematopoietic growth factor which 
is also known to induce DCs from bone marrow progenitors [212]. We tested the 
use of Flt3l during BMDC induction, and compared the process of BMDC induction 
by Flt3l and GM-CSF to investigate which method induced a better CD11c+ 
population. We found that at day 8 of generation, the day on which GM-CSF DCs 
are harvested and used in our experiments, Flt3l DCs expressed less CD11c than 
DCs generated by GM-CSF exposure (Figure 4-4). 
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Figure 4-4 CD11c expression by DCs derived using Flt3l is lower than CD11c expression of 
DCs derived by recombinant GM-CSF 
Bone marrow was isolated from femurs of C57BL/6 mice and cells were cultured with recombinant 
GM-CSF (red line) or Flt3l (blue line) for 8 days, after this time the cells were harvested and stained 
for CD11c and compared to CD11c isotype (filled histogram). Cells gated on live cells based on 
FSC and SSC as described in materials and methods. Histograms are representative of culture set 
up in triplicate. Data representative of 3 experiments. 
However, we found that Flt3l DCs were more immature when unstimulated as 
represented by little to no CD40 or CD86 expression compared to recombinant 
GM-CSF derived DCs that have a small population of CD40/CD86 positive cells 
under unstimulated conditions (Figure 4-5). This small population of CD40/CD86+ 
cells that we see in unstimulated recombinant GM-CSF derived DCs is most likely 
due to some activation of cells upon agitation during preparation, by moving and 
washing in cold PBS, and upon adherence to tissue culture treated plastics, as 
these DCs are found to be quite sensitive to activation by these means. Upon 
stimulation with LPS, there is a distinct increase in CD40 and CD86 expressing 
cell populations, and percentages of cells in these populations, in GM-CSF 
derived DCs (Figure 4-5). In comparison Flt3l DCs, which had no CD40+ or CD86+ 
cells under unstimulated conditions, appear to all become activated illustrated 
by a full CD40/CD86 shift upon activation. Furthermore, it appears as if there is 
an both intermediate and a positive population of both markers, as 2 populations 
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are evident that are both increased from the CD40- and CD86- populations 
observed when Flt3l induced DCs are unstimulated (Figure 4-5). 
 
Figure 4-5 Activation of Flt3l derived DCs using LPS 
DCs differentiated by recombinant GM-CSF or Flt3l media were stimulated with LPS (blue line) or 
left unstimulated (red line) for 90 minutes after which time cells were harvested, stained for CD40 
and CD86 and analysed by flow cytometry. Cells gated on CD11c and positive gates for CD40 and 
CD86 were set on isotype for each marker on each cell type. Histograms are representative of co-
culture set up in triplicate. Data representative of 3 experiments.  
These results show that unstimulated recombinant GM-CSF DCs have a small 
CD40/CD86+ populations that are up-regulated upon LPS stimulation, showing 
them to become activated with this stimulus. Whereas, Flt3l derived DCs show 
little CD40 or CD86 when unstimulated, with large CD40 and CD86 populations 
generated upon stimulation with LPS. 
Flt3l derived DCs show a better up-regulation of the co-stimulatory molecules 
with both an intermediate and a positive population indicating that they are 
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better at activating upon stimulation than recombinant GM-CSF cells, but as 
CD11c populations in Flt3l derived DCs are low, they cannot be readily identified 
as DCs according to the literature.  
It is claimed that Flt3l derived DCs gain CD11c expression as they age, with 
CD11c expression appearing around day 9 and increasing to 100% CD11c+ cells by 
day 14 [213], and so we tested Flt3l derived DCs at a later stage, day 14, to see 
if CD11c had been up-regulated on these cells.  We did not see this claimed 
increase in CD11c but a decrease, along with reduced CD40 and CD86 (data not 
shown). Due to this we examined the cells at this time point for their viability, 
based on the uptake of 7-AAD, a fluorescent dye that binds to DNA liberated 
from cells upon death. Day 14 GM-CSF derived DCs show an 80% live population 
in unstimulated conditions whereas live cells at day 14 in unstimulated Flt3l 
derived DCs are less than half of this, at 39% (Figure 4-6). 
 
Figure 4-6 Cell death with day 14 Flt3l derived DCs 
DCs differentiated by recombinant GM-CSF or Flt3l media were harvested at day 14 were stained 
for 7-AAD to investigate cell death.  Data representative of 2 experiments.  
These results illustrate that Flt3l DCs do not increase their CD11c+ expression 
overtime and in fact more than half of the cells are not viable by this time 
point. Due to these combined observations, recombinant GM-CSF derived DCs 
were used at day 8 for all experiments.  
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4.3 DCs from frozen bone marrow 
Others in the group have observed previously that bone marrow progenitor cells 
can be frozen in 10% DMSO and 90% FCS at -80°C for a number of weeks to 
months, before being thawed and washed out of the DMSO mix, which are still 
functional in induction of macrophages. We wished to investigate if DCs could 
also be induced from bone marrow previously frozen and treated to induce DCs 
using GM-CSF as was performed for fresh DCs, as described in materials and 
methods. 
A CD11c+ population can still be observed when frozen and thawed bone marrow 
is induced to be DCs using GM-CSF (Figure 4-7). 
 
Figure 4-7 DCs from frozen bone marrow progenitors 
Bone marrow isolated from femurs of C57BL/6 mice was frozen in 10%DMSO and 90% FCS at -80 
°C for several weeks, after which time it was defrosted and cells were cultured with recombinant 
GM-CSF for 7 days to induce DCs. Cells were harvested and stained for CD11c (black line) and 
analysed by flow cytometry compared to isotype (filled histogram). Cells gated on live cells based 
on FSC and SSC as described in materials and methods. Data representative of 3 experiments. 
The presence of a CD11c+ population indicates that bone marrow progenitors 
that have been frozen and thawed, retain their capacity to become our cells of 
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interest under the right culture conditions as has been observed for macrophages 
by others in the group previously.  
However, upon LPS stimulation these cells do not have any up-regulation of co-
stimulatory molecule CD86 indicating that they are not functional (Figure 4-8). 
 
Figure 4-8 Lack of activation from DCs from frozen bone marrow progenitors 
Bone marrow isolated from femurs of C57BL/6 mice was frozen in 10%DMSO and 90% FCS at -80 
°C for several weeks, after which time it was defrosted and cells were cultured with recombinant 
GM-CSF for 7 days to induce DCs. Cells were left unstimulated (blue line) or stimulated with LPS 
for 90 minutes (red line), harvested, stained for CD40 and analysed by flow cytometry compared to 
isotype (filled histogram). Cells gated on live cells based on FSC and SSC as described in 
materials and methods. Data representative of 3 experiments. 
Lack of CD86 up-regulation in response to potent immunogenic LPS indicates 
that DCs induced from frozen bone marrow progenitors are not functional. Due 
to this frozen bone marrow was not used and fresh bone marrow was used for all 
DC cultures. 
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4.4 P. aeruginosa activates BMDCs 
The main aim of our experiments is to co-culture P. aeruginosa activated DCs 
with naive T cells to see if there is an induction of Th17 cells and use two P. 
aeruginosa strains, ΔUΔT and ΔpcrV, one with and one without IL-1β secretion 
inducing capacities respectively, to investigate if IL-1β plays a role in Th17 
induction to P. aeruginosa. The difference in IL-1β production in each strain is 
due to the presence or absence of a functional type 3 secretion system (T3SS) 
which, as discussed in the introduction, is important for allowing intracellular 
recognition of pathogens, inflammasome activation and thus IL-1β production. 
First, however, we wished to ascertain that P. aeruginosa does in fact activate 
DCs and induce up-regulation of important co-stimulatory molecules CD40 and 
CD86 that would aid in T cell activation. BMDCs were harvested and stimulated 
with pathogen for 90 minutes before addition of antibiotics to kill the pathogen. 
DCs were then left overnight to allow maturation and up-regulation co-
stimulatory molecules. Cells were then harvested and stained for CD11c, CD86 
and CD40 and measured by flow cytometry. 
Upon infection with both P. aeruginosa strains ΔUΔT and ΔpcrV, DC activation is 
evident as illustrated by an increase in CD11c+ CD40+ cells and CD11c+ CD86+ 
cells (Figure 4-9) from unstimulated conditions, confirming that both strains of 
the pathogen activate DCs.  
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Figure 4-9 P. aeruginosa infection activates DCs to up-regulate co-stimulatory markers 
CD40 and CD86 
DCs differentiated by recombinant GM-CSF were left unstimulated or infected with P. aeruginosa 
strains ΔUΔT or ΔpcrV for 90 minutes before the addition of antibiotics to kill the pathogen, and 
cells were incubated overnight. After this time cells were harvested and stained for CD11c, CD40 
and CD86 and analysed by flow cytometry. Cells gated on live cells based on FSC and SSC as 
described in material and methods. Positive gates were set on isotype for each marker on PA103 
ΔUΔT stimulated cells.  Dot plots are representative of culture set up in triplicate. Data 
representative of 3 experiments.  
As before a population of CD40+ CD11c+ cells and CD86+ CD11c+ cells, 12% and 
19% respectively, can be observed when the DCs are unstimulated. This 
percentage of CD40+, CD86+ cells is probably due to the fact that disturbing the 
DCs, with spins, and washes with cold PBS, may allow some activation as 
discussed earlier. However, an increase in both co-stimulatory markers can be 
observed upon P. aeruginosa infection with both strains of PA103 ΔUΔT and 
ΔpcrV. This indicates that presence or absence of an operational T3SS is not 
necessary for DC activation as based on up-regulation of CD40 and CD86. From 
these results we can thus conclude that infection of DCs with both stains of live 
P. aeruginosa allows activation of the cells observed by up-regulation of the co-
stimulatory molecules CD40 and CD86. 
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4.5 Initial IL-1β production from DCs upon P. aeruginosa 
infection is T3SS dependent 
As discussed more fully in the introduction, IL-1β processing and secretion is 
dependent on a complex called the inflammasome. Briefly, pro-IL-1β is made in 
cells upon TLR stimulation, and IL-1β is only released when pro-IL-1β is cleaved 
and converted into active IL-1β by products of inflammasome activation.          
P. aeruginosa activates the inflammasome unintentionally when injecting toxins 
into the host cells using its T3SS. During this process P. aeruginosa also 
inadvertently passes bacterial proteins into the host cell that the inflammasome 
complex recognises, activating the inflammasome and allowing downstream 
cleavage of pro-IL-1β and eventual IL-1β release. 
We used 2 bacterial strains of P. aeruginosa PA103, one with a functional T3SS 
but no T3SS exotoxins, PA103 ΔUΔT, and a strain with a non-functional T3SS, 
PA103 ΔpcrV, to demonstrate the contribution of an intact T3SS in 
inflammasome activation and therefore IL-1β output. 
After infection of DCs for 90 minutes and resting for 2 hours after antibiotic 
additon, PA103 ΔUΔT induces IL-1β release from the DCs, but as expected PA103 
ΔpcrV does not (Figure 4-10). This confirms that the presence of a T3SS system is 
important for inflammasome activation and downstream IL-1β release from DCs 
in response to the pathogen P. aeruginosa. 
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Figure 4-10 IL-1β is secreted from DCs infected with T3SS competent PA103 ΔUΔT but not 
T3SS deficient PA103 ΔpcrV  
DCs differentiated by recombinant GM-CSF were left unstimulated or infected for 90 minutes with 
P. aeruginosa strains ΔUΔT and ΔpcrV before addition of antibiotics to kill the pathogen. After 2 
hours incubation, supernatants were harvested and analysed for IL-1β by ELISA. All error bars 
represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates.  ***p<0.001. 
This was considered to be standard as had also been shown previously by our 
group in macrophages [193], and experiments were continued under the 
assumption that the strain ΔUΔT allowed IL-1β release and ΔpcrV did not. 
However, if the cells were given antibiotics to kill the pathogen after the 90 
minutes and then left overnight to mature, as is our set up for the co-culture of 
infected DCs with naive T cells, it appears other factors activate the 
inflammasome and allow IL-1β increase from both bacterial strains (Figure 4-11) 
making this bacterial model, representing IL-1β presence or absence, 
ineffective. 
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Figure 4-11 IL-1β is secreted from DCs infected with both PA103 strains after overnight 
incubation, regardless of T3SS contribution  
DCs differentiated by recombinant GM-CSF were left unstimulated or infected for 90 minutes with 
P. aeruginosa strains ΔUΔT and ΔpcrV before addition of antibiotics to kill the pathogen. Cells were 
incubated overnight before supernatants were harvested and analysed for IL-1β by ELISA from 
experimental triplicates.  All error bars represent mean ± SEM. Data are representative of 3 
separate experiments of experimental triplicates. 
These other factors that lead to overnight IL-1β secretion from DCs infected with 
T3SS deficient ΔpcrV are unknown and require investigation.  
DC activation at an earlier time point was then investigated to see if DCs 
infected for 90 minutes and then given antibiotics and allowed to activate for 2 
hours, which do show a difference in IL-1β between the 2 strains (Figure 4-10), 
could be used for co-culture. However, T cells co-cultured with DCs only allowed 
2 hours to mature after infection all died giving no measurable results. We thus 
conclude that overnight incubation of 90 minute infected DCs is necessary after 
antibiotic addition to allow full activation of the DCs and thus full co-operation 
with T cells, allowing T cell activation and survival. 
It appears there is a balance to be met in the timing of the experiment. Freshly 
infected DCs show a difference of IL-1β from the pathogens and would be useful 
tool to show the contribution of IL-1β to Th17 generation. However these DCs 
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are lacking in co-stimulatory molecules and thus will not co-operate with and 
activate T cells, thereby passively allowing the T cells to die. Upon careful 
consideration it was decided that as we are searching for a specific response 
from T cells to that of P. aeruginosa and therefore DC presentation and co-
stimulation is important, that the overnight process would remain intact. We 
could then use this set up to investigate if naive IL-17 responses can be induced 
using pathogen primed DCs but we cannot make any assumptions about IL-1β 
contribution using this experimental setup. Therefore bacterial strains are not 
compared on their contribution to IL-1β in our experiments. 
4.6 DC activation by P. aeruginosa occurs early with few 
bacteria, and increases over time and MOI 
We wished to test how quickly P. aeruginosa infected and activated the DCs, and 
the influence of different multiplicity of infections (MOI) on DC activation and 
IL-1β secretion. DCs were infected with T3SS competent ΔUΔT at different MOIs 
ranging from 0-30, at 30 minute intervals from 0-150 minutes, following which 
antibiotics were added and cultures were left for an additional 2 hours to allow 
time for some activation. Following infection and resting for 2 hours, significant 
concentrations of IL-1β were detected at as little as 30 minutes infection, which 
appears to remain somewhat stable till 2.5 hours of infection (Figure 4-12). Also 
it appears that an MOI of as little as 2 is enough to induce IL-1β secretion, 
indicating that it only takes a few bacteria in this setting to infect host cells and 
induce IL-1β secretion.  
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Figure 4-12 P. aeruginosa infection of DCs over time at various MOIs 
DCs differentiated by recombinant GM-CSF were infected with P. aeruginosa strain ΔUΔT at 30 
minute intervals at various MOIs before addition of antibiotics to kill the pathogen. Cells were 
incubated for 2 hours before supernatants were harvested and analysed for IL-1β by ELISA. All 
error bars represent mean ± SEM. Data are representative of 3 separate experiments of 
experimental triplicates.***p<0.001.  
At earlier time points a high MOI appears to induce more IL-1β but as time goes 
on it appears that the MOIs 2-30 may not differ significantly. At the latest time 
point measured, 150 minutes, it appears that IL-1β concentrations from the 
highest MOI of 30 decrease from that of the same MOI 30 minutes previously. For 
our experiments an MOI of 10 and infection time of 90 minutes was sufficient. 
This MOI and time point was carried through the remaining experiments.  
4.7 IL-23 output from P. aeruginosa infected DCs 
As we are investigating IL-17 from cells with a primary interest in Th17 cells, we 
wished to look at IL-23 secretion from P. aeruginosa infected DCs as IL-23 is an 
essential maintenance factor for Th17 cells [154]. The supernatants of P. 
aeruginosa DCs infected for 90 minutes and left overnight to incubate after 
additon of antibiotics were harvested and IL-23 was measured by ELISA. 
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Figure 4-13 IL-23 secretion from PA103 ΔUΔT and ΔpcrV infected DCs does not differ 
DCs differentiated by recombinant GM-CSF were left unstimulated or infected for 90 minutes with 
P. aeruginosa strains ΔUΔT and ΔpcrV before addition of antibiotics to kill the pathogen. Cells were 
incubated overnight before supernatants were harvested and analysed for IL-23 by ELISA. All error 
bars represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. * p<0.05, ***p<0.005.  
Upon P. aeruginosa infection both strains, PA103 ΔUΔT and PA103 ΔpcrV, induce 
secretion of substantial amounts of IL-23 from DCs (Figure 4-13), with no 
significant difference between strains indicating that IL-23 production from DCs 
is independent of T3SS. 
4.8 Streptococcus pneumoniae activates BMDCs 
To investigate if IL-17 induced responses differed between Gram-positive and 
Gram-negative bacterial strains, Gram-positive S. pneumoniae was used to infect 
the DCs in the same manner as the P. aeruginosa had been used. Two strains of 
S. pneumoniae were used, D39 wild type (WT) and D39 ΔPLY, a variant of the WT 
S. pneumoniae that lacks the PLY toxin. As discussed in the introduction PLY is 
very cytotoxic, and so it is expected that the WT may just kill all the cells 
whereas the ΔPLY mutant will not kill the cells and may allow the DCs to process 
the pathogen allowing activation. 
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It is important to confirm that as with P. aeruginosa, S. pneumoniae does 
activate DCs and allows up-regulation of the co-stimulatory markers CD40 and 
CD86, and therefore has the potential to activate T cells and induce a Th17 
response. Preliminary studies by others in the lab suggest that S. pneumoniae 
infection of DCs with both strains D39 WT and D39 ΔPLY, requires a much lower 
MOI than required for P. aeruginosa to induce activation of DC. They found that 
the MOI of 10 that we use for P. aeruginosa, kills all DCs when this MOI of S. 
pneumoniae is applied in these in vitro conditions. 
Initial work suggests use of MOIs below 10 for S. pneumoniae infection. We 
tested this by infecting DCs with differing MOIs of S. pneumoniae, 0.5, 1, 2 and 5 
and looking at the activation of DCs via up-regulation of co-stimulatory markers 
CD40 and CD86. We also see, as others in the group have, that lower MOIs of S. 
pneumoniae infection are better at inducing up-regulation of CD40 (Figure 4-14) 
and CD86 (data not shown) on DCs, with higher MOIs showing no up-regulation of 
these co-stimulatory markers at all. 
 
Figure 4-14 DC activation with S. pneumoniae occurs at low MOIs 
DCs differentiated by recombinant GM-CSF were left unstimulated (filled histogram) or infected 
with S. pneumoniae (black line) for 90 minutes before the addition of antibiotics to kill the pathogen 
and cells were incubated overnight. After this time cells were harvested and stained for CD40 and 
analysed by flow cytometry. Cells gated on live cells based on FSC and SSC as described in 
materials and methods. Positive gates were set on isotype on D39 WT stimulated cells.  
Histograms are representative of culture set up in triplicate. Data representative of 3 experiments. 
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With D39 WT an MOI of 1 and 2 appears to induce the best up-regulation of 
CD40, with a higher MOI of 5 appearing to induce very little up-regulation of this 
marker at all (Figure 4-14). For the PLY deficient strain, D39 ΔPLY, MOIs of 0.5 
and 1 appear to be the most effective at DC activation with regards to up-
regulation of CD40. This confirms what others in the group have seen, that lower 
MOIs are more effective at activating DCs during S. pneumoniae infection. Due 
to this lower MOIs were used for S. pneumoniae infection experiments. 
4.8.1 S. pneumoniae activation of DCs requires overnight 
incubation 
As with P. aeruginosa infection, proper DC activation requires overnight 
incubation of the DCs after the 90 minute infection to allow sufficient time for 
co-stimulatory markers to be up-regulated. DCs infected for 90 minutes before 
antibiotic addition, only allowed to incubate for 2 hours before being harvested 
and stained, showed no up-regulation of CD40 (Figure 4-15) and CD86 (data not 
shown) in any of the infection conditions. 
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Figure 4-15 DC activation with S. pneumoniae harvested after 2 hours after 90 minute 
infection and addition of antibiotics 
DCs differentiated by recombinant GM-CSF were left unstimulated (filled histogram) or infected 
with S. pneumoniae for 90 minutes before addition of antibiotics to kill the pathogen, and incubated 
for 2 hours. After this time cells were harvested and stained for CD40 (black line) and analysed by 
flow cytometry compared to isotype. Cells gated on live cells based on FSC and SSC as described 
in materials and methods. Histograms are representative of culture set up in triplicate. Data 
representative of 3 experiments.  
Thus, 2 hours is not sufficient time after destruction of pathogen for activation 
of DCs demonstrated by up-regulation of CD40 and CD86. 
With these results we confirm that lower MOIs should be used for S. pneumoniae 
infection of DCs such as MOI 1 and 2, and that these infected DCs must be 
allowed to incubate overnight to allow sufficient up-regulation of co-stimulatory 
molecules to thus allow proper T cell activation. 
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4.9 IL-1β output from S. pneumoniae infected DCs 
DCs were infected with S. pneumoniae in the same manner as P. aeruginosa, and 
the supernatants analysed for IL-1β by ELISA to see the effects of S. pneumoniae 
pathogen on IL-1β secretion from DCs. We wished to investigate if there was any 
difference in IL-1β secretion between the WT and PLY deficient strains of D39, 
as it has been shown that PLY deficient S. pneumoniae strains show significantly 
less IL-1β production from phagocytes [37, 38]. 
 
Figure 4-16 S. pneumoniae D39 WT allows IL-1β secretion from DCs whereas the PLY 
deficient mutant D39 ΔPLY does not  
DCs differentiated by recombinant GM-CSF were infected for 90 minutes with S. pneumoniae 
strains D39 WT and D39 ΔPLY before addition of antibiotics to kill the pathogen. Cells were 
incubated overnight before supernatants were harvested and analysed for IL-1β by ELISA.  All 
error bars represent mean ± SEM. Data are representative of 3 separate experiments of 
experimental triplicates. ***p<0.005.  
We observe IL-1β secretion from DCs infected with S. pneumoniae WT strain D39 
but not when DCs are infected with PLY deficient mutant D39 ΔPLY (Figure 
4-16), indicating the key role of PLY in IL-1β secretion from DCS.  
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4.10  IL-23 from S. pneumoniae infected DCs 
IL-23 release is thought to be TLR4 dependent [49]. The primary ligand for TLR4 
is LPS, a bacterial cell wall component present in Gram-negative bacteria but 
not Gram-positive pathogens such as S. pneumoniae, therefore indicating that S. 
pneumoniae would not lead to release of IL-23. However PLY is suggested to be 
a TLR4 ligand [39] and so IL-23 may be produced by infection with PLY 
competent D39 WT, but not with PLY deficient D39 ΔPLY. We investigated this 
by infecting DCs with both S. pneumoniae strains and analysing the supernatants 
for IL-23 by ELISA (Figure 4-17).  
 
Figure 4-17 Infection with S. pneumoniae strains D39 WT and D39 ΔPLY does not lead to IL-
23 release from DCs 
DCs differentiated by recombinant GM-CSF were infected for 90 minutes with S. pneumoniae 
strains D39 WT and D39 ΔPLY before addition of antibiotics to kill the pathogen. Cells were 
incubated overnight before supernatants were harvested and analysed for IL-23 by ELISA.  
Supernatants of PA103 ΔUΔT infected DCs, previously shown to secrete IL -23 (Figure 4-13), were 
also analysed as a positive control. All error bars represent mean ± SEM. Data are representative 
of 3 separate experiments of experimental triplicates. **p<0.005.  
Negligible IL-23 is produced by DCs infected with either strain of S. pneumoniae 
(Figure 4-17), as compared to IL-23 production by P. aeruginosa infected DCs. 
The lack of IL-23 observed from DCs during S. pneumoniae infection indicates 
that if IL-23 production is TLR4 dependent, perhaps PLY is not in fact a TLR4 
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ligand as no IL-23 is observed during infection with PLY competent strain D39 
WT. Thus, the role of PLY as a TLR4 ligand requires further investigation.  
4.11 DCs do not produce IL-17 in response to                   
P. aeruginosa  
Our primary goal is to see if naive T cells co-cultured with infected DCs secrete 
IL-17, the characteristic cytokine of Th17 cells, and it is therefore important to 
ascertain if DCs themselves secrete IL-17 and so could be a source of IL-17 in our 
co-culture. The supernatant of infected DCs was measured for IL-17A by ELISA, 
using naive T cells induced to become Th17 cells by culture with TGFβ, IL-6 and 
IL-1β as a positive control.  
 
Figure 4-18 DCs do not secrete IL-17 during P. aeruginosa infection 
DCs were left unstimulated, or infected with P. aeruginosa strains ΔUΔT and ΔpcrV for 90 minutes 
before addition of antibiotics and left overnight to mature.  After this time supernatants were 
harvested and measured of IL-17 by ELISA. Supernatants of T cells cultured with Th17 inducing 
cytokines TGFβ, IL-16 and IL-1β were also analysed for IL-17, as a positive control. All error bars 
represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates.* p<0.05.  
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Figure 4-18 shows that P. aeruginosa infected DCs do not secrete IL-17 and 
therefore we can be confident that any IL-17 we do see from our cultures is from 
T cells stimulated by DCs infected with pathogen, and not the infected DCs 
themselves. 
4.12 Isolation of mucosal tissue DCs 
BMDCs were used for cultures as they are easy to make and they are plentiful. 
We however wanted to investigate the use of tissue DCs from mucosal areas in 
which the respiratory pathogens P. aeruginosa and S. pneumoniae would 
encounter. It was hypothesised that these mucosal DCs may have properties or 
pre-dispositions to secrete certain cytokines upon defence to the respiratory 
pathogens, and induce cell types equipped to respond to mucosal pathogens 
effectively. We hypothesised that mucosal DCs may possess key differences that 
may allow them to respond more effectively to these pathogens than BMDCs. For 
example, mucosal DCs have been shown to display an immature phenotype 
[214], unlike BMDCs which we have shown to be somewhat mature due to some 
expression of CD40 and CD86 when unstimulated (Figure 4-9).  
We wanted to investigate if DCs isolated from mucosal tissues could induce Th17 
cells from splenic naive T cells upon pathogen infection, and this is explored in 
the next chapter. First we had to ascertain how to isolate DCs from mucosal 
tissues, and their properties of activation. 
To investigate this phenomenon we isolated DCs from the lung, the direct site 
where an inhaled pathogen would colonise and set up infection therefore 
encountering DCs, and from the nasal (or nasopharynx) associated lymphoid 
tissue (NALT), a small tertiary lymphoid structure in mice above the hard palate. 
Murine NALT is apparently equivalent to tonsils in humans [215, 216]. Mice do 
not have tonsils and humans were always thought not to have NALT, though 
recent studies suggest NALT tissues may exist in humans after all [217]. It is a 
tertiary lymphoid tissue, defined as a tissue not normally involved in day to day 
immune responses, that takes on an immune role when challenged [218, 219].  
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4.12.1 Immune cells in NALT 
As P. aeruginosa and S. pneumoniae are common lung pathogens that enter via 
inhalation, NALT tissue is optimally placed to respond to such inhaled antigens. 
The NALT was dissected from naive mice and cells were liberated from the 
tissue as described in materials and methods. These cells were then stained with 
antibodies to identify which immune populations may be present and in what 
percentages. 
 
Figure 4-19 Cell populations from NALT 
NALT cells were isolated from dissected NALT and populations were investigated by flow 
cytometry. Plot representative of 3 experiments. 
Three populations of cells were identified in the NALT based on their FSC and 
SSC (Figure 4-19). Two small and very dense populations can be observed, 
labelled A and B. Both these population have similar low SSC, indicating that 
they are not granular, but population B has a higher forward scatter and 
therefore is a population of larger cells, as FSC represents size. A third, larger 
and more granular population that encompasses these 2 smaller populations was 
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also gated, and labelled as C. These 3 populations were investigated as a whole 
and individually to see where the CD11c+ DCs and CD4+ T cells, if any, resided.  
It appears that population B, the population of non-granular larger cells as based 
on forward scatter, contains a small, but distinct compared to isotype, 
population of CD11c+ cells and CD4+ cells (Figure 4-20 and Figure 4-21). Looking 
at population B alone, and staining for CD4 we see 6% CD4 cells are contained 
within it (Figure 4-20). This population is small but extremely distinct from the 
CD4- cells and isotype, indicating that it is a true CD4+ T cell population.  
 
Figure 4-20 CD4 population of naive NALT 
NALT cells were isolated from dissected NALT and cells were stained for CD4 and analysed by 
flow cytometry compared to isotypes. Cells gated on population B identified in Figure 4-19.  Data 
representative of 3 experiments.  
The actual number of CD4 cells in the unstimulated NALT however is much 
smaller than this figure represents. This is CD4+ population is 6% of a 17.5% cell 
population (this is the percentage of all NALT cells that population B 
represents), making this CD4+ population less than 1% of the total NALT cells. 
However, it must be considered that the animals from which the NALT was 
dissected were naive, and as the NALT is a tertiary immune structure that 
responds to immune challenge, perhaps cell populations would be larger during 
infection. This is of consideration for future experiments.  
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CD11c populations in this tissue were also small, with 3.4% of cells in population 
B being CD11c+ (Figure 4-21). This population is not as distinct as that of CD4+ 
cells, but a CD11c+ population is still evident in the NALT.  
 
Figure 4-21 CD11c+ NALT cells 
NALT cells were isolated from dissected NALT and cells were stained for CD11c and analysed by 
flow cytometry compared to isotypes. Cells gated on population B identified in Figure 4-19.  Data 
representative of 3 experiments.  
These results confirm that the tissue we isolated was a lymphoid tissue that 
contains DCs, and thus DCs may be isolated from this tissue for further 
experimentation investigating the roles of mucosal DCs. 
4.12.2 Isolation of mucosal DCs 
Isolation of CD11c+ cells from these tissues was performed by digestion of the 
tissue and then using CD11c+ MACS kit to isolate the CD11c+ cells. Positive 
selection involves the retention of positively labelled cells on the magnetic 
column which are then removed by flushing of the column once removed from 
the magnetic field. Unfortunately this isolation is not very pure, with a positive 
yield of less than 50% on average (see Chapter 3 Methods Developed Figure 3-2 
and Figure 3-3). As discussed in Chapter 3, we believe it to be due to the rest of 
the cells in the tissue, epithelia cells, goblet cells and such that make the 
preparation very sticky and therefore stick to the magnetic column with the 
positively selected cells, only to then be mechanically flushed through as part of 
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the positive prep. Various methods of lung digestion and preparation before 
CD11c+ isolation were tested to maximise this selection process that are not 
discussed here (see Chapter 3 Methods Developed). Once a method of maximum 
yield was elucidated we found that we could isolate a >50% CD11c+ population 
from the lung with this positive selection kit (Figure 4-22). 
 
Figure 4-22 DC isolation from lung using positive selection MACS  
Lung tissue was digested and treated with CD11c+ MACS isolation kit to isolate CD11c+ cells, 
which were stained with CD11c (blue line) and analysed by flow cytometry compared to isotype 
(red line) ,to test efficacy of kit. Data representative of 3 experiments. 
Unfortunately this is the purest population of CD11c+ cells we could isolate from 
the lung via several methods and alterations. Methods to isolate purer 
populations need further investigation. 
4.12.3 Activation of lung DCs with P. aeruginosa infection 
CD11c+ lung DCs were infected with P. aeruginosa to test their ability to respond 
to and to become activated by P. aeruginosa as measured by up-regulation of 
CD40 on CD11c+ cells. 
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Figure 4-23 Lung DCs are activated by P. aeruginosa infection 
CD11c+ cells selected by positive MACS (known to be approximately 50% pure) were infected with 
P. aeruginosa strains ΔUΔT and ΔpcrV for 90 minutes before antibiotic addition to kill pathogen, 
and incubation overnight. After this time cells were harvested and stained for CD11c and CD40 and 
analysed by flow cytometry. Cells gated on CD11c. Positive gates were set on isotype for LPS 
stimulated cells. Dot plots are representative of culture set up in triplicate. Data representative of 3 
experiments. 
Upon infection with both P. aeruginosa strains ΔUΔT and ΔpcrV, an up-regulation 
of CD40 can been observed from unstimulated conditions (Figure 4-23), 
indicating that P. aeruginosa activates lung DCs to up-regulate co-stimulatory 
markers. This is also observed with LPS stimulation. This confirms that DCs 
isolated from lung can be activated in a similar manner to BMDCs as we have 
seen before and therefore they can also be used in co-culture to activate naive T 
cells. 
CD11c+ NALT cells were also purified using the CD11c+ MACS kit. Due to their 
reduced number, and therefore reduced availability, these cells were not 
stained for CD11c or tested for activation as lung CD11c+ isolated cells were, 
and were used directly for co-cultured experiments detailed in Chapter 5.  
4.13 Discussion 
There have been a number of studies looking into the contribution of pathogen 
infected APCs in their contribution to Th17 responses [220, 221] and we wanted 
to investigate this also in response to respiratory pathogen P. aeruginosa and to 
a lesser extent S. pneumoniae. This study first investigated various methods of 
DC induction from bone marrow progenitors to elucidate the best methods of DC 
induction for the outputs we required; up-regulation of CD40 and CD86, and IL-
1β output. Sufficient up-regulation of CD40 and CD86 will allow T cell activation, 
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and secretion of IL-1β may contribute to Th17 induction. We compared GM-CSF 
from two sources, recombinant GM-CSF as manufactured and purchased from a 
company, and ‘naturally’ occurring GM-CSF as harvested from a cell line, X63, 
that secretes GM-CSF into its supernatant and that others use routinely [210, 
211]. We found that recombinant GM-CSF gives a better CD11c+ population, as 
measured by a higher CD11c+ population and a higher percentage of cells 
present in this CD11c+ population. One reason for the higher CD11c+ population 
of cells observed in recombinant GM-CSF may be that the concentration of GM-
CSF in the X63 media isn’t known and may vary from batch to batch of harvested 
supernatant and consequently DC quality may vary in cultures with X63 media. 
We also found recombinant GM-CSF derived DCs to be better at up-regulation of 
CD40 and CD86 upon LPS stimulation. This indicates that recombinant GM-CSF 
may induce ‘better’ DCs than X63 media. However this is only with regards to 
CD11c+ populations and CD40 and CD86 up-regulation as we found both GM-CSF 
and X63 derived DCs to be similar in their IL-1β secretion in response to P. 
aeruginosa infection.  
We also investigated the use of Flt3l at DC induction, as it was suggested to 
induce better DC populations by another group in the lab. We found that Flt3l 
induced cells are more immature when unstimulated with no CD40 or CD86 
expression, and that these DCs are almost completely activated upon LPS 
stimulation with whole shifts to CD40 and CD86+ cells. In fact, using CD40 and 
CD86 stained unstimulated populations to represent negative populations, it 
appears that upon LPS stimulation of Fltl3 DCs there are positive and 
intermediate populations of CD40 and CD86. Why this is so is unclear, and was 
not explored any further as our main focus was finding a fully functional CD11c+ 
DC population and it appeared that Flt3l DCs were mostly CD11c-. We found that 
CD11c+ population with Flt3l were reduced, with GM-CSF giving better CD11c+ 
populations and thus, more DCs as defined by the literature. Due to these 
observations recombinant GM-CSF induced DCs were used throughout BMDC 
experiments. It appears in our set up that Flt3l DCs do not survive till 14 days to 
become 100% CD11c+ cells as some studies have claimed [213]. Our culture 
technique for Flt3l derived DCs, along with the Flt3l itself, was provided by 
another group in the lab who use Flt3l to derive DCs from bone marrow 
progenitors on a regular basis. However, this group use the cells at day 7-9 of 
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generation, also reporting cell death after day 9. This probably reflects why they 
have not suffered with this protocol beyond that time point and confirms our 
observation of cell death at day 14. 
We decided that due to their continued use in the literature to continue with 
GM-CSF derived DCs for our experiments. However, the rapid up-regulation of 
co-stimulatory molecules on early Flt3l derived DCs make them an attractive 
target of future studies where co-stimulation is of concern. 
We also confirmed that better and more functional CD11c+ populations are 
induced using freshly isolated bone marrow progenitors compared to frozen and 
thawed progenitors as the frozen and thawed bone marrow induced DCs are 
CD11c+ but show no up-regulation of co-stimulatory molecules CD40 or CD86. 
Thus it is better to use fresh bone marrow where co-stimulation is important. 
Once a DC induction method was decided upon we investigated activation of 
these DCs by the pathogen P. aeruginosa as it was important to ascertain the 
effect P. aeruginosa had on DCs before we cultured them with naive T cells to 
see if Th17 responses could be induced. We confirm that DCs infected with P. 
aeruginosa are activated, as demonstrated by up-regulation of CD40 and CD86 
and secretion of IL-23. P. aeruginosa strain ΔUΔT also allows secretion of IL-1β. 
Thus P. aeruginosa primed DCs may have factors in place that may allow 
induction of Th17 cells from naive T cells, as IL-1β is considered to have a role in 
enhancing Th17 development [121] and IL-23 has been shown to be important for 
Th17 maintenance [154]. Here recognition of bacterial components by TLRs is 
probably enough to up-regulate CD40 and CD86, and that may be why we do not 
see a difference in infection as both strains of P. aeruginosa will be recognised 
in the same manner as they only differ in their T3SS presence.  For effective up-
regulation of CD40 and CD86, DCs infected with P. aeruginosa for 90 minutes 
before addition of antibiotics had to be left overnight to fully mature as cells 
harvested after 2 hours of maturation that were subsequently co-cultured with 
naive T cells did not allow T cell survival. We therefore confirm that for 
maximum co-stimulation capabilities infected DCs must be left overnight to 
mature after 90 minutes infection and antibiotics addition. 
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We wanted to investigate the contribution of IL-1β in Th17 induction and used 2 
strains of P. aeruginosa to show this. PA103 ΔUΔT has a competent T3SS and so 
leads to inflammasome activation and downstream IL-1β release when infecting 
DCs. PA103 ΔpcrV lacks a functional T3SS and so lacks ability to activate the 
inflammasome and thus does not lead to IL-1β secretion from DCs that it infects. 
These strains can be used as a model of IL-1β contribution to Th17 induction 
when DCs infected with these bacterial strains are co-cultured with naive T 
cells. We confirmed that infection of DCs with ΔUΔT allows IL-1β release and 
infection of DCs with ΔpcrV does not. We discovered however that this 
observation is time dependent. IL-1β presence with ΔUΔT infection, and absence 
with ΔpcrV infection was observed when DCs were infected for 90 minutes and 
supernatants were harvested and analysed for IL-1β after 2 hours incubation. For 
our co-culture DCs needed to be left overnight to mature and allow full up-
regulation of CD40 and CD86, as has been discussed above. We found that DCs 
infected with P. aeruginosa strains ΔUΔT and ΔpcrV for 90 minutes before 
antibiotic addition and left overnight did not differ in their IL-1β secretion 
indicating that over this time other factors lead to inflammasome activation and 
IL-1β production. For example, dead and dying cells release factors called 
danger associated molecular patterns (DAMPS) [222] that may be recognised by 
PRRs that activate the inflammasome when a microbial pathogen is present 
[223], and ATP may activate the inflammasome via ligation to the P2X7 receptor 
[166]. Due to time constraints, the factors that lead to inflammasome activation 
and IL-1β secretion during PA103 ΔpcrV infection over time were not 
investigated further. Due to the observation that these P. aeruginosa strains do 
not show a difference in IL-1β secretion when left overnight after 90 minute 
infection and addition of antibiotics to kill the pathogen as was required for our 
co-culture set up, no assumptions could be made about the contribution of IL-1β 
in our following co-culture experiments, and therefore we could not use this 
model to investigate the contribution of IL-1β to Th17 induction in the next 
chapter. As not the primary focus of our study the contribution of IL-1β was not 
further investigated. However, if role of IL-1β was a focus of study with these 
pathogens one could use recombinant IL-1Ra to block IL-1β signalling. 
We found that P. aeruginosa infection of DCs occurs in a rapid manner, as 
demonstrated by IL-1β secretion observed from DCs in 30 minutes after 
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infection. In this time, to allow IL-1β release, the DC must recognise P. 
aeruginosa extracellularly with a PRR to allow downstream production of pro-IL-
1β, and intracellularly with a NLR to activate the inflammasome. This 
inflammasome activation cleaves and activates caspase-1 which in turn cleaves 
and activates IL-1β, allowing its secretion. We have shown that this complex 
process may occur in as little as 30 minutes indicating the pathogens ability to 
infect quickly but also the host’s ability to respond rapidly.  
We found that P. aeruginosa infected DCs also secreted IL-23 with both P. 
aeruginosa strains, indicating that IL-23 secretion from DCs is T3SS independent. 
The ability of P. aeruginosa to allow IL-23 secretion from DCs may contribute to 
Th17 population maintenance and IL-17 responses to the pathogen which is 
investigated in further chapters.  
We also wanted to investigate DC infection with the Gram-positive pathogen S. 
pneumoniae to see if there was a difference in DC activation and IL-1β and IL-23 
secretion in Gram-negative and Gram-positive respiratory pathogens. We found 
that, as with P. aeruginosa, S. pneumoniae activation of DCs required overnight 
incubation after infection and antibiotic addition to allow proper induction of 
CD40 and CD86, as 2 hours maturation after antibiotic addition showed no up-
regulation of these co-stimulatory molecules. Infection with S. pneumoniae 
requires lower MOIs than P. aeruginosa for adequate infection and stimulation of 
the DCs, as an MOI higher than 5 led to no activation as measured by CD40 and 
CD86 up-regulation. Furthermore, at MOI 5 cells appeared to be dead as could 
been observed by clustering of cells at the axis (data not shown). Thus under 
these conditions S. pneumoniae is a much more potent pathogen than P. 
aeruginosa as fewer bacteria per host cell are needed to cause a reaction and 
cell death is observed at a much lower MOI of S. pneumoniae than P. aeruginosa. 
IL-1β was produced by DCs infected with S. pneumoniae but significant 
differences were observed between the PLY competent strain D39 WT and the 
PLY deficient strain D39 ΔPLY indicating, as others have seen [37], that PLY has 
a key role in secretion of IL-1β from DCs during S. pneumoniae infection. This 
leads us to hypothesise that if IL-1β plays a key role in Th17 development that 
infection with S. pneumoniae D39 WT will induce a strong Th17 response, 
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whereas PLY deficient stain ΔPLY will not. This is investigated in the next 
chapter. 
IL-23 from S. pneumoniae is negligible, perhaps confirming the theory that IL-23 
secretion from DCs may be TLR4 dependent [49]. The ‘famous’ ligand of TLR4 is 
LPS, a bacterial wall component in Gram-negative pathogens. Gram-positive S. 
pneumoniae lacks LPS and therefore will not activate TLR4 by this means and 
this may explain the lack of IL-23 secretion from DCs infected with S. 
pneumoniae. However, it has been claimed that PLY is a TLR4 ligand [39] and as 
TLR4 leads to IL-23, we hypothesised that we may see IL-23 from the PLY 
competent strain D39 WT and not from its PLY deficient counterpart D39 ΔPLY. 
However we see no IL-23 from either strain. This may indicate that PLY is not a 
TLR4 ligand as others have suggested [39]. However, it may also indicate that IL-
23 is not TLR4 dependent and thus both these theories require further 
investigation. 
Mucosal DCs are DCs found at mucosal sites where these respiratory pathogens P. 
aeruginosa and S. pneumoniae would inhabit, and so we wanted to investigate if 
these DCs had abilities to induce Th17 responses from naive T cells when these 
DCs were infected with P. aeruginosa. Our tissues of interest were the lung, as 
P. aeruginosa is a respiratory pathogen that can infect and colonize the lung in 
immunocompromised individuals [66], and the NALT, a tertiary immune 
structure that lies between the mouth and nose and so will respond to inhaled P. 
aeruginosa into the lung. NALT is very small and difficult to identify for 
isolation, especially in naive uninfected mice, as by definition a tertiary immune 
structure is not involved in day to day immune responses but responds when 
challenged [219]. Hence we believe, as with all immune tissues when under 
challenge, that the NALT may increase in size when challenged and therefore be 
easier to identify and dissect. Isolation of NALT (as described in Chapter 2 
Materials and Methods) was difficult as NALT tissue is not readily visible by eye, 
but we have shown by flow cytometry that we do liberate immune cells, 
including CD4+ and CD11c+ cells, and thus we are confident that we are 
liberating NALT as others have reported use of this technique for NALT isolation 
also [224]. The mice from which the NALT was dissected were naive in the sense 
that they had not been treated with infection, and so the NALT is small and has 
low lymphoid cell numbers. It would be interesting to see if the size of this 
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organ increased upon in vivo infection, and if the lymphoid cell numbers 
differed. 
Isolation of DCs from the lung using positive selection MACS appeared a tricky 
process that never gave a better than 50% CD11c+ population. However, we did 
see that CD11c+ populations from the lung are activated by P. aeruginosa 
infection and LPS stimulation indicating that there is the potential that they 
could co-stimulate naive T cells in response to this pathogen, making them of 
interest for co-culture studies.  
CD11c+ NALT cells were never stained for CD11c and investigated by flow 
cytometry to check kit purity as NALT cells were so few to begin with and thus 
so reduced after CD11c+ selection that there were only enough numbers left to 
proceed with culture. We however imagine percentages would be similar if not 
better than that of lung as there are fewer cell types in the NALT tissue that 
may contaminate the CD11c+ preparation. As stated, with reference to lung 
tissue, selection of DCs using CD11c positive MACS selection appears to only be 
50% effective, however we proceeded with infection and co-culture to give us a 
sense of what may happen using cells from this mucosal site. These results can 
be found in chapter 5 of this thesis. Perhaps other DC isolation techniques such 
as sorting by flow cytometry may give a cleaner and purer CD11c+ population 
from these sites. This must be considered by groups hoping to isolate CD11c+ 
DCs from these sites in the future. 
In conclusion the results presented in this chapter demonstrate that recombinant 
GM-CSF may be the best method of DC differentiation with regards to CD11c+ 
populations. However, if using CD11c to identify DCs was not the most important 
quality in an experiment, the results in this chapter suggest that Flt3l derived 
DCs may be an attractive target for studies where co-stimulation is of 
importance.  We found Flt3l DCs to be in a completely immature state when 
unstimulated, that show 2 positive populations of CD40 and CD86 when 
stimulated with LPS, showing better up-regulation of these markers than GM-CSF 
derived DCs do. We also showed that P. aeruginosa activates DCs and allows up-
regulation of co-stimulatory molecules CD40 and CD86 to allow activation of T 
cells. P. aeruginosa infection of DCs also leads to release of IL-1β and IL-23 
which may contribute to Th17 induction as is investigated in the next chapter.  It 
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was shown that strains of P. aeruginosa with a functional T3SS allow secretion of 
IL-1β from DCs, whereas strains without functional T3SS do not, in a time 
dependent manner as this is observed after 90 minutes but not when infected 
cells have been incubated overnight after antibiotic addition to kill pathogen, 
indicating other factors may play a role in inflammasome activation over this 
time. Gram-positive S. pneumoniae was also shown to activate DCs and allow IL-
1β production in a manner that is amplified by PLY presence.  
Thus this chapter confirms that the pathogens P. aeruginosa and S. pneumoniae 
activate DCs, allowing up-regulation of co-stimulatory markers and secretion of 
pro-inflammatory cytokines. Therefore these DCs may be used in co-culture with 
T cells to investigate the contribution of these pathogen primed APCs during 
Th17 induction. 
116 
5 In vitro IL-17 responses induced by the mucosal 
pathogens Pseudomonas aeruginosa and 
Streptococcus pneumoniae 
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5.1 Introduction 
Recently a novel subset of CD4+ helper T cells entitled Th17 cells, named due to 
their characteristic secretion of IL-17 [225], have been described that have 
varying roles in disease as described in the introduction of this thesis. Th17 cells 
are identified by CD markers CD3 and CD4, cytokine receptors IL-23R and  IL-
1βR, chemokine receptor CCR6 and by production of cytokines IL-17A, IL-17F, IL-
21 and IL-22 [113]. It must be noted that not all CD4+ cells that secrete IL-22 are 
Th17 cells, as a new subtype of helper T cells that secrete IL-22 but not IL-17 
have recently been identified. These cells are named Th22 cells [184, 185] and 
have been discussed more thoroughly in the introduction.  
The process of Th17 cell induction is a somewhat understood, with TGFβ and IL-6 
thought to have the main roles at inducing Th17 cells from naive CD4+ 
progenitors in mice [97, 119, 120] with pro-inflammatory cytokine IL-1β thought 
to amplify this process [121]. In humans Th17 cell induction is less understood 
and is still under investigation. As with mice, the 3 cytokines TGFβ, IL-6 and IL-
1β are thought to be the classic combination at Th17 cell induction used in 
culture but studies are showing that these 3 cytokines are not always necessary 
in humans. For example, studies have shown that Th17 cell populations have 
been induced from naive CD4+ T cells in an IL-1β and IL-6 dependent manner, 
independent of TGFβ [124]. There is also evidence that other pro-inflammatory 
cytokines such as IL-21 may play roles in Th17 induction also [125]. The role of 
IL-1β in Th17 cell induction in human and mice seems to differ and is worthy of 
investigation. 
As discussed in the previous chapter, P. aeruginosa strain PA103 ΔUΔT is able to 
activate the inflammasome due to the presence of a functional Type III Secretion 
System (T3SS) and therefore allows IL-1β release from dendritic cells (DCs), 
whereas PA103 ΔpcrV does not lead to IL-1β release due to lack of a functional 
T3SS. We wished to investigate if naive CD4+ T cells became Th17 cells in 
response to co-culture with P. aeruginosa infected DCs, and to see if IL-1β from 
the infected DCs contributed to this Th17 induction. However, as can be seen in 
the previous chapter, our culture technique of DCs leads to IL-1β secretion from 
both P. aeruginosa strains and thus IL-1β contribution can no longer be 
investigated by this means. 
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The aim of this chapter is to investigate if Th17 cells can be induced in response 
to P. aeruginosa, and if DC presence is important or only that of the cytokines 
produced by the infected DCs, as studies have shown in vitro that exposure to 
cytokines TGFβ, IL-6 and IL-1β can induce Th17 cells in mice [97]. Do the P. 
aeruginosa infected DCs secrete these factors, and are they sufficient to induce 
a strong Th17 cell response? We showed in the previous chapter that P. 
aeruginosa infected DCs secrete IL-1β and IL-23, and thus P. aeruginosa infected 
DCs are a source of these pro-inflammatory cytokines in culture. A source of 
TGFβ in this culture is unknown but we would predict that T cells themselves 
may secrete this, as T cells are a source of TGFβ [226]. Thus, many of the 
components are there for a Th17 cell response. Others have shown that bacteria 
primed APCs can promote induction of Th17 cells in humans [220, 221] and we 
wished to explore if this occurs in mice also. 
5.2 Co-culture of CD4+ T cells with P. aeruginosa infected 
DCs allows T cell proliferation 
We wanted to investigate if upon co-culture with P. aeruginosa infected DCs, 
total CD4+ splenic T cells were induced to proliferate indicating that the cell 
types have co-operated and led to T cell activation. We investigated this using 
CFSE incorporation. As expected, co-culture of total CD4+ T cells with DCs 
infected with both stains of P. aeruginosa leads to T cell proliferation (Figure 
5-1). 
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Figure 5-1 T cells co-cultured with P. aeruginosa infected DCs are induced to proliferate 
MACS sorted total CD4+ T cells were pre-treated with CFSE and left unstimulated (filled 
histogram) or co-cultured with P. aeruginosa ΔUΔT (blue line) or ΔpcrV (red line) infected DCs and 
cultured for 6 days before harvest and analysis by flow cytometry. Data representative of 3 
experiments. 
We confirmed that T cells cultured with P. aeruginosa infected DCs proliferate 
and thus the DCs are interacting with the T cells and activating them and 
therefore we may investigate these cells for IL-17 production knowing that they 
are activated by the P. aeruginosa infected DCs. No difference in T cell 
proliferation can be seen between PA103 strains, indicating that T cell 
proliferation when stimulated by an active DC is T3SS independent. 
5.3 Co-culture of CD4+ T cells with P. aeruginosa infected 
DCs allows IL-17 production 
We confirmed that in mice, as others have observed in with other pathogens in 
humans [220, 221], that co-culture of total CD4+ T cells with P. aeruginosa 
primed DCs leads to IL-17 secretion. We show that CD4+ T cells sorted by 
negative selection MACS co-cultured with P. aeruginosa infected DCs but not 
unstimulated DCs induces production of an IL-17+ population (Figure 5-2). 
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Figure 5-2 Culture with P. aeruginosa infected DCs induces IL-17+ populations from MACS 
isolated CD4+ T cells 
MACS sorted CD4+ T cells were co-cultured with P. aeruginosa infected DCs for 6 days, after 
which time cells were stimulated with PMA and ionomycin in the presence of brefeldin A for 5 
hours. Cells were then harvested and stained for IL-17 and analysed by flow cytometry. Cells gated 
on live cells based on forward scatter (FSC) and side scatter (SSC) as described in materials and 
methods. Positive gates were set on isotype on ΔUΔT stimulated cells.  Dot plots are 
representative of co-culture set up in triplicate. Data representative of 3 experiments.  
Thus it appears that Th17 cells can be induced from CD4+ T cells co-cultured 
with P. aeruginosa infected DCs. 
5.4 IL-2 diminishes the IL-17 producing population 
observed upon P. aeruginosa infection 
IL-2, formerly known as lymphocyte activating factor, is a T cell cytokine known 
to be important in the survival and proliferation of T cells in culture [227], but 
in the case of Th17 cells it is considered to be inhibitory [228]. We wanted to 
investigate if IL-2 addition reduced IL-17 secretion from CD4+ T cells co-cultured 
with P. aeruginosa infected DCs, indicating a reduction in Th17 cells, and to 
investigate if our cultures survive until day 6 to allow sufficient time for 
induction of Th17 cells. Stimulating anti-CD3 antibody was added in these 
experiments to activate the T cell receptor, as we wished to maximise any 
response from naive T cells which would require T cell activation; the DCs would 
provide accessory molecule stimulation.  
Total CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected 
DCs, in the presence or absence of IL-2 for 6 days after which time the 
supernatants of the culture were analysed for IL-17 by ELISA. With the addition 
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of IL-2, the concentration of IL-17 from T cells cultured with P. aeruginosa 
infected DCs is significantly reduced (Figure 5-3). 
 
Figure 5-3 IL-2 reduces IL-17 production from MACS isolated CD4+ T cells 
MACS sorted CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected DCs with 
or without addition of IL-2 for 6 days, after which time supernatants were harvested and analysed 
for IL-17 by ELISA. All error bars represent mean ± SEM. Data are representative of 3 separate 
experiments of experimental triplicates. * p<0.05.  
 
We further wanted to investigate if this was just a reduction in IL-17 production 
by the IL-17 secreting cells or if there were reduced IL-17 secreting populations 
upon addition of IL-2 to culture. To investigate this we analysed the IL-17 
populations in this culture by flow cytometry. Co-culture of T cells with DCs 
infected with P. aeruginosa in the presence of 50 units/ml of IL-2, which is the 
recommended concentration for optimal T cell survival, shows a population of 
1.5% IL-17+ cells. In the absence of IL-2, the IL-17+ population more than 
doubles to 3.6% IL-17+ cells (Figure 5-4). 
  122 
 
Figure 5-4 IL-2 reduces IL-17+ populations 
MACS sorted CD4+ T cells were co-cultured with PA103 ΔUΔT infected DCs in the presence or 
absence of exogenous IL-2 for 6 days, after which time cells were stimulated with PMA and 
ionomycin in the presence of brefeldin A for 5 hours. Cells were then harvested and stained for IL -
17 and analysed by flow cytometry. Cells gated on live cells based on FSC and SSC as described 
in materials and methods. Positive gates were set on isotype on ΔUΔT stimulated cells.  Dot plots 
are representative of co-culture set up in triplicate. Data representative of 3 experiments.  
 
This shows that IL-2 addition does not only block IL-17 secretion from IL-17+ 
cells but reduces IL-17 secreting populations. These results confirm that addition 
of IL-2 reduces production of IL-17 cells. We also witness that IL-17+ cells in our 
set-up survive up to 6 days in culture without exogenous IL-2 addition. However 
the T cells themselves make IL-2 which will aid in T cell survival and thus we 
cannot discount the effect of endogenous IL-2. We were concerned that lack of 
additional  T cell survival signals would lead to cell death after 6 days, but this is 
not observed suggesting addition of anti-CD3, and factors secreted in the culture 
are enough to ensure T cell survive for the time period. Due to these 
observations IL-2 was not added to subsequent experiments. 
5.5 IL-17 producing cells observed during co-culture of 
CD4 MACS sorted cells with P. aeruginosa infected 
DCs are CD4- 
We have established that co-culture of P. aeruginosa infected DCs with total 
CD4+ T cells isolated by negative selection MACS leads to an IL-17+ population 
(Figure 5-2). However, co-staining with CD4 antibodies to confirm that these 
cells are CD4+, and thus Th17 cells, revealed that this IL-17+ population is not a 
CD4+ population as others have seen and hence is not a Th17 cell (Figure 5-5). 
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Figure 5-5 IL-17+ populations during co-culture with P. aeruginosa infected DCs are CD4- 
MACS sorted CD4+ T cells were co-cultured with P. aeruginosa infected DCs in the presence or 
absence of IL-2 for 6 days, after which time cells were stimulated with PMA and ionomycin in the 
presence of brefeldin A for 5 hours. Cells were then harvested and stained of IL-17 and analysed 
by flow cytometry. Cells gated on live cells based on FSC and SSC as described in materials and 
methods, and further gated on the IL-17+ cell containing  population. Dot plots are representative 
of co-culture set up in triplicate. Positive gates were set on isotypes on ΔUΔT stimulated cells. Data 
representative of 3 experiments.  
IL-17+ cell populations are apparent in both ΔUΔT and ΔpcrV infections 
indicating that both these bacterial strains can lead to IL-17 secretion from 
selected cells. Oddly, we see that this IL-17+ population is a CD4- population and 
not a CD4+ source. As we have selected CD4+ cells by MACS isolation, the 
observation that these cells are CD4- is confounding. As the CD4+ cells have 
been isolated using negative selection, a process whereby all other cells are 
labelled and retained and that the CD4+ cells pass through untouched, we 
wondered if we were perhaps not adding enough of the antibody cocktail stage 
that would deselect everything else. We tried several times adding more beads 
to retain more CD4- cells and still saw the same IL-17+, CD4- population upon 
co-culture with P. aeruginosa infected DCs. The antibody cocktail component 
that labels all other cells for retention contained antibodies to CD8 cells (CD8a), 
macrophages (CD11b), B cells (B220), NK cells (DX5) and red blood cells (ter-
119). We noted that γδ T cells are not retained by this kit, whereas they are in 
the human kit, and so this prompted us to stain our cultures for γδ T cells to 
investigate they are responsible for our IL-17 positive populations observed upon 
co-culture with P. aeruginosa infected DCs. 
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5.6 γδ T cells are prolific producers of IL-17 and do so in 
an antigen independent manner 
Upon investigation of this IL-17+ CD4- population that we see upon co-culture 
with P. aeruginosa infected DCs in a theoretically CD4+ isolated cell preparation, 
we find that the source of IL-17 in our co-culture is γδ T cells (Figure 5-6). 
 
Figure 5-6 IL-17 observed upon co-culture with P. aeruginosa infected DCs is from γδ T cells 
MACS sorted CD4+ T cells were co-cultured with P. aeruginosa infected DCs for 6 days, after 
which time cells were stimulated with PMA and ionomycin in the presence of brefeldin A for 5 
hours. Cells were then harvested and stained of IL -17 and γδ and analysed by flow cytometry. 
Cells gated on live cells based on FSC and SSC as described in materials and methods. Positive 
gates were set on isotypes on ΔUΔT stimulated cells. Dot plots are representative of co-culture set 
up in triplicate..  Data representative of 3 experiments.  
 
71% of the IL-17 producing cells observed upon co-culture with P. aeruginosa    
infected DCs are γδ T cells, and 40% of the γδ T cells in this preparation are IL-
17+. This indicates that γδ T cells may have a big role to play in IL-17 production 
during P. aeruginosa infection. This relatively small 1.6% of γδ+ IL-17+ cells, 
along with a small population, 0.65%, of IL-17+ CD4- γδ- cells that have not been 
identified, make prolific amounts of IL-17 in this experimental set up with no 
significant difference seen between P. aeruginosa stains (Figure 5-7), indicating 
that γδ T cells are abundant sources of IL-17 during infection.  
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Figure 5-7 IL-17 from CD4+ γδ + cells co-cultured with P. aeruginosa infected DCs 
stimulated with anti-CD3 
MACS sorted CD4+ T cells were co-cultured with P. aeruginosa infected DCs in the presence of 
anti-CD3 for 6 days, after which time supernatants were harvested and analysed for IL-17 by 
ELISA. All error bars represent mean ± SEM. Data are representative of 3 separate experiments of 
experimental triplicates. *** p<0.001. 
In these cultures IL-17 can be observed even in unstimulated conditions, albeit 
significantly lower than in infection conditions. γδ T cells are considered to be a 
more innate like T cell and have been shown to secrete IL-17 upon stimulation of 
the CD3 receptor in the absence of other stimuli [137]. This explains the surge of 
IL-17 from T cells co-cultured with unstimulated DCs observed in culture. This 
led us to investigate the role of γδ T cells in IL-17 production during P. 
aeruginosa infection which is described in the next chapter.  
5.7 CD44 and CD62L are interchangeable markers of T 
cell memory status and naive CD44- T cells become 
CD44+ memory T cells upon activation. 
As our CD4 negatively selected cell preparation contained naive and memory 
CD4+ T cells as well as contamination from γδ T cells we decided to isolate naive 
T cells from this preparation and culture them with our P. aeruginosa infected 
DCs to determine if Th17 cells could be induced from naive T cells under these 
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conditions. Naive and memory cells can be identified using cell surface markers 
CD62L and CD44 respectively as discussed in the introduction. We used a CD62L 
MACS kit to positively select CD62L+ naive cells which we used for culture, and 
we stained the remaining CD62L- preparation (memory T cells) with antibodies 
to CD44 and analysed them using flow cytometry (Figure 5-8). 
 
Figure 5-8 CD62L- cells are CD44+ 
CD62L- cells selected by MACS were stained for CD44 (black line) and analysed by flow cytometry 
against corresponding isotype (filled histogram) to investigate comparability of these 2 
memory/naive T cell markers. Cells gated on live cells based on FSC and SSC as described in 
materials and methods. Histograms are representative of co-culture set up in triplicate. Data 
representative of 2 experiments.  
 
96% of the CD62L- MACS isolated cells are CD44 positive, confirming that the 
purification protocol has resulted in a population of essentially pure naive and 
memory T cells.  
We also confirmed that during co-culture CD62L+ CD44- naive cells are activated 
and become CD44+ cells further confirming use of this marker as a 
memory/naive indicator (Figure 5-9). 
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Figure 5-9 Naive CD44- cells become CD44+ upon activation  
Naive CD62L+ CD44- CD4+ T cells were co-cultured with P. aeruginosa infected DCs for 6 days, 
after which time cells were harvested and stained for CD44 (black line) and analysed by flow 
cytometry against corresponding isotype (filled histogram). Cells gated on live cells based on FSC 
and SSC as described in materials and methods. Histograms are representative of co-culture set 
up in triplicate. Data representative of 3 experiments. 
CD44 expression levels on CD62L+ naive cells was not measured before 
stimulation, as all CD62L+ cells were used for experimental set-up. But as CD44 
and CD62L appear to be interchangeable markers as we have seen from CD44+ 
staining of CD62L memory cells, one may speculate that naive CD62L+ cells 
would be CD44- before stimulation, and that there is almost a complete shift to 
CD44+ cells during stimulation upon co-culture (Figure 5-9). This observation 
would be logical as these cells are now activated and CD44 is present on 
activated cells. 
5.8 γδ T cells are memory like with regards to CD62L 
expression 
As it is known that CD4+ T cell selection using negative selection MACS kit is not 
pure, we purified the CD4+ population further by dividing it into naive and 
memory populations. By selecting CD62L+ naive cells only we hope to eliminate 
the γδ T cells from the preparation, leaving only the naive CD4+ T cells and thus 
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allowing us to conclude that any IL-17 we see in our co-culture is from Th17 
cells. 
 
Figure 5-10 γδ T cells are CD62L - ‘memory like’ cells 
MACS isolated CD4+ T cells were divided into naive and memory preparations on the basis of 
CD62L using MACS and stained for γδ to identify if γδ T cells are CD62L+ or CD62L -. Cells gated 
on live cells based on FSC and SSC as described in materials and methods. Dot plots are 
representative of co-culture set up in triplicate. Data representative of 3 experiments. 
 
We confirm that γδ T cells are more ‘memory like’ with regards to surface 
marker expression of CD62L and do not express this marker as γδ T cells cannot 
be found in the CD62L+ preparation (Figure 5-10). Thus purifying the CD4 MACS 
selected cell preparation with CD62L MACS to isolate naive CD4+ T cells 
eliminates γδ T cell contamination in the preparation, leaving just naive CD62L+ 
CD4+ T cells. This allows us to see if upon culture with P. aeruginosa infected 
DCs Th17 cell responses can be induced from naive CD4+ T cells.  
5.9 Naive CD4+ T cells become Th17 cells upon              
co-culture with P. aeruginosa infected DCs 
Naive CD4+ T cells were isolated as described above and co-cultured with P. 
aeruginosa infected DCs in the presence of anti-CD3 to see if IL-17, and 
therefore Th17 cell responses, may be induced by P. aeruginosa primed DCs. We 
see that IL-17 is produced upon co-culture of naive T cells with P. aeruginosa 
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infected DCs, but not unstimulated DCs indicating that Th17 cell responses can 
be generated from naive CD4+ T cells in response to P. aeruginosa (Figure 5-11). 
 
Figure 5-11 Co-culture with P. aeruginosa infected DCs induces naive CD4+ T cells to 
become Th17 cells 
Naive CD62L+ CD4+ T cells were cultured with unstimulated or P. aeruginosa infected DCs for 6 
days, after which time supernatants were harvested and analysed for IL-17 by ELISA. All error bars 
represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. ** p< 0.005.  
An IL-17 producing population can be observed in both P. aeruginosa strains 
ΔUΔT and ΔpcrV with no significant difference in IL-17 production seen between 
strains indicating that IL-17 production is from these cells is T3SS independent. 
The presence of IL-17 from naive CD4+ T cells co-cultured with P. aeruginosa 
infected DCs indicates that Th17 cells can be induced upon infection with P. 
aeruginosa. 
Analysis of the cells by flow cytometry show small, 0.5%, but clear IL-17+ IFNγ- 
populations from naive CD4+ T cells co-cultured with P. aeruginosa infected DCs, 
but not unstimulated DCs (Figure 5-12). 
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Figure 5-12 IL-17 producing populations upon co-culture with P. aeruginosa infected DCs 
Naive CD62L+ CD4+ T cells were cultured with unstimulated or P. aeruginosa infected DCs for 6 
days, after which time cells were stimulated with PMA and ionomycin in the presence of brefeldin A 
for 5 hours. Cells were then harvested and stained of IL-17 and IFNγ and analysed by flow 
cytometry.  T cells cultured with Th17 inducing cytokines TGFβ, IL-16 and IL-1β were also 
analysed for IL-17, as a positive control to show techniques were sound. Cells gated on live cells 
based on FSC and SSC as described in materials and methods. Positive gates were set on 
isotypes on ΔUΔT stimulated cells.   Dot plots are representative of co-culture set up in triplicate. 
Data representative of 3 experiments. 
 
This population may not be large but is unquestionably increased from 
unstimulated, and taken together with the ELISA results (Figure 5-11) imply that 
Th17 cells are induced to P. aeruginosa infection during this co-culture. 
5.10  IL-17 secretion from naive CD4+ T cells is DC 
dependent 
The literature describes that Th17 cells can be induced from naive CD4+ Th0 
precursors upon ligation of CD3 and CD28 in the presence of TGFβ, IL-6 [97, 120] 
and perhaps also IL-1β. In our culture we hypothesise that the DCs will provide 
some of these factors as we have previously seen IL-1β secretion and up-
regulation of co-stimulation markers from the P. aeruginosa infected DCs (see 
previous chapter). Thus, we set out to determine if DCs secrete the cytokines 
needed to induce Th17 cell and is this sufficient for their induction. We have 
demonstrated that Th17 cells develop from naive T cells co-cultured with P. 
aeruginosa infected DCs, but wish to explore if the DCs role in Th17 cell 
induction is to provide only basic co-stimulation and cytokines or do they supply 
other factors. 
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We investigated this by culturing naive T cells the presence of DCs or in their 
absence with co-stimulation provided artificially by anti-CD28 addition. For 
conditions in the absence of DCs, T cells were cultured in the supernatants of 
the infected DC where all soluble factors and cytokines secreted from the DCs 
would be, referred to therein as conditioned media. For conditions in the 
presence of DCs, T cells were cultured with infected DCs carried over in their 
conditioned media. Both conditions received anti-CD3 to stimulate the TCRs, as 
without TCR stimulation the naive cells will not respond and will die without 
stimulation in culture over 6 days. Using this set-up we found that naive T cells 
only secrete IL-17 in the presence of both DCs and their conditioned media and 
not in DC absence even when co-stimulation was provided artificially (Figure 
5-13).  
 
Figure 5-13 IL-17 secretion from naive T cells requires DC presence  
Naive CD62L+ CD4+ T cells were cultured with DC conditioned media in the presence or absence 
of DCs, in presence of anti-CD28, for 6 days, after which time supernatants were harvested and 
assayed for IL-17 by ELISA. All error bars represent mean ± SEM. Data are representative of 3 
separate experiments of experimental triplicates.*p <0.05  *** p<0.001.  
The difference in IL-17 secreted from T cells in DC absence or presence in both 
infection conditions is significant. A small amount of IL-17 can be observed from 
unstimulated DCs but we have shown previously that even unstimulated DCs up-
regulate some CD40 and CD86 and secrete some IL-23, upon aggravation upon 
plating (see previous chapter).  
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This result indicates that the DCs play a bigger role than just standard co-
stimulation, which we provided with anti-CD28, and cytokines, which would have 
been present in the conditioned media.  
5.11  Role of IL-1β contribution in Th17 cell development 
We previously discovered that infection of DCs with both P. aeruginosa strains 
ΔUΔT and ΔpcrV, for 90 minutes before overnight incubation allowed better up-
regulation of co-stimulatory markers but IL-1β from both strains when we hoped 
to use these strains as a model to represent the presence of or absence of IL-1β, 
(see previous chapter). Due to this we can no longer make any assumptions of 
role of IL-1β in Th17 cell induction with use of these strains in our co-culture, as 
no IL-1β difference can be observed between strains under our co-culture 
conditions. We wished to define the role of IL-1β in Th17 cell induction by 
skewing naive T cells to become Th17 cells in the presence of CD3, CD28, TGFβ 
and IL-6, with or without addition of IL-1β. We found no significant difference in 
IL-17 concentration in naive cells induced to be Th17 cells in the presence or 
absence of IL-1β, and similar percentages of IL-17+ populations, as based on 
isotype, from both cultures (Figure 5-14). Positive gates were set using the 
isotype control, set on TGFβ, IL-6 and IL-1β stimulated cells, to represent a 
negative population. We recognise that less stringent gating on this isotype 
would encompass a larger population in the positive samples and it thus may be 
insinuated that the majority of cells are IL-17+. 
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Figure 5-14 IL-17 production from naive T cells is IL-1β independent 
Naive CD62L+ CD4+ T cells were cultured with anti-CD3, anti-CD28, TGFβ, IL-6 and with or 
without IL-1β for 6 days, after which time supernatants were harvested and analysed for IL-17 by 
ELISA (A). All error bars represent mean ± SEM. Data are representative of 3 separate 
experiments of experimental triplicates. Cells were stimulated with PMA and ionomycin in the 
presence of brefeldin A for 5 hours, after which time they were harvested and stained for IL -17 and 
analysed by flow cytometry compared to isotype control stained on T cells cultured with TGFβ, IL -6 
and  IL-1β (B). Cells gated on CD4+ cells. Dot plots are representative of co-culture set up in 
triplicate. Data representative of 3 experiments.  
Thus we see that induction of IL-17 from naive CD4+ T cells isolated from the 
spleen, does not require IL-1β in our in vitro set up, although IL-1β addition may 
enhance IL-17+ populations.  
5.12  IL-17 secreting cells induced from co-culture with    
P. aeruginosa do not co-express IL-22 
Th17 cells are described as both IL-17 and IL-22 secreting [71] and we wished to 
investigate if the CD4+ IL-17+ cells that we see during co-culture with P. 
aeruginosa infected DCs were also IL-22+, representing ‘true’ Th17 cells. 
However, the IL-17 secreting cells we see here derived from naive CD4+ T cells 
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appear to secrete low levels of IL-22, in comparison to the levels we observed of 
IL-17 (Figure 5-11), as evident by ELISA analysis of cell culture supernatants 
(Figure 5-15). 
 
Figure 5-15 IL-22 secretion from naive T cells culture with P. aeruginosa infected DCs is low 
Naive CD62L+ CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected DCs for 
6 days, after which time supernatants were harvested and analysed for IL-22 by ELISA. All error 
bars represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. * p<0.05, *** p<0.001.  
 
Our initial observation is that IL-22 production from naive T cells co-cultured 
with P. aeruginosa infected DCs is low compared to the concentrations of IL-17 
we have observed.  IL-22 concentrations of only 100pg/ml are found, whereas IL-
17 levels reached 1000pg/ml (Figure 5-11). However, the IL-22 secreted from 
naive cells upon culture with infected DCs is significantly different statistically 
to that of culture with unstimulated DCs (Figure 5-15) indicating that this is a 
real difference. However, no IL-22+ stained populations are observed by flow 
cytometry in these cultures (Figure 5-16). 
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Figure 5-16 IL-22+ cells are not induced from naive CD4+ T cells co-cultured with P. 
aeruginosa infected DCs 
Naive CD62L+ CD4+ T cells were cultured with unstimulated or P. aeruginosa infected DCs for 6 
days, after which time cells were stimulated with PMA and ionomyc in in the presence of brefeldin A 
for 5 hours. Cells were then harvested and stained for CD4 and IL-22 and analysed by flow 
cytometry. Cells gated on live cells based on FSC and SSC as described in materials and 
methods. Positive gates were set on isotype on ΔUΔT stimulated cells. Dot plots are representative 
of co-culture set up in triplicate. Data representative of 3 experiments.  
Furthermore, naive T cells induced to be Th17 cells by stimulation with CD3 and 
CD28 in the presence of IL-1β, TGFβ and IL-6, secrete IL-17 but not IL-22 as can 
be observe by both flow cytometry and ELISA (Figure 5-17). We are confident 
that our IL-22 antibody is functional as we see IL-22 staining with the same 
antibody when investigating γδ T cells in chapter 6.  
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Figure 5-17 Cytokine induced Th17 cells are IL-17+ and IL-22- 
Naive CD62L+ CD4+ T cells were induced to become Th17 cells in the presence of TGFβ, IL -6 and 
IL-1β for 6 days, after which time supernatants were harvested and cells were stimulated with PMA 
and ionomycin in the presence of brefeldin A for 5 hours. Cells were then harvested and stained of 
IL-17 and IL-22 and analysed by flow cytometry (A). Cells gated on live cells based on FSC and 
SSC as described in materials and methods. Positive gates were set on isotypes on TGFβ, IL -6, IL-
1β stimulated cells.   Dot plots are representative of co-culture set up in triplicate. Data 
representative of 5 experiments. Supernatants were analysed for IL-17 and IL-22 by ELISA (B). All 
error bars represent mean ± SEM.  Data are representative of 5 separate experiments of 
experimental triplicates. *** p<0.001.  
 
Thus, it appears that our CD4+ IL-17+ cells derived from naive cells co-cultured 
with P. aeruginosa DCs, or in the presence of Th17 inducing cytokines, are IL-22- 
and not archetypal Th17 cells.  
5.13  CD4+ naive T cells can be induced to secrete IL-17 
when cultured with S. pneumoniae infected DCS 
We wished to investigate if Th17 cells could be induced following infection with 
a Gram-positive respiratory pathogen such as S. pneumoniae. Gram-positive and 
Gram-negative pathogens fundamentally differ in their cell walls and as this is a 
surface that the DCs would directly come in contact with and potentially 
recognise, this cell wall difference may well lead to a different response. LPS i s 
a main component of Gram-negative bacterial walls and has been used 
previously as a non-specific control of activation for the P. aeruginosa 
experiments. Gram-positive bacterial strains do not have LPS, making use of LPS 
as a comparison void. Bacterial lipoprotein (BLP) is a component of Gram-
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positive and Gram-negative bacteria cell walls, recognised by TLR2 that can be 
used as a positive DC activation control for Gram-positive S. pneumoniae. 
In preliminary experiments DCs were infected with two S. pneumoniae strains; 
D39 WT and D39 ΔPLY, a variant of D39 that lacks cytotoxic PLY toxin and thus 
will be less cytotoxic to the DCs. We have shown in the previous chapter that 
infection of DCs with S. pneumoniae leads to DC activation, some IL-1β secretion 
but no IL-23 secretion as was witnessed with infection with Gram-negative P. 
aeruginosa. IL-1β secretion differs between the S. pneumoniae strains D39 WT 
and D39 ΔPLY, with low secretions of IL-1β during infection with PLY deficient 
D39 ΔPLY, and significantly higher IL-1β concentrations from infection with PLY 
competent D39 WT. Thus if IL-1β does contribute considerably to Th17 
induction, a difference will be observed between infection with these S. 
pneumoniae strains during co-culture. S. pneumoniae infected DCs and their 
conditioned media were co-cultured with naive T cells as has been described for 
P. aeruginosa infected DCs and IL-17 presence was investigated by ELISA (Figure 
5-18) and flow cytometry (Figure 5-19).  
 
Figure 5-18 Co-culture with PLY deficient S. pneumoniae infected DCs induces naive CD4+ T 
cells to become Th17 cells 
Naive CD62L+ CD4+ T cells were cultured with unstimulated or S. pneumoniae infected DCs for 6 
days, after which time supernatants were harvested and analysed for IL-17 by ELISA. All error bars 
represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. 
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In these sets of experiments, the unstimulated DCs unusually gave a high 
background level of IL-17 production (Figure 5-18).  However, a non significant 
trend (p=0.0601) can be observed upon D39 ΔPLY infection, whereby IL-17 
production is increased from that of unstimulated.  IL-17 production by naive T 
cells co-cultured with unstimulated DCs is further observed by flow cytometry as 
a 2.2% IL-17+ population can be observed (Figure 5-19). An increase in IL-17+ 
population to 3.79% is seen upon infection with D39 WT. However infection with 
ΔPLY which appears to allow better IL-17 secretion (Figure 5-18) shows a 
reduced IL-17+ population from unstimulated, 1.13%  (Figure 5-19). Co-culture of 
naive T cells with BLP stimulated DCs seems to give the largest population of IL-
17+ cells as measured by flow cytometry (Figure 5-19) suggesting induction of IL-
17+ cells in this set up is not S. pneumoniae specific. 
 
Figure 5-19 Th17 cell populations are induced from naive T cells co-cultured with S. 
pneumoniae infected DCs 
Naive CD62L+ CD4+ cells were co-cultured with S. pneumoniae infected DCs for 6 days, after 
which time cells were stimulated with PMA and ionomycin in the presence of brefeldin A for 5 
hours. Cells were then harvested and stained for IL-17 and analysed by flow cytometry. Cells gated 
on live cells based on FSC and SSC as described in materials and methods. Positive gates were 
set on isotype on D39 WT stimulated cells. Dot plots are representative of co-culture set up in 
triplicate. Data representative of 3 experiments.  
Therefore the FACS data does not correlate with the ELISA data. The ELISA 
implies that D39 ΔPLY induces better IL-17 production with concentrations 
observed appreciably different from that of ‘unstimulated’, however the IL-17 
populations seen when investigating these co-cultures by flow cytometry would 
indicate that there are fewer IL-17 producing cells in D39 ΔPLY than 
unstimulated or D39 WT infection, and an increase of IL-17+ cells from 
unstimulated under D39 WT infection. This disagreement between FACS and 
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ELISA, and IL-17+ population and secretion observed in unstimulated conditions 
was observed 3 times and is discussed further in the discussion.  
5.14  Naive CD4+ T cells become Th17 cells upon           
co-culture with S. pneumoniae infected DCs, and 
require DC-T cell contact for optimal IL-17 production 
As with P. aeruginosa, we wished to investigate if IL-17 production from naive T 
cells co-cultured with S. pneumoniae infected DCs was DC contact dependent. 
We explored this by culturing naive T cells either with S. pneumoniae infected 
DC conditioned media in the presence of artificially provided anti-CD28, or by 
co-culturing naive T cells with S. pneumoniae infected DCs washed out of their 
conditioned media and resuspended in fresh media. As with P. aeruginosa, S. 
pneumoniae induction of IL-17 from naive CD4+ T cells is dependent on presence 
of DCs in culture as naive CD4+ T cells cultured with S. pneumoniae infected DC 
conditioned media express significantly lower levels of IL-17 than when DCs are 
present in culture (Figure 5-20). 
 
Figure 5-20 IL-17 secretion from naive T cells co-cultured with S. pneumoniae infected DCs 
is DC contact dependent. 
Naive CD62L+ CD4+ T cells were co-cultured with unstimulated or S. pneumoniae infected DCs 
washed out of their conditioned media and resuspended in fresh media, or cultured in the 
conditioned media of these DCs for 6 days, after which time supernatants wer e harvested and 
analysed for IL-17 by ELISA. All error bars represent mean ± SEM. Data are representative of 3 
separate experiments of experimental triplicates. ** p<0.005, *** p<0.001. 
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It would appear that S. pneumoniae infected DC conditioned media may have 
some contribution as it can be observed upon D39 ΔPLY infection IL-17 
production is increased from that of unstimulated (Figure 5-20). However, these 
concentrations are reduced in comparison to those observed where DCs are 
present, indicating DC presence is important.  
These observations are confirmed on analysis of the cells by flow cytometry 
(Figure 5-21). 
 
Figure 5-21 Production of IL-17+ populations from naive T cells co-cultured with S. 
pneumoniae infected DCs is DC contact dependent 
Naive CD62L+ CD4+ cells were co-cultured with S. pneumoniae infected DCs in fresh media, or in 
S. pneumoniae infected DC conditioned media alone, for 6 days, after which time cells were 
stimulated with PMA and ionomycin in the presence of brefeldin A for 5 hours. Cells were then 
harvested and stained for IL-17 and analysed by flow cytometry. Cells gated on live cells based on 
FSC and SSC as described in materials and methods. Positive gates were set on isotype on D39 
WT stimulated cells.   Dot plots are representative of co-culture set up in triplicate. Data 
representative of 3 experiments.  
IL-17+ cell populations are observed in DC presence, and these populations are 
reduced when DCs are absent and T cells are cultured solely in conditioned 
media. In agreement with the ELISA data (Figure 5-20) it appears that even in 
the absence of DCs co-culture of naive T cells with the conditioned media of D39 
ΔPLY allows production of IL-17+ populations, although reduced from populations 
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observed when DCs are present (Figure 5-21). It is unclear why D39 ΔPLY may 
lead to IL-17 producing populations in a DC contact independent manner and this 
was not investigated further as was not a focus of this thesis. 
These results indicate that DC presence is important for IL-17 secretion from 
naive cells in response to S. pneumoniae and it appears that D39 ΔPLY infected 
DCs are better than its WT counterpart at inducing such responses. 
5.15  IL-17 may be induced from naive CD4+ T cells when 
cultured with P. aeruginosa infected mucosal DCs. 
As P. aeruginosa is a mucosal pathogen, colonising lungs and mucosal surfaces, 
we wished to investigate if mucosal DCs were superior to the ‘artificial’ GM-CSF 
derived BMDCs that we induced at stimulating IL-17 responses from naive T cells 
when co-cultured.  
5.15.1 P. aeruginosa infected NALT DCs induce IL-17 
responses from naive CD4+ T cells 
Co-culture with P. aeruginosa infected NALT DCs but not uninfected NALT DCS 
allows production of an IL-17 secreting population from naive splenic CD4+ T 
cells (Figure 5-22). 
 
Figure 5-22 Naive T cells co-cultured with P. aeruginosa infected NALT DCs become IL-17+ 
Naive CD62L+ T cells were co-cultured with unstimulated or P. aeruginosa infected NALT DCs for 
6 days, after which time cells were stimulated with PMA and ionomycin for 5 hours. Cells were then 
harvested and stained for IL-17 and analysed by flow cytometry. Cells gated on CD4+ cells. 
Positive gates were set on isotype on ΔUΔT stimulated cells.  Dot plots are representative of co-
culture set up in triplicate. Data representative of 2 experiments.  
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Naive T cells cultured with P. aeruginosa infected DCs show 4.4% and 1.8% IL-17+ 
populations with ΔUΔT and ΔpcrV respectively, whereas none is observed when T 
cells are cultured with unstimulated DCs. This indicates that P. aeruginosa 
infected NALT DCs have the capacity to induce IL-17 responses from naive T 
cells. We observe that PA103 ΔUΔT induces a much higher IL-17+ population than 
PA103 ΔpcrV (Figure 5-22) although upon investigation of IL-17 in the culture 
supernatant by ELISA, both strains appear to secrete similar levels of IL-17 
(Figure 5-23). 
 
Figure 5-23 IL-17 production from co-culture of naive T cells with P. aeruginosa infected 
NALT DCs.  
CD62L+ Naive CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected NALT 
DCs for 6 days after which time supernatants were harvested and analysed for IL-17 by ELISA. All 
error bars represent mean ± SEM. Data are representative of 2 separate experiments of 
experimental triplicates.  
The same results were observed on repeating the experiment. Ideally this would 
have been repeated several more times to confirm this result but due to scarcity 
of material further analysis was not performed. 
We digested whole NALT tissue and stimulated it with anti-CD3 and anti-CD28 to 
mimic the presence of DCs and co-stimulation to see if an innate IL-17+ 
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population exists in the naive NALT tissue that we liberate and could it be 
responsible for IL-17 production upon anti-CD3 stimulation (Figure 5-24). 
 
Figure 5-24 Stimulated whole NALT does not contain an innate IL-17 producing population 
Whole NALT was stimulated with anti-CD3 and anti-CD28 for 3 days before being stimulated with 
PMA and ionomycin in the presence of brefeldin A for 5 hours. After this time cells were harvested 
and stained for IL-17 and analysed by flow cytometry. Cells gated on live cells based on FSC and 
SSC. Positive gates were set on isotype on anti-CD3 and anti-CD28 stimulated cells. Dot plots are 
representative of co-culture set up in triplicate. Data representative of 2 experiments.  
Whole NALT tissue stimulated with anti-CD3 and anti-CD28 does not lead to 
emergence of an IL-17+ population (Figure 5-24) indicating that there is not an 
IL-17 producing innate population in this tissue that is activated by anti-CD3 and 
we therefore consider the IL-17+ population we see from naive CD4+ T cells upon 
co-culture with P. aeruginosa infected NALT DCs (Figure 5-22) to be from the 
development of Th17 cells. These observations indicate that NALT derived DCs 
may be better at inducing IL-17 responses from naive T cells upon P. aeruginosa 
infection as opposed to GM-CSF derived BMDCS. This may be as NALT DCs are 
biological DCs placed at sites of P. aeruginosa invasion and thus they may have 
factors that aid in responses to respiratory pathogen. This requires further 
investigation but could be a potential area of interest for further P. aeruginosa 
infection and DC studies. 
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5.15.2 P. aeruginosa infected lung DCs induce IL-17 
responses from naive CD4+ T cells 
When analysing our BMDC/splenic T cell co-cultures by flow cytometry we 
normally see one population of cells that has a low side scatter and a middling 
to high forward scatter. It is this population that we select to represent our live 
cells, as everything else is on the axis, and this is where we have previously 
observed our IL-17+ cells. However when looking at cultures with lung derived 
DCs we see a new population in our co-culture based on forward scatter that we 
do not normally see when culturing naive splenic T cells with BMDCs and did not 
witness when culturing with NALT DCs either. We gate this new population 
separate to our usual ‘live’ population and brand it ‘activated’ as it is not see in 
unstimulated conditions but only in infection conditions (Figure 5-25).  
 
Figure 5-25 A new ‘activated’ population of T cells is observed when naive T cells are co-
cultured with P. aeruginosa infected lung DCs 
Naive CD62L+ T cells were co-cultured with unstimulated or P. aeruginosa infected lung DCs for 6 
days, after which time cells were then harvested and stained for and analysed by flow cytometry. 
Dot plots are representative of co-culture set up in triplicate. Data representative of 3 experiments. 
 
Usually for analysis we gate on the whole ‘live’ population as marked in Figure 
5-25 to encompass all live cells and ensure we include the IL-17+ population 
which is normally found here. If we gate on ‘live’ in the lung DC- splenic T cell 
co-cultures we see a 1.74% IL-17+ population upon ΔUΔT infection up from 0.12% 
of unstimulated (Figure 5-26) indicating that there is a population of IL-17+ cells 
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present in this co-culture and confirming that IL-17+ T cells can be induced upon 
co-culture of naive CD4+ T cells with P. aeruginosa exposed lung DCs. However if 
we focus on this new ‘activated’ population which isn’t normally observed in our 
co-culture set up and is clearly a visible addition from unstimulated to infected 
based on FSC, we see that there are 1.05% IL-17 cells in unstimulated but an 
increase to 7.15% upon ΔUΔT infection (Figure 5-26). It would thus appear that 
all our IL-17 producing cells are in this ‘activated’ population.  
 
Figure 5-26 'Live' and 'activated' T cell populations from co-culture with lung DCs contain IL-
17+ populations 
Naive CD62L+ T cells were co-cultured with unstimulated or P. aeruginosa infected lung DCs for 6 
days, after which time cells were stimulated with PMA and ionomycin for 5 hours. Cells were then 
harvested and stained for IL-17, and analysed by flow cytometry. Plots gated on ‘live’ and 
‘activated’ populations identified by FSC and SSC.  Positive gates were set on isotype on ΔUΔT 
stimulated cells.   Dot plots are representative of co-culture set up in triplicate. Data representative 
of 3 experiments. 
 
Although small, as 7.5% of 30% of a total population only amounts to approx 2% 
of all cells, there is still clearly a Th17 cell induction upon culture of naive T 
cells with P. aeruginosa infected lung DCs. These IL-17+ cell populations are not 
observed when lung DCs were treated with LPS (Figure 5-26), indicating that it is 
not just an activated DC, but a P. aeruginosa infected DC that is leading to this 
production of IL-17 from the naive T cells and so a specific response to P. 
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aeruginosa may be induced by lung DCs co-cultured with naive CD4+ T cells. 
Production of IL-17 from T cells co-cultured with P. aeruginosa infected lung DCs 
is further confirmed by ELISA and analysis of the culture supernatants for IL-17 
where a significant concentration of IL-17 is observed with infected DCs 
compared to unstimulated DCs (Figure 5-27). 
  
Figure 5-27 Naive T cells co-cultures with P. aeruginosa infected lung DCs are IL-17 
secreting.  
Naive CD62L+ CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected lung 
DCs for 6 days, after which time supernatants were harvested and analysed for IL-17 by ELISA. All 
error bars represent mean ± SEM. Data are representative of 3 separate experiments of 
experimental triplicates. *** p<0.001. 
 
These results indicate that mucosal DCs induce IL-17 responses from naive T 
cells when infected with P. aeruginosa, and comparison to populations observed 
when using BMDCs suggest mucosal DCs may induce these responses in a more 
robust manner. 
5.15.3 IL-22 responses from naive CD4+ T cells co-cultured 
with P. aeruginosa infected mucosal DCs. 
IL-22 levels were also analysed by ELISA and flow cytometry in the above 
experiments with mucosal DCs to investigate if IL-17+ cells observed in these co-
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cultures co-expressed IL-22, as IL-22 was not evident from IL-17+ cells induced 
by culture with BMDCs (Figure 5-15 and Figure 5-16).  
Very small, but significant, levels from IL-22 can be observed from naive T cells 
cultured with P. aeruginosa infected lung DCs compared to culture with 
unstimulated DCs (Figure 5-28). 
 
Figure 5-28 IL-22 secretion from naive T cells co-cultured with P. aeruginosa infected lung 
DCs is low 
Naive CD62L- CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected lung DCs 
for 6 days, after which time supernatants were harvested and analysed for IL -22 by ELISA. All error 
bars represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. * p<0.05.  
Co-culture with NALT infected DCs gave even smaller concentrations of IL-22 
that did not differ significantly from unstimulated and therefore are considered 
to be negligible. 
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Figure 5-29 Naive T cells co-cultured with P. aeruginosa infected NALT DCs do not secrete 
IL-22 
Naive CD62L+ CD4+ T cells were co-cultured with unstimulated or P. aeruginosa infected NALT 
DCs for 6 days, after which time supernatants were harvested and analysed for IL-22 by ELISA. All 
error bars represent mean ± SEM. Data are representative of 3 separate experiments of 
experimental triplicates. 
No IL-22+ populations could be observed by flow cytometry for culture with 
either mucosal DC (data not shown). 
These results indicate that IL-22 is not co-expressed by IL-17+ cells induced by 
co-culture with mucosal DCs suggesting that, as was observed with co-culture 
with P. aeruginosa  infected BMDCs, these cells are not archetypal Th17 cells.  
5.16  Discussion 
It has been shown that Th17 cells can be induced in human studies from APCs 
that are primed with a variety of innate immune stimuli [220, 221]. We wished 
to investigate this phenomenon in mice in relation to the respiratory pathogen P. 
aeruginosa, while also looking at the contribution of IL-1β in Th17 cell induction 
as its importance in mice is still subject of debate. 
Our original model for the investigation of IL-1β contribution was to use 2 
bacterial strains of P. aeruginosa, one with a competent T3SS that leads to IL-1β 
release from DCs upon infection, PA103 ΔUΔT, and another strain that does not 
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have a functional T3SS and thus does not lead to IL-1β release from the DCs 
during infection, named PA103 ΔpcrV. We showed however in the previous 
chapter that overnight incubation of P. aeruginosa infected DCs after killing of 
the live pathogen, to allow full DC maturation for T cell activation- a necessity 
in our co-culture set up, led to IL-1β secretion from both strains and therefore 
this model could no longer be used to investigate IL-1β contribution to Th17 cell 
induction. We then sought to investigate the contribution of IL-1β in Th17 cell 
generation by simple induction of Th17 cells from naive CD4+ T cells with the 
cytokines TGFβ and IL-6 in the absence or presence of IL-1β. We saw no 
significant difference between IL-17 secretion upon IL-1β absence or presence, 
and similar IL-17+ populations as ascertained by flow cytometry, indicating that 
IL-1β is not needed for Th17 cell induction in mice. We thus imagine that if the 
overnight culture of DCs with both bacteria strains did allow a model of IL-1β 
presence or absence that we may have in fact not observed any difference in IL-
17 induction between strains in this set-up. This agrees with previous studies 
that IL-1β contribution may not be as important in mice as it is in humans [97, 
120, 121, 124]. Another possibility to investigate the role of IL-1β during culture 
would be the use of recombinant IL-1Ra to block IL-1β signalling, but as this was 
not the main focus of our study this was not investigated. 
We confirmed that addition of exogenous IL-2 to culture reduces IL-17 
production, not only by reducing IL-17 secretions by these cells but by reducing 
the IL-17 secreting populations themselves. Studies show that IL-2 signalling via 
stat 5 is what inhibits Th17 cell generation as deletion of Stat 5 restored a 
previously absent Th17 cell population [228]. We did not investigate this 
however as we wanted only to confirm that addition of IL-2 would inhibit our IL-
17 cultures and thus we should not add IL-2 to our culture to maximise IL-17 
populations. We were curious as to how lack of IL-2 would affect survival of T 
cells in our culture as it is known to be vital for T cell survival [227]. It appears 
artificial IL-2 addition is not necessary for Th17 cell survival in our culture as our 
cells appear survive till day 6 without addition of IL-2 as gauged on scatter of 
cells by flow cytometry. However the T cells themselves may produce 
endogenous IL-2 which may contribute to T cell survival, thus we cannot claim 
complete absence of IL-2 in our culture.  
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We discovered that CD4 negative isolation using MACS was not pure and was 
contaminated with γδ T cells which upon stimulation of their TCRs with anti-CD3 
could be induced to secrete vast amounts of IL-17 that was enhanced upon co-
culture with P. aeruginosa infected DCs and their supernatants. γδ T cells are 
considered to be a more innate like T cell that respond in a different manner to 
Th17 cells and must be considered and treated differently. For Th17 induction 
from a naive CD4+ T cell, stimulation through the CD3 receptor is necessary. 
Stimulation of the CD3 receptor in the presence of antigen activated DCs and 
appropriate cytokines leads to formation of an activated CD4+ helper T cell. 
However in the absence of TCR stimulation, naive cells are not activated and no 
response is induced. In contrast, stimulation of the CD3 receptor alone in γδ T 
cells is enough to allow IL-17 secretion in the absence of other stimuli [137]. IL-
23 addition with IL-1β, is also enough to induce IL-17 secretion from γδ T cells 
[129] in the absence of TCR stimulation and addition of both these cytokines in 
combination of TCR stimulation has a synergistic effect which we believe to be 
seeing here in infection conditions as we have already shown in the previous 
chapter that P. aeruginosa infected DCs secrete IL-23 and IL-1β, and we have 
stimulated our culture with anti-CD3.  This explains the surge of IL-17 from T 
cells co-cultured with unstimulated DCs observed in culture, and the significant 
increase seen during infection conditions. This led us to further investigate γδ T 
cells and their IL-17 secretion as can be seen in the next chapter.  
We overcame this obstacle of γδ contamination of our CD4+ population by using 
CD62L to isolate naive CD62L+ CD4+ T cells, as we found γδ T cells to be 
contained in the CD62L- memory preparation. We found that upon culture of 
these naive cells with P. aeruginosa infected DCs IL-17 responses could be 
induced with no significant difference observed between P. aeruginosa strains 
indicating that the presence or absence of a T3SS system may not effect such 
induction, although assumptions of IL-1β contribution cannot be made. 
Furthermore T cell proliferation does not appear to differ between strains 
indicating that T cell proliferation in response to P. aeruginosa infected DCs is 
T3SS independent.  
Flow cytometry of IL-17+ populations in these cultures indicate that IL-17 
producing populations are small, approx 0.5%, yet we see lots of IL-17 secreted 
from these populations with concentrations higher than 1000pg/ml when naive T 
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cells are co-cultured with P. aeruginosa infected DCs. We believe this lack of 
detection of a distinct IL-17+ population by flow cytometry in these cultures, 
where IL-17 is clearly observed by ELISA, is a kinetics problem as the cells are 
left in culture for 6 days with no additional stimulation. This may lead to a 
down-regulation of their IL-17 producing capability by some means or perhaps a 
shift in IL-17 producing capacity of these cells due to increased presence of 
IFNγ. As discussed in the introduction Th17 cells are plastic and may shift to 
becoming IFNγ producing Th1 cells under influence of Th1 cytokines [127], losing 
their IL-17 producing capabilites. We do observe some IFNγ cells from our co-
cultures (Figure 5-12) and thus presence of these cells may down-regulate IL-17. 
One way to investigate if there had been a substantial IL-17+ cell population at 
some point during the culture, would be to use recently developed reporter mice 
that express enhanced yellow fluorescense protein (eYFP) with IL-17a. These 
mice permanently label IL-17a producing cells and these can be identified as 
such by flow cytometry, even if they no longer make IL-17 upon restimulation 
[128]. Use of these mice would allow identification of cells that had capacity to 
produce IL-17 at any stage, therby allowing us to investigate if the IL-17 
producing population in this set up had been considerably larger before our point 
of detection. 
Co-culture of naive CD4+ T cells with P. aeruginosa infected DCs leads to 
induction of Th17 cells in a DC dependent manner. Culture of naive T cells in the 
absence of DCs but still in the presence of their conditioned media with artificial 
co-stimulation provided by addition of anti-CD28 did not allow secretion of IL-17 
from culture indicating that the DCs provide something more during Th17 cell 
induction rather than just delivery of cytokines such as IL-23 and IL-1β, and co-
stimulation via CD28. What these other factors that DCs supply may be are 
unclear. It could be a number of things from extra co-stimulation of the T cell 
provided by the DC, for example CD40 ligation has been found to be important 
for Th17 development [220], to presentation and recognition of antigen. If 
antigen recognition is the extra factor that DC presence provides for production 
of Th17 cells during P. aeruginosa infection, this would indicate a specific Th17 
response to P. aeruginosa, although this was not investigated and so no 
conclusions can be made.  
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IL-22 concentration levels from these co-cultures were low, at around 100pg/ml, 
in comparison to that of IL-17 which displayed concentrations of over 
1000pg/ml. We wonder, as standard, are secreted IL-22 concentrations during P. 
aeruginosa infection lower than that of IL-17? Considering IL-22 secretion alone, 
we see that upon culture with P. aeruginosa infected DCs, naive cells secrete 
statistically significant amounts of IL-22 compared to co-culture with 
unstimulated DCs. This would indicate that the IL-22 secreted from the T cells 
upon co-culture with infected DCs, albeit low, is real. However we do not see 
any IL-22+ populations as identified by flow cytometry. Do these IL-22+ 
populations not restimulate their production of IL-22 upon polyclonal stimulation 
with PMA and ionomycin as IL-17 production does? Or are there no IL-22 
populations present and the IL-22 concentrations we see from our ELISA 
negligble? Investigation of Th17 cells induced by cytokines TGFβ, IL-6 and IL-1β 
in the presence of  anti-CD3 and anti-CD28, a well documented technique for 
Th17 cell induction which we have shown to be IL-17+ via flow cytometry and 
ELISA, showed no IL-22 from these cells by either output. However, upon further 
investigation into the background of IL-22 production by Th17 cells it is claimed 
that IL-22 from Th17 induced cells IL-23 dependent [229]. IL-23 is not added to 
these Th17 inducing positive control cultures, and may explain the lack of IL-22 
here where we see well-defined IL-17+ populations. It is also claimed that 
secretion of IL-22 could be considered to be a measure of maturation stage of 
Th17 cells [229]. This indicates that Th17 cells are not always IL-22+, but may 
gain expression of the cytokine during development. During our infection co-
culture the IL-17+ CD4+ cells we see are single IL-17+ producers that do not 
appear to secrete IL-22 but this cannot be attributed to lack of IL-23 as we know 
IL-23 is present in the conditioned media of P. aeruginosa infected DCs as we 
have shown in the previous chapter. Therefore lack of IL-22 from our co-cultures 
cannot be explained by lack of IL-23, and the reasons are unclear. IL-22 secreted 
from a CD4+ cell has generally been regarded to be from Th17 cells as these 
cells are considered double producers of IL-17 and IL-22 [71]. However recent 
studies have unveiled the existence of a CD4+ IL-22+ IL-17- cell, named Th22 
[184]. This poses the question that conversely could there be a CD4+ IL-17+ cell 
population that does not secrete IL-22. Studies have shown a single CD4+ IL-17+ 
cell in humans in responses to Mycobacterium [230], thus existence of such a 
cell during P. aeruginosa infection may not be unreasonable. 
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Co-culture of naive CD4+ T cells with Gram-positive S. pneumoniae also appears 
to lead to induction of IL-17+ cells. Curiously the flow cytometry and ELISA data 
disagree about the contributions of the 2 strains D39 WT and D39 ΔPLY to IL-17 
induction, with ELISA giving evidence that D39 ΔPLY is better at IL-17 secretion 
while flow cytometry observations suggest that D39 WT induced better IL-17+ 
populations. We are more inclined to believe the ELISA data as it is an 
accumulative observation of IL-17 secreted over the 6 days whereas the FACS 
data is a snap shot on day 6 where the cells are non-specifically re-stimulated 
and induced to secrete cytokines, and so may not be an actual representation of 
what went on but what could have occurred upon this non-specific stimulation. 
Though it is hard to make definite assumptions with this data due to the high 
background of IL-17 seen when DCs are uninfected, which may suggest some 
contamination, IL-17 secretion from co-culture with D39 ΔPLY infected DCs is 
signifigantly higher than the ‘basal’ contaminated level and so we regard this to 
be real. Due to this we are inclined to say that, as with P. aeruginosa infection, 
IL-17 is induced from naive CD4+ T cells upon co-culture with S. pneumoniae  
infected DCs. It appears that infection with D39 ΔPLY leads to higher IL-17 
secretion that D39 WT which could be due to the reduced cytotoxicity of D39 
ΔPLY to cells. Reduced cytotoxicity results in reduced cell death in D39 ΔPLY 
infected DCs which results in more live cells, more cytokine secretion and more 
activation to naive T cells in culture, than its toxic WT counterpart. Furthermore 
as D39 ΔPLY seems to induce better IL-17 secretion than D39 WT, it suggests that 
the role of IL-1β during Th17 induction in response to S. pneumoniae is negligble 
as we have shown in the previous chapter that IL-1β production from D39 ΔPLY is 
low, whereas D39 WT produces significant concentrations of the cytokine. Thus 
high IL-17 concentrations where low IL-1β concentrations are present indicates 
that IL-1β is not neccessary for Th17 induction. The IL-17 secretion from these 
cells does not appear to be specific to S. pneumoniae as co-culture of naive T 
cells with DCs stimulated with BLP, a component of S. pneumoniae cell walls, 
also induced IL-17+ T cells. This may indicate that co-stimulation and cytokines 
provided by an activated DC that has recognised bacterial components, may be 
enough to induce a Th17 cell response. However upon culture of the naive T 
cells with S. pneumoniae infected DC conditioned media in the presence of co-
stimulation provided by antibodies, reduced IL-17 is observed from these cells. 
This is also true for P. aeruginosa. This indicates that DCs do not only just 
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provide basic CD28 co-stimulation and cytokines but some other physical factor 
that requires contact, which has been discussed above.  However unlike P. 
aeruginosa, where culture of naive T cells with both strains did not lead to IL-17 
production when cultured with conditon media alone, S. pneumoniae strain D39 
ΔPLY may activate DCs in such a manner that they allow naive T cells to become 
Th17 cells in DC absence. In DC absence cultures with this strain small levels of 
IL-17 secretion and a fairly substantial IL-17+ populations were observed, albeit 
significantly lower than when DCs were present. This suggests that Th17 cells 
may be induced from secreted factors produced by D39 ΔPLY infected DCs such 
as cytokines, and that this population is enhanced when DCs are present. As this 
was observed with Gram-positive S. pneumoniae and not Gram-negative P. 
aeruginosa this could be a Gram-postive/Gram negative difference in Th17 cell 
induction, or it may be specific to S. pneumoniae. This requires further 
investigation to establish if S. pneumoniae and other Gram-positive but not 
Gram-negative pathogens may induce Th17 cells from naive T cells when 
cultured with their infected DC conditioned media in absence of physical DC-T 
cell contact. 
Interestingly we observe ‘better’ populations of Th17 cells induced from mucosal 
DCs ex vivo than artificially derived DCs induced with commercial GM-CSF. This 
was measured by the ability to see a large and distinct IL-17+ population by flow 
cytometry from NALT and lung isolated DC co-cultures on day 6, which was not 
observed in BMDC co-cultures.  We believe mucosal DCs are more effective than 
BMDCs at inducing robust Th17 responses that survive to point of detection and 
retain their IL-17 secreting capabilities. We struggled to see IL-17+ populations 
as demonstrated by flow cytometry during out naive T cell/infected BMDC co-
cultures even where we observed IL-17 concentrations in the supernatant and 
thus know an IL-17+ population has been present. The observation that we can 
see a clearer IL-17+ cell populations by flow cytometry with mucosal DC co-
culture than with BMDC co-culture, even with exact same harvest, stimulation 
and staining protocols, suggests that P. aeruginosa infected mucosal DCs induce 
a much more robust population of Th17 cells that survive 6 days in culture to be 
re-stimulated and stained. Thus it would appear that mucosal NALT and lung 
DCs, which would encounter P. aeruginosa upon infection of an animal, may 
have the potential to induce IL-17 responses in a much more robust manner than 
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in vitro induced BMDCs can. In 2009 a few studies elucidated the importance of 
lung and NALT DCs in inducing Th17 cell responses. A study in mice investigating 
immunisation with cholera toxin indicates that lung DCs may be induced to, 
under this stimulation, secrete Th17 cell inducing cytokines in the lung [231]. 
Another study in humans investigated the contribution of lung DCs to Th1 and 
Th17 cell responses in emphysema [232]. NALT DCs have been shown to secrete 
more IL-6 than DCs isolated from cervical lymph nodes and spleens of intranasal 
immunised mice with OVA [233] indicating that by this production they may be 
better equipped at inducing Th17 cells than other DCs. Thus evidence exists that 
mucosal DCs may be equipped to allow efficient, robust Th17 cell induction 
during infection, and we see this also. 
As with co-culture of P. aeruginosa infected BMDCs with naive T cells, co-culture 
with P. aeruginosa infected mucosal NALT and lung DCs lacked IL-22 secretion or 
presence of IL-22+ populations. This again suggests that the IL-17+ cells we 
observe during P. aeruginosa infection are not archetypal Th17 cells and could 
possibly belong to a CD4+, IL-17+, IL-22- subtype. Together these observations 
suggest that this CD4+, IL-17+, IL-22- cell population is generated from naive 
CD4+ splenocytes regardless of type and origin of DC used to induced them. 
It would be interesting to see if IL-17 production increases in our co-cultures if 
the lung DC population wasn’t contaminated with other cells due to erroneous 
positive selection, which was discussed in the previous chapter. Would better 
Th17 cell responses be observed if the DC population was pure, and exclusively 
committed to being activated and potentially inducing Th17 cells? Or are there 
cells carried over from the lung and NALT in these contaminated preparations 
that aid in contribution to Th17 responses, and so reduced Th17 cell populations 
would be observed if the co-culture was solely naive T cells and infected DCs? It 
poses the question, could one of these contaminated cells be responsible for IL-
17 production and so elimination of it may eradicate IL-17+ populations. This 
requires further investigation of all cells present in the ‘DC’ isolated cultures by 
MACS from mucosal sites, and perfecting of DC isolation techniques to obtain 
purer populations.  It is also of interest to co-culture lung derived DCs with lung 
derived T cells, thereby isolating both cell types from the site where pathogen 
would encounter and a response would be induced. To isolate lung DCs perfectly 
and to also isolate naive CD4+ T cells from the lung would be a time consuming 
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process that unfortunately we could not commit to and therefore could not 
investigate, but we believe this to be an interesting area for those investigating 
respiratory pathogens in the future. 
In conclusion we demonstrated that Th17 cell responses can be induced to Gram-
negative P. aeruginosa and Gram-positive S. pneumoniae in a DC contact 
dependent manner.  The contribution of IL-1β during these P. aeruginosa 
infections is unclear, but we have shown with S. pneumoniae strains that the 
contribution of IL-1β to Th17 induction is negligible. Furthermore, in vitro 
addition of IL-1β to naive T cells cultured with TFGB and IL-6, does not make a 
significant difference to IL-17 secretion from naive T cells. IL-22 secretion is not 
evident in these cultures suggesting that the cells are a CD4+, IL-17+ and IL-22- 
subtype, still to be legitimately identified. Mucosal DCs isolated from lung and 
NALT were found to induce more robust IL-17+ cell populations than BMDCs and 
are of great interest for future studies investigating the role of DCs in inducing 
immune responses to pathogens. 
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6 IL-17 secretion from γδ T cells following             
P. aeruginosa infection 
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6.1 Introduction 
γδ T cells are a subset of T cells that differ from conventional αβ T cells at their 
T cell receptor (TCR). They are much less common in peripheral blood than αβ T 
cells and as a consequence have been much less studied, though this appears to 
be changing with discoveries of the emerging importance of γδ T cells in immune 
responses and a shift of focus of T cell studies in immunity. The main quality 
that makes γδ T cells stand out from their αβ counterparts is that unlike αβ T 
cells, γδ T cells do not require antigen presented by major histocompatability 
complexes (MHCs) to become activated, as they lack CD4 and CD8 [139]. γδ T 
cells do not need antigen presentation from antigen presenting cells (APCs), 
have a limited TCR repertoire, and can recognise poorly defined polymorphic 
structures directly. Additionally, they have pattern recognition receptors (PRRs) 
on their surface such as Toll-like receptor 2 (TLR2) [72] which recognises 
bacterial lipo-protein (BLP) a component of cell walls in Gram-positive bacteria, 
and dectin-1 [72] a receptor that recognises β-glucans, components of plants, 
yeast and fungi. Therefore γδ activation occurs in a faster manner, as antigen 
does not need to be processed. Furthermore, it has been shown that addition of 
pro-inflammatory cytokine IL-23 is sufficient to induce pro-inflammatory IL-17 
responses from γδ T cells [72, 129] without the involvement of the TCR. 
However, ligation of their TCR by anti-CD3 also known to be adequate stimulus 
for IL-17 secretion in the absence of IL-23 [137]. Due to this ability to directly to 
recognise unprocessed antigen and to induce immune responses with lack of a 
co-stimulatory cell, γδ T cells are thought to be a more ‘innate’ like type of 
cell. However, they do express CD44 and are CD62L- as we have confirmed in the 
previous chapter, classifying them as having a ‘memory’ phenotype on that 
basis. Classification of cells as naive and memory is normally reserved for 
adaptive immune cells, making γδ T cells ‘memory like’ ‘innate like cells’. It is 
due to these spectrum of qualities that γδ T cells are frequently referred to as a 
bridge between innate and adaptive immune responses [234]. 
In the previous chapter, during our investigation with CD4+ T cells cultured with 
P. aeruginosa infected dendritic cells (DCs) and their conditioned media we 
found that the source of IL-17 in these cultures was γδ T cells. This was due to 
contamination of the CD4+ cells with γδ T cells as the negative selection MACS 
kit that was used to isolated CD4+ T cells did not retain γδ T cells and thus they 
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could be found in the CD4+ cell preparation also. The discovery that γδ T cells 
were responsible for our IL-17 production upon culture with P. aeruginosa 
infected DCs led us to investigate this cell population in more depth. 
As γδ T cells have been found in the sub-epithelium of alveolar and non-alveolar 
regions of the lung [134] and are thought to be involved in the regulation of 
immune responses to microbial pathogens [235] this implies that we may find γδ 
T cells in the response to P. aeruginosa, a respiratory pathogen of the lung. 
This chapter aims to look at γδ T cells in culture with P. aeruginosa infected DCs 
to see if DC presence is important for IL-17 production from γδ T cells as it was 
for naive CD4+ T cells, and to look at IL-22 secretion from these cells as it could 
not be found in IL-17 secreting CD4+ T cells in the previous chapter. We 
investigated this by either culture of memory CD62L- preparation from the CD4+ 
negatively selected splenocytes fraction that we know to contain γδ T cells as 
these cells and their IL-17 production could be identified using flow cytometry, 
or isolation of γδ T cells alone from the spleen using γδ positive isolation MACS 
which we show to be over 75% effective at isolating a pure γδ population. The 
CD62L- CD4+ γδ containing preparation was used in some instances as γδ T cells 
represent such a small percentage of cells in the spleen, that to isolate them 
alone would give very small numbers thereby reducing the number of conditions 
we could set up. By using the CD4+ CD62L- ‘memory’ preparation, which we 
know contains our cells of interest that can be readily identified by flow 
cytometry; we increase our cell number and therefore our conditions. These 
cells were cultured with P. aeruginosa infected DC and/or their conditioned 
media as the naive cells had been, but in the absence of anti-CD3 as CD3 ligation 
is enough to induce γδ T cells to secrete IL-17 [137] in an uncontrolled and 
unspecific manner. 
6.2 γδ T cells are contained in the CD62L- memory 
preparation of CD4+ negatively selected cells by 
MACS, and proliferate upon stimulation 
In the previous chapter we confirmed that γδ T cells are memory-like in their 
expression of CD44 and thus can be found in the CD62L- memory preparation of 
CD4 MACS negatively isolated T cells. Upon culture with unstimulated DCs a 
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small 1.8% population of γδ T cells can be observed in this CD62L- ‘CD4+’ 
preparation, but upon co-culture with P. aeruginosa infected DCs this γδ 
population increases to 4.2% demonstrating that γδ T cells proliferate upon 
stimulation (Figure 6-1). 
 
Figure 6-1 γδ T cells proliferate upon stimulation 
γδ T cells, as part of the memory CD62L- CD4+ preparation, were co-cultured with P. aeruginosa 
infected DCs carried over in their conditioned media for 6 days. After this time cells were harvested 
and stained for γδ and analysed by flow cytometry. Cells gated on live cells based on forward 
scatter (FSC) and side scatter (SSC) as described in materials and methods. Dot plots are 
representative of co-culture set up in triplicate. Data representative of 3 experiments.  
These cultures were set up in the absence of IL-2, to increase IL-17+ populations 
as IL-2 has been described to reduce IL-17+ cells [228] which we confirmed in 
the previous chapter. Thus, proliferation of γδ T cells is independent of 
exogenous IL-2, though as stated previously we cannot account for endogenous 
IL-2 made by the T cells themselves. 
6.3 γδ isolation using MACS 
We have shown in the previous chapter that γδ T cells reside in the CD4+ 
preparation using negative selection MACS, and that these cells can be identified 
by flow cytometry for their IL-17 secretion upon culture with P. aeruginosa 
infected DCs. We wanted to investigate this splenic γδ population alone to see if 
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it responded to DCs and their conditioned media infected with P. aeruginosa in 
the same manner as γδ T cells as part of the ‘CD4+’ preparation do. We were 
interested to see if the induction of IL-17+ secretion from γδ T cells was solely 
due to culture of γδ T cells and the infected DCs, or if memory CD4+ T cells in 
the preparation may contribute somehow to IL-17 secretion from γδ T cells, and 
thus needed to find an effective way to isolate γδ  T cells. To isolate γδ T cells 
for these experiments we used a positive selection MACS kit which labels the γδ 
T cells and retains them in the magnetic column, allowing all other unlabelled 
cells to pass through. After MACS treatment samples of these γδ + cells were 
stained for γδ and investigated by flow cytometry to check the purity of the kit 
before further experiments were carried out (Figure 6-2). 
 
Figure 6-2 γδ T cells isolated using positive selection MACS  
Splenocytes were treated using γδ positive selection MACS kit and stained for γδ T cells (black 
line) to test kit efficacy, and analysed by flow cytometry against isotype control (filled histogram).  
Data representative of 5 experiments. 
The γδ positive selection MACS kit appears over 75% effective and we are 
comfortable to proceed knowing we have isolated mainly γδ + T cells but will 
still confirm this population by flow cytometry upon experimentation before 
making any claims about its IL-17 secreting activity. 
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6.4 γδ T cells are IL-17 producing upon co-culture with    
P. aeruginosa infected DC conditioned media in a DC 
contact independent manner. 
In the previous chapter we discovered that Th17 cells differentiated from naive 
CD4+ T cells need stimulation of their TCR and co-stimulation provided by DCs in 
order to secrete IL-17. We wanted to investigate if γδ T cells respond in the 
same DC dependent manner. γδ T cells do not have CD4 or CD8 on their surface 
and thus lack MHC recognition, meaning they do not require DC presence in the 
same manner as CD4 and CD8 T cells; however, they may still require co-
stimulation provided by DCs to allow adequate activation. We were curious as to 
how γδ T cells would respond to DC absence, and therefore absence of co -
stimulation. We have already observed in the previous chapter that CD3 ligation 
is enough to allow IL-17 secretion from γδ T cells, and that γδ T cells survive till 
day 6 without anti-CD3 addition where naive CD4+ T cells do not, and thus CD3 
stimulation is not supplied in these co-cultures. We have discovered previously, 
while looking for Th17 responses, that γδ T cells co-cultured with P. aeruginosa 
infected DCs and their conditioned media induce IL-17 secretion, and so we 
wanted to investigate if isolated γδ T cells cultured with DC conditioned media 
in the absence of DC’s, CD3 and CD28 stimulation would still secrete IL-17. As 
shown in Figure 6-3, when purified γδ T cells were cultured with conditioned 
media from infected DCs they were activated to secrete IL-17 in a CD3 
independent, DC contact independent manner. 
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Figure 6-3 γδ T cells cultured in P. aeruginosa infected DC conditioned media in the 
absence of DCs secrete IL-17 
γδ T cells were isolated using MACS and cultured in the conditioned media of P. aeruginosa 
infected DCs for 6 days in the absence of DCs and any other co-stimulation, before being 
stimulated with PMA and ionomycin in the presence of brefeldin A for 5 hours. After this time cells 
were harvested and stained for IL-17 by flow cytometry. Cells gated on live cells based FSC and 
SSC as described in materials and methods. Positive gates were set on isotype on ΔUΔT 
conditioned media stimulated cells.   Dot plots are representative of co-culture set up in triplicate. 
Data representative of 3 ex periments. 
These results show that culture of γδ T cells alone with P. aeruginosa infected 
DC conditioned media allows IL-17 secretion cells and that unlike Th17 cells, γδ 
T cells do not need the presence of DCs or even artificial co-stimulation provided 
by commercial anti-CD28 to induce IL-17 production. To confirm the IL-17 
secreted during this co-culture set-up was in fact from γδ T cells the cells were 
double stained with γδ and IL-17 (Figure 6-4). 
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Figure 6-4 IL-17 cells observed during γδ T cell cultured in P. aeruginosa infected DC 
conditioned media are γδ+  
γδ T cells were isolated using MACS and cultured in the conditioned media of P. aeruginosa 
infected DCs for 6 days in the absence of DCs and any other co-stimulation, before being 
stimulated with PMA and ionomycin in the presence of brefeldin A for 5 hours. After this time cells 
were harvested and stained for IL-17 and γδ and analysed by flow cytometry.  Cells gated on live 
cells based FSC and SSC as described in materials and methods. Positive gates were set on 
isotypes on ΔUΔT conditioned media stimulated cells. Dot plots are representative of co-culture set 
up in triplicate. Data representative of 3 experiments. 
We see from Figure 6-4 that the majority of IL-17+ cells are γδ+. A further 
notable observation from this figure is the reduction in γδ+ populations. We 
have previously shown that γδ isolation from spleens results in over 75% γδ + T 
cells (Figure 6-2), so why are large γδ + T cell populations not observed in the 
co-culture analysis? The γδ staining to test the efficacy of the kit was performed 
immediately after isolation, whereas the results above are after 3 days in 
culture, and so we suppose that not all cells have survived the 3 days, and this is 
why we see a reduction in γδ+ T cells. We are happy however that the above 
flow cytometry plots show that the IL-17+ population is γδ+, confirming that the 
IL-17+ cells we see in our cultures with isolated γδ T cells are in fact IL-17+ γδ T 
cells. 
These results indicate that γδ T cells are more innate like, not needing DC co-
stimulation and lacking specific antigen recognition as they can be induced to 
secrete IL-17 in response to LPS stimulated DC conditioned media. 
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The contribution of DCs in IL-17 induction from γδ T cells was further 
investigated by culturing γδ T cells with P. aeruginosa infected DCs carried over 
in their conditioned media to represent the contribution of DCs plus cytokines 
and secreted factors, or with P. aeruginosa infected DCs washed out of their 
conditioned media and resuspended in fresh media to represent the sole 
contribution of the DCs alone, albeit they may continue to activate and secrete 
factors during culture time under the correct stimulus (Figure 6-5). 
 
Figure 6-5 Secreted factors from activated DCs are more important than DC contact at 
inducing production of IL-17 from γδ T cells 
γδ T cells were co-cultured with DCs carried over in their conditioned media or DCs washed out of 
their conditioned media and resuspended in fresh media for 6 days. After this time cells were 
stimulated with PMA and ionomycin in the presence of brefeldin A for 5 hours before being 
harvested, stained for IL-17 and γδ and analysed by flow cytometry. Cells gated on live cells based 
FSC and SSC as described in materials and methods. Positive gates were set on isotypes on LPS 
conditioned media stimulated cells. Dot plots are representative of co-culture set up in triplicate. 
Data representative of 2 experiments. 
In the presence of the DCs washed of their conditioned media and resuspended 
in fresh media a small percentage, 3.27%, of IL-17 can be observed from γδ T 
cells cultured with P. aeruginosa infected DCs (Figure 6-5). However this IL-17+ 
population is much larger when DC conditioned media is present also, 6.57%, 
indicating that DC conditioned media from infected DCs plays a much bigger role 
in IL-17 secretion from γδ T cells than the DCs do themselves (Figure 6-5). This 
implies that it is cytokine contribution from DCs rather than a cellular 
  166 
interaction with γδ T cells that to induce IL-17 from these cells. This response is 
seen to be non-specific to P. aeruginosa as stimulation of DCs with LPS induces 
much larger IL-17+ populations, 17.6%, (Figure 6-5) indicating that an activated 
DC by a non-specfic means is sufficient to secrete factors that induce IL-17 from 
γδ T cells. The contribution of conditioned media versus DCs is still evident 
where LPS has  been used to stimulate DCs.  
This observation was confirmed by analysing the supernatants of the co-culture 
for IL-17 secreted by the cells, analysed by ELISA (Figure 6-6). Significantly 
higher concentrations of IL-17 are observed in the cell culture when DC 
conditioned media is present, as opposed to just stimulated DCs. 
 
Figure 6-6 Production of IL-17 from γδ T cells requires conditioned media from stimulated 
DCs 
γδ T cells were co-cultured with DCs carried over in their conditioned media or DCs washed out of 
their conditioned media and resuspended in fresh media for 6 days. After this time supernatants 
were harvested and analysed for IL-17 by ELISA. All error bars represent mean ± SEM. Data are 
representative of 3 separate experiments of experimental triplicates.  *** p< 0.001.  
6.5 γδ T cells do not directly recognise P. aeruginosa    
γδ T cells express PRRs on their surface such as TLR2 and dectin-1 [72].              
P. aeruginosa would not be recognised by dectin-1, and although TLR2 can 
recognise P. aeruginosa components it has been shown to have a more limited 
role in inducing immune responses to P. aeruginosa than TLR4 does [236]. We 
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wished to investigate if γδ T cells could recognise P. aeruginosa directly via 
TLR2, or perhaps by way of a currently unidentified receptor. To test this γδ T 
cells were directly infected with P. aeruginosa for 90 minutes before addition of 
antibiotics (Figure 6-7). γδ T cells were also set up with LPS stimulation, as it 
has been shown to be a strong inducer of IL-17 from these cells when γδ T cells 
are cultured with conditioned media of LPS stimulated DCs (Figure 6-5). This was 
to investigate if LPS had a direct effect on γδ T cells although it is known that 
γδ T cells do not have TLR4 [72], the best characterised recognition receptor for 
LPS. As a positive control to check the that the γδ T cells cultured were 
functional and had IL-17 producing capabilities, γδ T cells were cultured in P. 
aeruginosa infected conditioned media, as we have previously shown in Figure 
6-3 such culture leads to IL-17+ production from γδ T cells.  
 
Figure 6-7 Direct infection of γδ T cells with P. aeruginosa does not induce IL-17+ γδ+ T cell 
populations 
γδ T cells were left unstimulated, stimulated with LPS, directly infected with live P. aeruginosa, or 
cultured with P. aeruginosa infected DC conditioned media for 6 days. After this time cells were 
stimulated with PMA and ionomycin in the presence of brefeldin A for 5 hours before being 
harvested, stained for IL-17 and γδ and analysed by flow cytometry. Cells gated on live cells based 
FSC and SSC as described in materials and methods. Positive gates were set on isotypes on 
ΔUΔT conditioned media stimulated cells.    Dot plots are representative of co-culture set up in 
triplicate. Data representative of 3 experiments.  
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As can be observed from Figure 6-7, direct infection of γδ T cells with P. 
aeruginosa does not induce IL-17 secretion from these cells indicating that γδ T 
cells do not directly recognise P. aeruginosa, and respond to direct infection 
with the pathogen by way of IL-17 secretion. TLR2 on γδ T cells may recognise P. 
aeruginosa in this set up but not induce IL-17 responses, a relationship that 
would require more investigation. The inclusion of γδ T cells cultured with P. 
aeruginosa infected DC conditioned media that does allow IL-17 secretion shows 
that the cells used in these experiments are functional and have the capacity to 
secrete IL-17, confirming that the fact that direct infection of γδ T cells with P. 
aeruginosa does not induce IL-17, as opposed to the lack of IL-17 due to quality 
of cells or experimental set up. Furthermore, there is no IL-17 response from γδ 
T cells directly stimulated with LPS confirming the lack of TLR4 on γδ T cell 
surface and any other means of LPS recognition. These results are confirmed 
when looking at IL-17 secretions from these cells in the supernatant (Figure 6-8). 
 
Figure 6-8 Direct infection of γδ T cells with P. aeruginosa does not lead to IL-17 secretion 
γδ T cells were left unstimulated, stimulated with LPS, directly infected with live P. aeruginosa, or 
cultured with P. aeruginosa infected DC conditioned media for 6 days. After this time supernatants 
were harvested and analysed for IL-17 by ELISA. All error bars represent mean ± SEM. Data are 
representative of 3 separate experiments of experimental triplicates.*** p<0.001.  
Together these results confirm that γδ T cells do not directly recognise P. 
aeruginosa or LPS, and respond via IL-17 production. They also suggest that IL-17 
secretion from γδ T cells occurs in a DC dependent manner.  
  169 
We have shown previously that IL-17 may be secreted from γδ T cells in a DC 
contact independent manner (Figure 6-4 and Figure 6-5). Yet the data here 
suggests DCs are still neccessary at some point during culture to secrete the 
factors that drive IL-17 secretion from γδ T cells, as absolute DC absence from 
co-culture leads to lack of IL-17 secretion from γδ T cells. Thus, IL-17 secretion 
from γδ T cells may be described as DC dependent but DC contact independent.  
6.6 γδ T cells produce IL-17 in an IL-23 dependent 
manner 
We have previously shown in chapter 4 that P. aeruginosa infected DCs secrete 
IL-23, a well known Th17 maintenance factor, and we have shown in this chapter 
that factors secreted by the DCs into their media are sufficient and important 
for IL-17 induction. We wished to investigate if IL-23 from the DCs could be 
responsible for IL-17 production from the γδ T cells as it has been shown to have 
an important role by others [129]. To investigate if IL-23 was responsible for IL-
17 production from γδ T cells, we set up cultures of γδ T cells as part of a CD4+ 
memory preparation isolated by CD4 negative MACS selection, as it is also known 
to contain γδ T cells. γδ T cells are clearly identified by flow cytometry to be 
the source of IL-17 during these cultures and CD4+ cells are shown to be IL-17 
negative under these conditions (see previous chapter) so we are confident that 
any IL-17 we see in this set up is coming from IL-17+ γδ T cells. Cells were set up 
with unstimulated and P. aeruginosa infected conditioned media as this has been 
shown to be enough to induce an IL-17 response (Figure 6-3), in the absence or 
presence of a commercially purchased functional IL-23 blocking antibody. These 
conditions are named untreated or blocked, referring respectively to the 
absence of presence of this blocking antibody. As a control an isotype matched 
antibody was used to show that the contribution of the IL-23 blocking antibody 
was specific. In the IL-23 block untreated conditions large concentrations of IL-
17 are observed from γδ T cells cultured with conditioned media from P. 
aeruginosa infected DCs but not in the condition where media from uninfected 
DCs was used. Addition of IL-23 blocking antibody to these cultures significantly 
lowers the concentration of IL-17 observed in the positive cultures (Figure 6-9). 
Whereas use of an antibody of the same isotype as the blocking antibody does 
not reduce IL-17, indicating that the reduction in IL-17 from the γδ T cells is due 
to IL-23 blocking and not non-specific antibody addition. In fact, isotype addition 
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to culture appears to increase IL-17 secretion in this culture. This phenomenon 
was not further explored and therefore we do not know why this is. 
 
Figure 6-9 IL-17 secretion from γδ T cells is IL-23 dependent 
MACS sorted CD4+ T cells that are known to contain γδ T cel ls, which were identified to be the IL-
17 secreting population by flow cytometry in previous experiments, were cultured with unstimulated 
or P. aeruginosa infected DC conditioned media in the absence or presence of IL-23 blocking 
antibody for 6 days before supernatants were harvested and analysed for IL -17 by ELISA. An 
isotype control was also set up for these conditions.  All error bars represent mean ± SEM. Data 
are representative of 3 separate experiments of experimental triplicates.  *** p<0.001. 
This confirms that IL-23 is important in IL-17+ γδ T cell maintenance, and that 
IL-23 contribution from DCs plays a key role in IL-17 secretion from γδ T cells. 
6.7 γδ T cells are IL-22 producing upon co-culture with   
P. aeruginosa infected DC conditioned media in a DC 
contact independent and IL-23 dependent manner. 
IL-17 secreting CD4 cells, Th17 cells, are also considered to be IL-22 secreting, 
though we did not observe this in the previous chapter exploring IL-17+ CD4+ 
cells during P. aeruginosa infection. However we wanted to investigate if IL-22 
was secreted from IL-17+ γδ cells, and if so were the same γδ T cells responsible 
for both IL-17 and IL-22 secretion.  This was investigated by culturing γδ T cells 
with P. aeruginosa infected DC condition media as previously described and 
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analysing for IL-22 by intracellular flow cytometry staining and ELISA analysis of 
culture supernatants.  
We observe IL-22+ γδ T cells when isolated γδ T cells are cultured with P. 
aeruginosa infected DC conditioned media. This indicates, as was observed with 
IL-17 secretion from γδ T cells, that IL-22 production from γδ T cells is DC 
contact independent (Figure 6-10). 
 
Figure 6-10 γδ T cells cultured in P. aeruginosa infected DC conditioned media in the 
absence of DCs secrete IL-22  
γδ T cells were cultured with conditioned media of P. aeruginosa infected DCs for 6 days in the 
absence of DCs and any other co-stimulation. After this time cells were stimulated with PMA and 
ionomycin in the presence of brefeldin A for 5 hours, harvested and stained for IL-22 and γδ and 
analysed by flow cytometry. Cells gated on live cells based FSC and SSC as described in materials 
and methods. Positive gates were set on isotypes on ΔUΔT conditioned media stimulated cells.    
Dot plots are representative of co-culture set up in triplicate. Data representative of 3 experiments.  
Figure 6-10 demonstrates that production of IL-22 from γδ T cells does not 
require DC presence and thus occurs upon exposure to cytokines and secreted 
factors produced by P. aeruginosa infected DCs. As with IL-17+ γδ T cells we 
wished to investigate if IL-23 secreted into the P. aeruginosa infected DC 
supernatant was responsible for IL-22 secretion from γδ T cells, and done so by 
analysing the supernatants of the γδ T cells cultured in the conditioned media of 
infected DCs in the presence of absence or IL-23 blocking antibody, which 
showed reduction in IL-17, by IL-22 ELISA (Figure 6-11). (Isotype control was not 
analysed for IL-22 production). 
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Figure 6-11 IL-22 secretion from γδ T cells is partly IL-23 dependent 
MACS sorted CD4+ T cells that are known to contain γδ T cells were cultured with uninfected or P. 
aeruginosa infected DC conditioned media in the absence or presence of IL-23 blocking antibody 
for 6 days before supernatants were harvested and analysed for IL-22 by ELISA. All error bars 
represent mean ± SEM. Data are representative of 3 separate experiments of experimental 
triplicates. *** p<0.001. 
The observed reduction in IL-22 from γδ T cells is not as dramatic as it appears 
to be for IL-17 upon IL-23 blocking, indicating that cytokines other than IL-23 
may stimulate IL-22 production. However the reduction of IL-22 upon IL-23 
blocking is still statistically significant (Figure 6-11) indicating IL-22 production 
from γδ T cells is in part IL-23 dependent, a theory considered further in the 
discussion of this chapter. 
6.8 The majority of IL-17 secreting cells induced from  
co-culture with P. aeruginosa do not co-express IL-22 
Upon further investigation of these IL-17 and IL-22 populations obtained from 
isolated γδ T cells cultured with P. aeruginosa infected DC conditioned media, 
we see that although some of these cells may be IL-17+ IL-22+ double producers, 
the majority of each appear to be single producers (Figure 6-12). Traditionally 
Th17 cells are both IL-17 and IL-22 secreting, but the IL-17 secreting cells we 
observed in the previous chapter derived from naive CD4+ T cells do not appear 
to secrete IL-22 at all, as shown by FACS and ELISA. γδ T cells are considered to 
be an innate form of a Th17 cell as they share so many characteristics, and as 
  173 
Th17 cells are generally regarded as IL-17 and IL-22+, we hypothesized that the 
IL-22+ population that we see upon culture of γδ T cells with P. aeruginosa 
infected DC conditioned media would be the same cell population as the IL-17+ 
cells seen under these circumstances. However, the IL-22+ γδ T cell population 
we see upon culture with P. aeruginosa infected DC condition media appears to 
be a mainly separate population from that of the IL-17 producing γδ population 
based on flow cytometric analysis of intracellular cytokine production (Figure 
6-12). 
 
Figure 6-12 IL-17+ and IL-22+ γδ populations are distinct  
γδ T cells were cultured with conditioned media of P. aeruginosa infected DCs for 6 days in the 
absence of DCs and any other co-stimulation. After this time cells were stimulated with PMA and 
ionomycin in the presence of brefeldin A for 5 hours, harvested and stained for IL-17 and IL-22 and 
analysed by flow cytometry. Cells gated on live cells based FSC and SSC as described in materials 
and methods. Positive gates were set on isotypes on ΔUΔT conditioned media stimulated cells.    
Dot plots are representative of co-culture set up in triplicate. Data representative of 3 experiments.  
Upon culture of γδ T cells with PA103 ΔUΔT infected condition media we see 38% 
of the IL-22+ cells are also IL-17+, and 24% of the IL-17+ cells are also IL-22 
producing. With PA103 ΔpcrV infection conditioned media a similar pattern is 
observed with 36% of IL-22+ cells also being IL-17+, and 27% of IL-17+ cells also 
IL-22+. However, in both conditions the majority of cells are single IL-17 or IL-22 
producers. This indicates in both infections that the majority of IL-17+ and IL-
22+ γδ T cells are single producers and so IL-17 and IL-22 production from γδ T 
cells is distinct.  
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6.9 Discussion 
γδ T cells exist in small populations in tissues but respond in a prolific manner to 
pro-inflammatory stimulus such as IL-23 and IL-1β [129].  
The results in this chapter show that γδ T cells are differentially IL-17 and IL-22 
producing in response to P. aeruginosa in a DC dependent yet DC contact 
independent manner, that is dependent on IL-23. The necessary physical 
presence of DCs for inducing IL-17 from γδ T cells was shown to be negligible, 
with γδ T cells cultured in the conditioned media of P. aeruginosa infected DCs 
shown to be sufficient at allowing abundant secretion of IL-17 from γδ T cells. 
Culture of γδ T cells with infected DCs washed out of their conditioned media 
and resuspended in fresh media to represent the contribution of DCs alone, still 
induced a small percentage of IL-17+ cells compared to culture with uninfected 
DCs, indicating that the cells retain some capacity to secrete the important 
cytokines. But as culture of γδ T cells with these infected DCs and their 
conditioned media increased IL-17+ populations by double, this indicates that it 
is early on and while still exposed to the pathogen/stimulus that DCs secrete 
their IL-17 inducing cytokines such as IL-23. The importance of IL-23 at IL-17+ 
producing cell maintenance was verified by almost complete blockade of IL-17 
when anti-IL-23 was used. This confirms that γδ T cells secrete IL-17 in response 
to IL-23, in the absence of TCR stimulation, and that an important IL-17 
producing factor produced by DCs and found in the conditioned media is IL-23. 
IL-22 secretion from γδ T cells was also seen to be independent of DC contact 
but dependence of IL-23 is uncertain. IL-22 was significantly reduced in these 
cultures upon IL-23 blockade as is evident by statistical analysis, yet this 
reduction was not as dramatic as that observed with IL-17 where IL-23 blockade 
almost abolished secretion of the cytokine. This indicates that IL-22 production 
by γδ T cells may not be IL-23 dependent, but merely IL-23 may enhance IL-22 
secretion from γδ T cells.  
Controversially we found that IL-17 and IL-22 γδ+ T cells may be principally 
different cells. IL-17 γδ T cells have been shown to be double producers of IL-17 
and IL-22 with addition of artificial aryl hydrocarbon receptor (AhR) ligands [72] 
but we see single producers of IL-17 and IL-22 during culture with P. aeruginosa 
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infected DCs, with a small fraction of double producers. Studies of bacterial 
infection by others have also shown differential subsets of IL-17 and IL-22 
production during infection with Gram-positive Bacillus subtilis [179]. 
Interestingly in this study IL-17 and IL-22 producers appear to differ in their γδ 
expression, with IL-22 producers appearing to have lower γδ expression than 
that of IL-17 producers [179]. This suggests functional differentiation of γδ T 
cells, and is of interest for future studies. Furthermore other groups in the lab 
have seen single IL-17 and IL-22 producers in other models such as collagen 
induced arthritis (CIA) (unpublished data) indicating that IL-22 and IL-17 single 
producing γδ T cells exist and need further investigation. The observation by 
others in the lab of single producers in CIA signifies that these cells are not 
limited to pathogen infection as CIA is an animal model of autoimmune disease, 
and so may play a bigger role in immunity than previously realised. Both IL-17 
and IL-22 were observed to be significantly reduced when IL-23 contribution to 
γδ T cell stimulation was blocked. Although both cytokines showed a significant 
reduction statistically, the reduction in IL-17 is more dramatic with an almost 
complete block, whereas IL-22 showed only a reduction. The emergence of IL-22 
single producing γδ T cells that dominate the culture over IL-17+IL-22+ double 
producers, poses the question that perhaps the IL-22 reduction with IL-23 block 
is not as dramatic as observed for IL-17, as IL-22 is mainly secreted by a single 
IL-22 secreting producer that may have different dynamics and respond 
differently to IL-23, if at all. Perhaps the reduction we see in IL-22 with IL-23 
blockade is from the IL-17+ IL-22 double producers and these IL-22 single 
producers continue to produce IL-22 in an IL-23 independent manner. This is all 
speculation at present and requires further investigation, but it would be of 
great interest to isolate these 3 cytokine producing populations, single IL-17+, 
single IL-22+ and double producing IL-17+ IL-22+cells and investigate the effect 
of IL-23 blockade on secretion of IL-17 and IL-22 in these individual γδ 
populations. These distinct populations, and the effect of IL-23 on them, are of 
great interest and must be investigated further.  
The IL-17+ responses from γδ T cells were found not to be specific to P. 
aeruginosa as culture of γδ T cells with LPS stimulated DC condition media 
induced greater IL-17+ populations than that of infection. This indicated that it 
may in fact be DC recognition of LPS on P. aeruginosa cell walls that leads to DC 
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activation. In chapter 4 we demonstrated that IL-23 secretion from DCs 
stimulated with LPS is higher than that of P. aeruginosa infection, giving an 
explanation for the higher IL-17+ γδ T cell population we see here during culture 
with LPS stimulation.  
These results confirm that γδ T cells are more innate like as they do not need DC 
co-stimulation, and lack specific antigen recognition as they can be induced to 
secrete IL-17 in response to LPS stimulated DC conditon media.  
Although these IL-17 responses were found to be DC contact independent, they 
are still found to be dependent on DCs to supply IL-17 secreting factors such as 
IL-23. Direct infection of γδ T cells or culture with LPS, in the absence of DCs, 
showed no IL-17 in the supernatants and no IL-17 producing populations as 
identified by flow cytometry. This shows that γδ T cells do not directly recognise 
and respond to P. aeruginosa or LPS by way of IL-17 production, and in fact IL-17 
secretion from γδ T cells does depend on DCs. DCs are needed to be stimulated 
by the pathogen or stimulus to become activated and secrete IL-23 and other 
factors to induce γδ T cells to become IL-17 secreting. Thus although γδ T cells 
may produce IL-17 independently of DC presence and a physical DC interaction, 
DCs are still needed to provide γδ T cell activating cytokines. In vivo DCs may 
not play as large a role, as IL-23 can also be supplied by macrophages exposed to 
P. aeruginosa [237] and thus IL-17 secretion from γδ T cells may be able to occur 
in a completely DC independent manner. However in our set up DCs are the 
source of cytokines that drive IL-17 responses from γδ T cells in response to P. 
aeruginosa infection. 
The lack of need for DC contact and co-stimulation provided by these cells 
indicates that we would be able to use our IL-1β presence and absence model 
using P. aeruginosa strains ΔUΔT and ΔpcrV, previously described in Chapter 4 
and 5, to investigate the contribution of IL-1β to IL-17 production by γδ T cells. 
Briefly ΔUΔT allows IL-1β secretion, where ΔpcrV does not, as it has a competent 
T3SS, a feature necessary for inflammasome activation, which that leads to IL-1β 
production and secretion. ΔpcrV has a disrupted non-functional T3SS and thus 
does not activate inflammasome activation or allow downstream production and 
release of IL-1β. The obstacle which we came up against with previous use of 
this model while trying to investigate the contribution of IL-1β during initiation 
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of Th17 responses from naive CD4+ T cells was that the IL-1β difference seen 
between strains was only evident in the supernatants after a few hours post 
infection and addition of antibiotics. This was not adequate time to allow 
sufficient up-regulation of co-stimulatory molecules CD40 and CD86 to co-
stimulate the naive T cells. Overnight maturation of the infected DCs after 
antibiotic addition lead to adequate up-regulation of CD40 and CD86 which 
would stimulate naive T cells, but other unknown factors during this time lead to 
inflammasome activation and IL-1β secretion by both strains making the model 
of IL-1β presence and absence ineffective in this case. However as we have 
shown that γδ T cells secrete IL-17 in a DC contact independent manner, 
adequate up-regulation of CD40 and CD86 is unnecessary for γδ T cell culture. 
Thus we could mature DCs for a shorter time after antibiotic addition allowing a 
difference in IL-1β to be observed, and may use this model to investigate IL-1β 
contribution at IL-17 induction from γδ T cells. Unfortunately this observation 
was made later in the course of experiments and due to time constraints this 
was never investigated but is of interest for future work investigating the 
contribution of IL-1β in IL-17 induction from γδ T cells. IL-17+ γδ T cells in the 
spinal cords of mice have themselves have been shown to secrete IL-1β, thus 
indicating that IL-1β  may play a role [238]. 
Overall this chapter shows that γδ T cells are prolific producers of IL-17 in a DC 
dependent but DC contact independent manner and that IL-17 secretion from 
these cells is IL-23 dependent. IL-22 is also secreted from γδ T cells, but in what 
looks to be a different γδ T cell from IL-17+ γδ T cells where contribution of IL-
23 needs further explored. These findings make these cells an interest of further 
study especially when looking at in vivo infections to see if these cells are 
sources of IL-17 and IL-22 during P. aeruginosa infection. 
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7 In vivo responses to Pseudomonas aeruginosa 
and Streptococcus pneumoniae 
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7.1 Introduction 
We have observed IL-17 responses to both P. aeruginosa and S. pneumoniae in 
our in vitro set up but we wished to explore these responses in vivo, 
investigating if IL-17 is produced by cells in the lung in vivo upon infection with 
these pathogens and if so, does it occur in the manner that we have observed in 
vitro, and are the same cells responsible for in vivo and in vitro IL-17 
production. 
Our aim was to investigate IL-17 producing cell populations in the lung following 
induction of pneumonia with the Gram-negative bacterium P. aeruginosa and the 
Gram-positive organism S. pneumoniae to see if the response varied with 
infection with these two pathogens.  This was carried out by infecting wild-type 
(WT) mice with the pathogens intranasally to induce acute pneumonia. Mice 
were left for 48 hours or until they had became sick and had to be sacrificed 
(according to home office regulations). The strains of P. aeruginosa and S. 
pneumoniae used for the in vitro trials differed from that of the in vivo work.   
P. aeruginosa PA103 was used for the in vitro work, and PAO1 was used in the in 
vivo work, and S. pneumoniae D39 was used in in vitro work, with TIGR4 being 
used for in vivo work. The in vitro stains of each pathogen used are commonly 
used experimental strains and this is the reason for their use. The stains for the 
in vivo work differed as we wanted to use bioluminescent strains that we would 
be able to visualise with the IVIS (in vivo imaging system) to see if the bacteria 
had colonised the lung, and it was only these strains of the pathogen that were 
available for this purpose. This is not ideal as these pathogen strains differ in 
some ways (not discussed); however, we are confident that both strains of each 
pathogen effectively show genuine responses of the immune system to P. 
aeruginosa and S. pneumoniae and thus the results are a good basis for future 
work. 
A preliminary trial was also completed with IL-17 receptor (IL-17R) knock out 
(KO) mice to analyse the effects of IL-17 signalling in pneumonia. IL-17 signalling 
via the IL-17R is thought to aid in neutrophil recruitment [3, 61, 239]. Thus in 
the absence of IL-17R, one may predict that there may be less recruitment of 
neutrophils at the site of infection. This is what we wished to investigate in 
relation to P. aeruginosa and S. pneumoniae infection in the lung. As only one 
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experiment was performed using the KO mice (N=3), with S. pneumoniae 
infection, no firm assumptions can be made but it gives indications of what may 
be happening in vivo and how to perhaps proceed with repeats and future 
experiments. 
IL-17 producing cell populations were investigated in the lung tissue using flow 
cytometry, IL-17 concentrations in the bronchoalveolar lavage (BAL) and pleural 
space were measured by ELISA, overall lung tissue homology was inspected by 
histology and H&E staining, and cellular infiltrates in the BAL and pleural space 
were studied by cytospins and staining using rapid Romanowsky kit. 
This work was completed in collaboration with TJ Mitchell and his group, 
University of Glasgow. 
7.2 Establishment of pneumonia infection using              
P. aeruginosa  
The number of pathogens to induce acute pneumonia with S. pneumoniae has 
previously been established by the Mitchell group as 5x106 colony forming units 
(cfu), and so this figure was used in experiments with this pathogen. The dose of 
P. aeruginosa to use to deliver a similar level of infection was however was less 
clear. There is evidence that too high a dose will kill the mice very rapidly, but 
too little and the animals will clear the pathogen with little effect [55]. Thus, a 
pilot experiment was performed to test the number of pathogens to infect with 
intranasally to induce acute pneumonia.  
3 groups of 2 animals were infected intranasally with 5x106, 2x107 and 1x108 cfu 
and left for 48 hours. As predicted the animals given the highest dose of 
pathogens, 1x108 cfu, had to be sacrificed within a matter of hours. At the 48 
hour time point the animals that had been given the lowest dose, 5x106 cfu, 
appeared to have been outwardly unaffected by the bacteria and were still 
active and bright eyed with no weight loss, indicating that they were healthy. 
The animals that had been infected at 2x107 were moribund, and so it was 
concluded that pneumonia had been induced and had taken effect on the health 
of the animal. Due to these observations an infectious dose of 2x107 was used for 
all subsequent P. aeruginosa infections.  
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However, in subsequent experiments the 2x107 cfu dose of P. aeruginosa induced 
a rather more severe infection, necessitating sacrifice of infected mice after 24-
36 hours. We nonetheless have analysed the results and have made preliminary 
conclusions that may be considered when looking at future experiments.  
7.3 P. aeruginosa and S. pneumoniae intranasal infection 
induces lung disease 
The clinical health of the animals was monitored regularly over the course of 
infection and recorded at certain time points; 0 hours post infection (p.i), 24 
hours p.i and 30 or 48 hours p.i for P. aeruginosa and S. pneumoniae 
respectively. Health was gauged on weight loss and external appearance. 
Animals that were lively and active with shiny coats indicated good health, 
whereas sickness was indicated by animals being lethargic, starey, matted coats, 
hunched backs and finally moribund-meaning near death.  
Unfortunately use of the IVIS to detect that the pathogen had entered the lung 
and was colonizing this space was hindered due to the dark fur and thick skin of 
the C57BL/6 WT mice used. The laser of the IVIS does not readily penetrate the 
fur and skin of black C57BL/6 mice as it would white BALB/c animals. We tried 
removing the hair of these animals to aid in imaging but still found the pathogen 
difficult to detect, and due to this we cannot comment on pathogen colonization 
with imaging. However, bacteriology of the blood, BAL and homogenised lung 
confirmed presence of the infectious pathogens in the animals (data not shown). 
Furthermore, due to clinical manifestations we were sure we had induced 
pneumonia in these animals. 
7.3.1 P. aeruginosa and S. pneumoniae infection induce 
hematomas in the lung. 
Following infection, it can be clearly observed that the dissected lungs of the 
infected animals, compared to that of the controls, are consolidated and 
hemorrhagic and thus indicate that pneumonia has ensued (Figure 7-1).  
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Figure 7-1 Dissected lungs from in vivo model 
Mice were uninfected (control), or intranasally infected with P. aeruginosa or S. pneumoniae to 
induce pneumonia. After 30-48 hours depending on infection, mice were culled and lungs were 
dissected and photographed to illustrate the haemorrhagic appearance of infected lungs. Pictures 
are representative of 3 individual animals per group. Data are representative of 3 experiments. 
The lungs of the infected animals are very consolidated and haemorrhagic, 
compared to the pinkish healthy lungs of the controls. These hematomas are 
indicative of lung tissue destruction, thus showing that the infections have 
developed. Pneumonia is associated as a hemorrhagic disease [240, 241] and 
thus these observations confirm that disease was induced.  
7.3.2 P. aeruginosa and S. pneumoniae both induce severe lung 
inflammation indicative of acute pneumonia. 
Looking at the histology of the infected lungs, it is evident that both pathogens 
induced inflammation in the lung and there are major morphological changes in 
the lung tissue, compared to the control, that are characteristic of pneumonia 
[242]. 
Healthy animal histology displays many alveolar spaces with thin walls, thin 
walled major airways, blood vessels with small surrounding spaces and no 
cellular infiltrate (Figure 7-2). 
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Figure 7-2 Section of healthy control lung stained with H&E 
Lungs of uninfected control animals sacrificed at 48 hours were fixed in paraffin, before being 
sectioned and stained with H&E. The thick arrow indicates airways and the thi n arrow indicates 
blood vessels. Magniﬁcation, x40. Pictures are representative of 3 individual animals per group. 
Data are representative of 3 experiments. 
In the P. aeruginosa infected mice this morphology is greatly distorted. Large 
areas of inflammation are evident, with immune cell infiltration throughout the 
tissue, loss of alveolar spaces, airway wall thickening, blood throughout the 
tissue and cellular infiltrate in the spaces surrounding blood vessels and within 
airways (Figure 7-3). 
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Figure 7-3 Section of P. aeruginosa infected lung stained with H&E 
Animals were infected with 2x10
7
 cfu P. aeruginosa, sacrificed at 30 hours and lung tissue was 
dissected and fixed in paraffin, before being sectioned and stained with H&E. The thick arrow 
indicates areas of cellular infiltrate, inflammation and haemorrhage. The thin arrow indicates areas 
of parenchymal haemorrhage. The dashed arrow indicates areas where cells are shed in the 
airway. Magnification x40. Pictures are representative of 3 individual animals per group. Data are 
representative of 3 experiments.  
In S. pneumoniae infected mice an inflammatory cell infiltrate in the lung tissue 
was also evident mainly centred around the bronchioles and associated blood 
vessel area (Figure 7-4). 
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Figure 7-4 Section of S. pneumoniae infected lung stained with H&E 
Animals were infected with 5x10
6
 cfu S. pneumoniae, sacrificed at 48 hours and lung tissue was 
dissected and fixed in paraffin, before being sectioned and stained with H&E. The thick arrow 
indicates areas of cellular infiltrate and inflammation in the tissue. The thin arrow indicates areas of 
cellular infiltrate in the peribronchial and perivascular spaces. Magnification x40. Pictures are 
representative of 3 individual animals per group. Data are representative of 3 experiments. 
These observations confirm that inflammation, and thus pneumonia, has been 
induced in the infections. It is difficult to assess fully the phenotype of these 
cells as the sections are orientated so that the cells lie upon one another making 
identification difficult, but using a higher magnification it can be seen that the 
densely stained cells are multi-lobed nuclei neutrophils, some of which are 
highlighted in Figure 7-5.  
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Figure 7-5 Inflammation in the lung during bacterial pneumonia is due to neutrophils 
Animals were infected with 5x10
6
 cfu S. pneumoniae, sacrificed at 48 hours and lung tissue was 
dissected and fixed in paraffin, before being sectioned and stained with H&E. Neutr ophils 
responsible for this inflammation are highlighted above. Magnification x100. Pictures are 
representative of 3 individual animals per group. Data are representative of 3 experiments. 
This infiltrate of neutrophils is further confirmation that pneumonia has been 
induced. 
Examining the histology of lung tissue to compare the two infections, (Figure 7-3 
and Figure 7-4), we see no real evidence as such that the infections differ in 
their inflammatory response. Both appear to have vast areas of inflammation 
characterised by neutrophils. Direct comparison is hindered as the P. aeruginosa 
infection was much more severe, as could be seen clinically, and so these 
sections cannot be compared as similar levels of infection and sickness. 
However, both infections have induced inflammation and pneumonia and thus 
we could investigate the cellular composition of P. aeruginosa and S. 
pneumoniae induced pneumonia further by examining cytospins of the BAL and 
pleural wash, and by flow cytometry of the lung homogenates.  
  187 
7.4 Neutrophils dominate the cellular population in the 
BAL of infected animals 
Further evidence of infection and pneumonia is a strong neutrophil infiltrate in 
the BAL of the infected animals.  
In healthy control animals macrophages are the predominant cell in the BAL. 
Following infection, we expect to see a large infiltration of neutrophils, the 
hallmark of inflammation during pneumonia [53, 54].  Using rapid Romanowsky 
staining, macrophages are identified as large cells with one large dark stained 
nucleus and abundant cytoplasm. Neutrophils are smaller, appear to have less 
cytoplasm and identified by dark stained multi-lobed nuclei (Figure 7-6). 
 
Figure 7-6 Examples of a macrophage and neutrophil identified by rapid Romanowsky 
staining 
Cells from a BAL were stained with rapid Romanowsky to identify macrophages and neutrophils. 
The macrophage (left) is larger with one nucleus and abundant cytoplasm, whereas the neutrophil 
(right) is smaller, has multi-lobed nuclei and less cytoplasm. 
The BAL of the control animals consists of mainly macrophages, whereas upon 
infection with both in P. aeruginosa and S. pneumoniae the cells in the BAL are 
mainly multi-nucleated neutrophils (Figure 7-7). 
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Figure 7-7 Cytospin of cells from BAL of control lung, P. aeruginosa infected lung and S. 
pneumoniae infected lung stained with rapid Romanowsky 
Animals were left uninfected (A), or infected with 2x10
7
 P. aeruginosa (B) or 5x10
6
 cfu S. 
pneumoniae (C), sacrificed at 30 or 48 hours according to animal health, and BALs were 
performed. Aliquots of the BAL were spun down onto slides and stained with rapid Romanowsky to 
show cellular differentiation of cell population. BAL of control animals (A) show mainly 
macrophages whereas upon infection with P. aeruginosa (B) and S. pneumoniae (C) this space is 
mainly occupied by neutrophils. Pictures are representative of 3 individual animals per group. Data 
are representative of 3 experiments.  
To investigate if this presence of neutrophils was due to recruitment of more 
cells or a change in cellular percentage of the cells present in the BAL the cells 
collected were counted, ratios of differentiated cells were counted and 
percentages of neutrophils, macrophages, lymphocytes and other cells were 
calculated. Total cells counted versus neutrophil number is graphed below 
(Figure 7-8). 
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Figure 7-8 Counts of neutrophil populations in BAL  
Animals were left uninfected, or infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae, 
sacrificed at 30 or 48 hours according to animal health, and BALs were performed. Total cell 
counts in the BAL were obtained for all conditions. Differential counts of a sample of BAL spun onto 
slides were performed and percentages of cell populations present in the BAL were calculated. 
This percentage was then applied to the total to estimate how many of the total cells neutrophils 
were.  All error bars represent mean ± SEM from 3 individual animals per group.  Data are 
representative of 3 separate experiments.  
In the control animals it appears that approximately one tenth of the whole cell 
population obtained from the BAL are neutrophils, with the remaining cells being 
macrophages (Data not shown). The neutrophil number increases upon S. 
pneumoniae infection, although the total cell number does not appear to have 
changed indicating a shift to neutrophils of the cells that occupy this space. In P. 
aeruginosa infection however, there appears to be an increase in cell number 
which appears to be totally dominated by neutrophils. These observations are 
evidence that pneumonia has been induced. 
7.5 IL-17 concentrations in the BAL 
We hypothesised that IL-17 and IL-17R signalling may be responsible for 
neutrophil recruitment in the lung during bacterial infection and so we measured 
the concentrations of IL-17 in the BAL to see if there was a correlation between 
increased IL-17 and increased neutrophils in this space (Figure 7-9). 
  190 
 
Figure 7-9 IL-17 concentrations in the BAL during P. aeruginosa and S. pneumoniae 
infection 
Animals were left uninfected, or infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae, 
sacrificed at 30 or 48 hours according to animal health. BALs were performed and cells were spun 
out, leaving the BAL wash which was analysed for IL-17 by ELISA. All error bars represent mean ± 
SEM from 3 individual animals per group.  Data are representative of 3 separate experiments. 
*p<0.05.  
IL-17 is significantly increased from control during both infections, in correlation 
with dominance of neutrophils in this space as witnessed in the cytospin (Figure 
7-7). IL-17 concentrations are increased greatly during P. aeruginosa infection, 
which correlates with increased cell numbers that were dominated by 
neutrophils (Figure 7-8). This correlation suggests that IL-17 may be responsible 
for increased neutrophil numbers in the BAL. 
7.6 S. pneumoniae infection induces inflammation at the 
pleural edge that is not observed in P. aeruginosa 
infection 
The edge of the lung where it comes into contact with the chest wall is covered 
in a membrane, the visceral pleural membrane. This is a thin layer of connective 
tissue covered in a flattened squamous epithelium, the mesothelium, that can 
be observed in Figure 7-10A. 
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We observed that in S. pneumoniae infection (Figure 7-10C) but not P. 
aeruginosa infection (Figure 7-10B) the visceral pleura is grossly inflamed, 
mainly with neutrophils (Figure 7-10 D). 
 
Figure 7-10 Pleural edge of S. pneumoniae mice is inflamed compared to control and P. 
aeruginosa infected animal 
Animals were left uninfected (A), or infected with 2x10
7
 P. aeruginosa (B) or 5x10
6
 cfu S. 
pneumoniae (C), sacrificed at 30 or 48 hours according to animal health, and lung tissue was 
dissected and fixed in paraffin, before being sectioned and stained with H&E. Magnification x40.    
A severely inflamed pleural edge, indicated by gross cellular infiltrate is evident in S. pneumoniae 
infected lung (C) compared to that of an uninfected animal (A) and a P. aeruginosa infected lung 
(B), that is composed of mainly neutrophils (D) which are highlighted. Magnification x100. Pictures 
are representative of 3 individual animals per group. Data are representative of 3 experiments. 
The most interesting observation here is that it is the visceral pleura of the 
moderately clinically sick S. pneumoniae infected mice is grossly inflamed 
whereas that of the extremely clinically sick P. aeruginosa infected mice is not, 
despite these animals having a worse prognosis and showing greater 
inflammation and cellular infiltrate in the lung parenchyma (Figure 7-3) as 
opposed to that of S. pneumoniae infection (Figure 7-4). Why this is, is unclear 
and led us to investigate the cells present in the pleural space during these 
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infections, to see if they differ between P. aeruginosa and S. pneumoniae 
infection. 
7.7 Immune cells migrate into the pleural space during  
S. pneumoniae infection 
To investigate this pleural inflammation, washes of the pleural space to liberate 
cells from this compartment were performed, cells were counted and ELISAs, 
cytospins and flow cytometry of the infiltrate were analysed. This was only 
performed on one experiment, with 4 animals per group and so results must be 
interpreted with caution, but as all animals in each group responded in the same 
manner these results may give preliminary indications as to what is going on in 
this pleural space upon infections and indicates a site of interest for future 
studies. 
7.7.1 More cells are found in the pleural space of infected mice 
than control animals 
We observe that upon infection more cells can be found in the pleural space of 
infected animals than are found in uninfected control animals (Figure 7-11). No 
significant difference in total cell number can be observed between P. 
aeruginosa and S. pneumoniae infection which is intriguing as gross inflammation 
at the pleural edge was not observed in the case of P. aeruginosa infection, only 
that of S. pneumoniae infected mice. Yet it would appear that many cells 
infiltrate this space during both infections (Figure 7-11). 
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Figure 7-11 Total cell numbers in pleural space of uninfected and infected animals 
Animals were left uninfected, or infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae and 
sacrificed at 30 or 48 hours according to animal health. Pleural washes of animals were performed 
and cells were counted to give totals of cells liberated from this area. All error bars represent mean 
± SEM from 4 individual animals per group.  Data are representative of 1 experiment.  * P< 0.05. 
There is an approximate 2-fold increase in cells in the pleural space during 
infection, indicating that upon both P. aeruginosa and S. pneumoniae infection 
cells are recruited to this site.  
7.7.2 Upon infection there is a cellular infiltrate of neutrophils into 
the pleural space 
We see from the cytospins of the cellular populations washed out of the pleural 
space that in control mice the pleural space is occupied by macrophages with a 
small presence of neutrophils (Figure 7-12A), unlike in the BAL where in the 
control mainly macrophages can be observed (Figure 7-7A). Upon infection the 
cellular infiltrate in this pleural space increases dramatically. In P. aeruginosa 
infection, the cells are both macrophages and neutrophils, as identified by their 
densely stained nuclei (Figure 7-12B). Following S. pneumoniae infection, the 
cellular infiltrate is almost exclusively neutrophils (Figure 7-12C). 
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Figure 7-12 Cytospins of lung pleural washes stained with H&E 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae, and 
sacrificed at 30 or 48 hours according to animal health. Pleural washes of the animals were 
performed, and aliquots of the pleural wash were spun down onto slides and stained with H&E to 
show cellular differentiation of cell population. Pleural washes of control animals (A) show mainly 
macrophages with small neutrophil presence, whereas upon infection with P. aeruginosa (B) and S. 
pneumoniae (C) there is recruitment of neutrophils to this space more so in S. pneumoniae 
infection. Pictures representative of 4 individual animals per group. Data representative of 1 
experiment.  
Differential cell counts of the cells liberated from the pleural space were 
performed and are graphed below in Figure 7-13. 
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Figure 7-13 Neutrophils dominate the pleural space during S. pneumoniae infection 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae, and 
sacrificed at 30 or 48 hours according to animal health. Pleural washes of the animals were 
performed, and cells were counted to obtain total cell counts. Aliquots of the pleural wash were 
spun down onto slides and stained with H&E to show cellular differentiation of cell population, and 
percentages of neutrophils and macrophages were counted and calculated. Pleural washes of 
control animals (A) show mainly macrophages whereas upon infection with P. aeruginosa (B) cell 
numbers are increased which are neutrophils and macrophages, wheras during infection with S. 
pneumoniae (C) this space is mainly occupied by neutrophils.  All error bars represent mean ± SEM 
from 4 individual animals per group.  Data are representative of 1 experiment. * p< 0.05.  
During both infections neutrophils are increased in the pleural cavity; however, 
the contribution of neutrophils during each infection is different. During P. 
aeruginosa infection, cells in the pleural space appear to be represented equally 
by macrophages and neutrophils. During S. pneumoniae infection this space 
appears to be completely dominated by neutrophils, and this may explain the 
gross inflammation observed at the visceral pleura during S. pneumoniae 
infection. 
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7.7.3 IL-17 in the pleural space  
As we wished to investigate the role of IL-17 in the lung during these infections 
and suspect that IL-17 may act upstream to attract neutrophils, we measured 
the concentrations of IL-17 in the washes of the pleural space (Figure 7-14). 
 
Figure 7-14 Concentrations of IL-17 are found in the pleural space during bacterial infection 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae and 
sacrificed at 30 or 48 hours according to animal health. Pleural washes of the animals were 
performed and these were analysed for IL-17 by ELISA. All error bars represent mean ± SEM from 
4 individual animals per group.  Data are representative of 1 experiment . * p< 0.05. 
Although somewhat low, concentrations of IL-17 differ significantly in the 
pleural space during infection compared to the control. Concentrations of IL-17 
do not differ significantly in this space between infections, indicating that IL-17 
responses in this space may not be Gram-negative or Gram-positive pathogen 
specific. This was observed in all 4 animals, but as this is only one experiment, 
must be repeated before conclusive results can be made. 
7.7.4 Sources of IL-17 in pleural space 
To investigate the source of IL-17 in the pleural space, cells in the pleural space 
were stimulated with PMA and ionomycin in the presence of brefeldin A to retain 
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any IL-17 produced by the cells for intracellular cytokine staining. Unfortunately 
no IL-17+ cells are observed in this experiment by this means. However we do 
notice that in the pleural space there are shifts in immune cell populations and 
these were investigated in the next section.  
7.7.5 Immune cells are increased in the pleural space upon 
infection 
Cytological examination cannot differentiate well all the different leukocytes 
present in the pleural cavity. Thus, the remaining cells harvested from the 
pleural space were stained for extracellular markers CD4, γδ, Gr-1 and CD19 to 
investigate the populations of CD4+ cells, γδ T cells, neutrophils and B cells in 
the pleural space respectively. We wished to examine if populations of these 
cells were present in the pleural space normally and if they altered during P. 
aeruginosa and S. pneumoniae infection. Note cells are gated on a live 
population of low side scatter where we have previously shown IL-17 cells to be 
located as these are our primary cells of interest, with exception of gating for 
Gr-1 cells, as described in materials and methods. 
In the pleural space of the uninfected animals there appears to be a high 
percentage of CD4+ T cells in the live gated cells, 64%, that increases slightly 
upon infection with P. aeruginosa, 68%, and appears to decrease slightly during 
S. pneumoniae infection to 58% (Figure 7-15A). However it must be considered 
that in the pleural space of the infected animals the cell numbers in this space 
are vastly increased (Figure 7-11) so in S. pneumoniae infection where CD4+ T 
cell percentage has dropped from that of control there are still many more CD4+ 
T cells present upon infection.  
γδ T cell presence in the pleural space is low with less than 3% γδ T cells found 
in this space, on gated cells, in the uninfected control animals. Comparatively 
this may not be a low percentage as γδ T cell populations in non-lymphoid 
tissues are generally regarded to be below 5% of T cell population [243]. This γδ 
population in the pleural space appears to decrease to approximately half, 1.5%, 
upon infection with both P. aeruginosa and S. pneumoniae (Figure 7-15B). Due to 
total cell numbers in this space being double upon infection, a percentage 
population of half would give the same number of γδ T cells in both uninfected 
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and infected animals. So it would appear that γδ T cell numbers are unchanged 
in the pleural space during both infections indicating that γδ T cells are not 
important at this site during infection with P. aeruginosa and S. pneumoniae. 
Analysis of the total cells found in the pleural space confirm that in S. 
pneumoniae infection, where we see gross inflammation at the visceral pleura, 
this inflammation may be caused by neutrophils. In the control animals 
approximately 3% of neutrophils can be observed when looking at all cells in this 
space. This increases slightly to 4.85% upon P. aeruginosa infection but increases 
dramatically to 28% upon S. pneumoniae infection (Figure 7-15C). This confirms 
the observation that many neutrophils are observed in the pleural space during 
S. pneumoniae infection as was observed on cytospins (Figure 7-12) and histology 
(Figure 7-10C) of these samples. It is worth noting that according to the 
cytospins and analysis of cells in this space by rapid Romanowsky staining, that 
during P. aeruginosa infection there appeared to be many neutrophils in this 
space, though not as many as S. pneumoniae infection. Yet this is not evident 
with the flow cytometry data and so the outputs conflict somewhat. More 
repeats must be performed before any firm assumptions can be made about 
neutrophil recruitment at this site during each infection. 
It would appear that in uninfected animals approximately a third of cells in the 
pleural space are B cells, as identified by marker CD19, in our gated population 
of interest. During infection with both P. aeruginosa and S. pneumoniae, B cell 
percentages in the pleural space seem to decrease (Figure 7-15D). Again it must 
be noted that although B cell percentages are lower upon infection, the total 
number of cells in this space has doubled and so there are still more B cells in 
the pleural space of infected animals than uninfected control animals. However 
as a percentage of all cells found in this space, B cells seem to reduce upon 
infection indicating that they do not have a major role in the pleural space 
during infection with P. aeruginosa and S. pneumoniae. 
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Figure 7-15 Immune cells in the pleural space during infection 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae and 
sacrificed at 30 or 48 hours according to animal health. Pleural washes of the animals were 
performed and cells were isolated and stained with CD4 (A), γδ (B), Gr-1 (C) and CD19 (D), and 
analysed by flow cytometry compared to their respective isotypes. Cells gated on live cells based 
on FSC and SSC with a larger gate set for Gr-1 analysis as described in materials and methods.  
Positive gates were set on isotypes for markers on cells isolated from P. aeruginosa infected 
animals. Dot plots represent data pooled from 4 animals. Data representative of 1 experiment.  
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These observations of immune cells in the pleural space are of one experiment 
only and so must be taken with caution. However, they do suggest that the 
pleural space is an area of great interest for further studies, as others have 
investigated in Mycobacteria infection [244, 245], and should be considered as a 
site of cytokine secretion and cellular infiltrate upon infection, especially that 
of S. pneumoniae infection.  
7.8 Immune cell populations in the lung increase during 
bacterial pneumonia 
To investigate the immune response in the lung tissue, the site of infection 
during acute pneumonia infection to the pathogens P. aeruginosa and S. 
pneumoniae, the lungs of these animals were digested to obtain single cell 
suspensions and cells were stained to assay for CD4 cells, γδ T cells, neutrophils 
and IL-17 production by these cells, which were analysed by flow cytometry. 
Again it must be noted that cells are gated on a live population of low side 
scatter, as described in materials and methods.  
During P. aeruginosa infection, an increase of almost double CD4+ cells from 
that of control was observed in our gated population. In S. pneumoniae infection 
the CD4+ cell population appears slightly reduced than that of control ( Figure 
7-16A). 
γδ T cells increase approximately 2.5 times in this gated population from control 
upon both P. aeruginosa and S. pneumoniae infection (Figure 7-16B), illustrating 
γδ T cells play a role in the lung in pneumonia during both infections. 
Gr-1 is a marker commonly used to identify neutrophils when analysing blood, 
which also appeared to effectively identify neutrophils in the pleural space 
(Figure 7-15). However in the lung Gr-1 expression is difficult to interpret, with 
Gr-1 populations in the control uninfected animals looking to be high (Figure 
7-16C). We know that there are few neutrophils in the uninfected control 
animals as we have observed in both their BAL (Figure 7-7A) and washes of the 
pleural space (Figure 7-12A), and from the histology (Figure 7-2). This leads us to 
question the use of Gr-1 as a marker for neutrophils in the lung tissue. 
Monocytes may also be Gr-1+ [246], and as the lung is known to be full of 
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alveolar macrophages we are inclined to say that in the lung tissue we are 
staining for these and any other monocytic like cells that may be present, as Gr-
1 is classed as a monocyte marker [246]. Thus, it would appear that Gr-1 cannot 
be used as a marker for neutrophils in the lung tissue and therefore we cannot 
make any assumptions about neutrophil contribution in the lung during infection 
by this means.  
 
Figure 7-16 Immune cells in the lung during pneumonia 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae and 
sacrificed at 30 or 48 hours according to animal health. Lungs of the animals were dissected and 
digested to obtain single cell suspensions. Cells were stained with CD4 (A), γδ (B) and Gr-1 (C) 
and analysed by flow cytometry compared to their respective isotypes. Cells gated on live cells 
based on FSC and SSC with a larger gate set for Gr-1 analysis as described in materials and 
methods. Positive gates were set on isotypes for markers on cells isolated from P. aeruginosa 
infected animals. Dot plots represent data pooled from 3 animals. Data representative of 3 
experiments. 
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7.9 Sources of IL-17 in the lung during bacterial 
pneumonia 
IL-17 production throughout the 3 in vivo experiments varied, and therefore it is 
difficult to make any firm conclusions based on these experiments alone. In one 
case we see no IL-17 in the uninfected control animals and an increase in IL-17+ 
cells during infection (data not shown). However an identical repeat of this 
experiment bore different results with IL-17 observed from uninfected animals 
also. It is worthy to note that PMA and ionomycin stimulation used to induce 
intracellular production of cytokines makes any cell that has been or is capable 
of secreting IL-17, secrete it again, and so the information we have obtained 
from the unstimulated lungs may not be very informative. We need a measure of 
cells that have produced IL-17 at some point during infection and this is 
discussed further in the discussion. However, where IL-17+ cells have been 
observed in the uninfected control animals we observe a shift in the cells that 
produce IL-17 during the infections and can formulate theories of IL-17 
production and the cells responsible for IL-17 secretion during P. aeruginosa and 
S. pneumoniae infection, as we see the same source of IL-17 from controls and 
each infection every time. Due to the fluctuating nature of these experiments, 
numerous repeats of these experiments must be performed in order to come to 
any firm conclusions, but we have documented our preliminary findings below. 
Upon S. pneumoniae infection, although less severe clinically than P. aeruginosa 
infection, more IL-17 is observed from cells in the lung tissue (Figure 7-17). 
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Figure 7-17 IL-17 cells are increased during S. pneumoniae but not P. aeruginosa infection 
Animals were left uninfected, infected with 2x10
7
 P. aeruginosa or 5x10
6
 cfu S. pneumoniae and 
sacrificed at 30 or 48 hours according to animal health. Lungs of the animals were dissected and 
digested to obtain single cell suspensions. Cells were stimulated with PMA and ionomycin in the 
presence of brefeldin A for 5 hours, after which time cells were harvested and stained for IL-17 and 
analysed by flow cytometry compared to isotype. Cells gated on live cells based on FSC and SSC 
as described in materials and methods.  Positive gates were set on isotypes for markers on cells 
isolated from P. aeruginosa infected animals. Dot plots represent data pooled from 3 animals. Data 
representative of 3 experiments.  
This is a curious observation as P. aeruginosa infection appeared to be more 
clinically severe. This led us to look at the sources of IL-17 during these 
infections to see if they differed during the two infections. 
In control mice 18% of the IL-17 producing cells are γδ T cells, and this increases 
to 42% upon P. aeruginosa infection showing a strong shift to IL-17 producing γδ 
T cells in P. aeruginosa infection. In S. pneumoniae infection γδ T cells are still 
only responsible for 18% of IL-17+ cells (Figure 7-18). 
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Figure 7-18 IL-17+ γδ T cells in the lung during P. aeruginosa and S. pneumoniae infection 
Lungs of uninfected control mice, P. aeruginosa infected mice and S. pneumoniae infected mice 
were dissected and digested to obtain single cell suspensions. Cells were stimulated with PMA and 
ionomycin in the presence of Brefeldin A for 5 hours before being harvested and stained for γδ and 
IL-17, and analysed by flow cytometry compared to their respective isotypes. Cells gated on live 
cells based on FSC and SSC as described in materials and methods. Positive gates were set on 
isotypes for markers on cells isolated from P. aeruginosa infected animals. Dot plots represent data 
pooled from 3 animals. Data representative of 3 experiments. 
This indicates that γδ T cells may be an important source of IL-17 during P. 
aeruginosa infection but not so during S. pneumoniae infection. It would appear 
that in correlation with this shift to IL-17 production from γδ T cells during P. 
aeruginosa infection the amount of IL-17 producing CD4 cells, Th17 cells, 
reduces during this infection (Figure 7-19). 
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Figure 7-19 Th17 cells in the lung increase during S. pneumoniae bacterial pneumonia, yet 
decrease during infection with P. aeruginosa 
Lungs of uninfected control mice, P. aeruginosa infected mice and S. pneumoniae infected mice 
were dissected and digested to obtain single cell suspensions. Cells were stimulated with PMA and 
ionomycin in the presence of Brefeldin A for 5 hours before being harvested and stained for CD4 
and IL-17, and analysed by flow cytometry compared to their respective isotypes. Cells gated on 
live cells based on FSC and SSC as described in materials and methods. Positive gates were set 
on isotypes for markers on cells isolated from P. aeruginosa infected animals. Dot plots represent 
data pooled from 3 animals. Data representative of 3 experiments. 
 It appears that although CD4 T cells increase during P. aeruginosa infection 
(Figure 7-16A) they are not IL-17 producing, (Figure 7-19), and therefore not 
Th17. This indicates that another CD4+ helper T cell is recruited during P. 
aeruginosa infection, although what is unclear as we did not test for any other 
cytokines that could characterize other helper T cell subsets.  
Th17 cells appear to increase slightly upon infection with S. pneumoniae but the 
majority of IL-17+ cells are CD4- (Figure 7-19).  
Using Gr-1 as a tissue granulocyte marker and not as a marker solely for 
neutrophils, we have identified during bacterial pneumonia caused by P. 
aeruginosa, granulocytes, including neutrophils, are not responsible for 
production of IL-17 (Figure 7-20). From control to S. pneumoniae infection the 
percentage of Gr-1+ IL-17+ cells doubles and visibly looks to be a more 
prominent population, but this Gr-1+ IL-17+ is only responsible for 22% of IL-17 
production according to percentages using gates that originate from clean 
isotypes, and this percentage does not differ from control or P. aeruginosa  
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infection. So it appears Gr-1+ cells including neutrophils and macrophages are 
not responsible for IL-17 production during these infections.  
 
Figure 7-20 IL-17+ Gr-1+ cells in the lung during bacterial pneumonia 
Lungs of uninfected control mice, P. aeruginosa infected mice and S. pneumoniae infected mice 
were dissected and digested to obtain single cell suspensions. Cells were stimulated with PMA and 
ionomycin in the presence of Brefeldin A for 5 hours before being harvested and stained for Gr-1 
and IL-17, and analysed by flow cytometry compared to their respective isotypes.  Cells gated on 
live cells based on FSC and SSC as described in materials and methods . Positive gates were set 
on isotypes for markers on cells isolated from P. aeruginosa infected animals. Dot plots represent 
data pooled from 3 animals. Data representative of 3 experiments. 
From these results it appears that the sources of IL-17 during P. aeruginosa and 
S. pneumoniae infection differ. These results give evidence of γδ T cells being a 
key cellular source of IL-17 during P. aeruginosa infection but the source of IL-17 
during S. pneumoniae infection is less clear. Small populations of IL-17+ γδ T 
cells, Th17 cells and IL-17+ Gr-1+ cells are evident during S. pneumoniae 
infection. However, the majority of IL-17+ cells appear to be CD4-, γδ- and Gr-1- 
cells.  This difference in IL-17 producing cells between P. aeruginosa and S. 
pneumoniae infection may represent a difference in host response and IL-17 
production between Gram-negative and Gram-positive bacteria species, or these 
responses may be pathogen specific. Many experiments with other Gram-
negative and Gram-positive pathogens must be performed before any 
assumptions about sources of IL-17 during Gram-positive and Gram-negative 
bacteria can be made, but these results give a preliminary indicating that roles 
of IL-17 and sources of IL-17 during these infections may differ. 
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7.10 Effects of IL-17 signalling via its receptor IL-17R     
on the immune responses in the lung during                   
S. pneumoniae pneumonia  
Preliminary experiments with IL-17RKO mice were performed to investigate the 
role of IL-17 and signalling via its receptor IL-17R, during S. pneumoniae 
pneumonia, and the effects that this cytokine and receptor pairing may have on 
the immune response in the lung during this infection. It is well documented 
that neutrophils are one of the first immune cells on site during infection, and 
that IL-17 plays a role in their recruitment [3, 61, 239]. In bacterial pneumonia 
in the lung, IL-17 released by cells at this site during the infection may bind to 
IL-17R on epithelial cells in the lung, which in turn secrete the neutrophil 
attractant chemokine IL-8 [247] (otherwise known as CXCL8 with homologs KC or 
MIP-2 in mice [248]). IL-8 attracts neutrophils to the site of IL-17 release, and as 
a result to the site of infection. It is therefore supposed that in IL-17RKO mice, 
neutrophil recruitment will be severely reduced due to lack of IL-17 signalling 
and as a consequence the mice will be sicker as neutrophils, which are clearly 
considered to be necessary due to the rapid speed of their influx during 
infection, are not present. Sickness in the animals is measured clinically by 
weight loss and observations in behaviour such as matted coat, staggered gait, 
lethargy and finally becoming moribund-a state of near death. Due to time 
constraints and slow breeding of the IL-17RKO mice, only one experiment in 
triplicate was performed with S. pneumoniae infection in IL-17 KO and WT mice, 
and although not conclusive, data was analysed and hypotheses were formed to 
be used as a template for future experiments.  
7.11 IL-17RKO mice are larger, heavier and have more 
subcutaneous fat that WT mice 
Firstly in this preliminary experiment the IL-17RKO mice infected with S. 
pneumoniae did not appear to be clinically sicker than the WT mice with the 
same infection. However, we are careful not to assume that this is due to IL-17R 
absence but could in fact be due to size differences between the strains as the 
IL-17KO mice were older and much larger, and therefore the number of 
pathogens given intranasally during infection may have had a lesser effect. 
Ideally this would have been accounted for before the experiment was carried 
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out and each animal would have been given a cfu to deliver a similar level of 
clinical sickness over the time. However, calculating the correct cfu to infect 
the larger mice with to obtain a similar level of sickness of these mice would 
have taken weeks and many animals to ascertain. Neither of these resources 
were available to us at this point and so it was decided that as a preliminary 
experiment the same number of pathogens would be used for both the WT and 
KO mice regardless of their age and size difference. The KO mice used were 
older by approximately 8 weeks, and were 16 weeks of age as opposed to 8 
weeks of age of the WT mice. However, age difference in these animals was not 
our greatest concern though as opposed to size difference between animals. The 
KO mice were much larger, and not just larger than the WT mice but much 
larger than any mice we have ever observed regardless of age. The KO animals 
were significantly heavier and almost double the weight of the WT animals as 
can be observed from Figure 7-21. 
 
Figure 7-21 IL-17RKO animals are significantly heavier than their WT counterparts 
The weight of IL-17RKO and WT animals infected with S. pneumoniae was monitored over a 24 
hour period to illustrate the difference in weight between these mouse strains.  All error bars 
represent mean ± SEM from 3 individual animals per group.  Data are representative of 1 
experiment. ** p< 0.005.  
The IL-17RKO animals were not just significantly heavier and bigger in size but 
much fatter, with lots of subcutaneous fat that was observed when dissecting 
the animals to liberate our tissues of interest. Ordinarily upon dissection when 
abdominal skin is removed the organs in the peritoneum can all be seen though 
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the thin peritoneum membrane. In the KO animals there were several layers of 
fat directly underneath the skin to penetrate before organs could be seen. It was 
initially supposed that as these mice were older this may be the reason for their 
size and weight increase. However, others have noticed fat and weight gain in 
IL-17R KO mice also [249] and this is discussed further in the discussion.  
During S. pneumoniae induced acute pneumonia, the IL-17RKO mice became 
sick, albeit not sick as the WT and unfortunately we cannot make any 
assumptions of whether this was down to IL-17R absence or not, due to such 
discrepancies in size as the pathogen cfu may have a lesser effect in the larger 
mice which have larger lungs. The apparent clinical sickness of the IL-17RKO 
mice, however, allows us to interpret our immunological findings in relation to 
the infection in the mice, albeit perhaps not directly in relation to infection in 
the WT.  
7.12 IL-17 signalling via IL-17R may induce inflammation 
in the lung during S. pneumoniae infection 
The histology of these preliminary experiments shows that the WT mice infected 
with S. pneumoniae have large areas of inflammation in the lung parenchyma 
with gross inflammation at the visceral pleura as previously discussed. The 
histology of the IL-17RKO S. pneumoniae infected lung almost looks like a 
healthy lung, with large spaces and little inflammation in the tissue and at the 
visceral pleura (Figure 7-22).  
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Figure 7-22 Histology of WT lung during S. pneumoniae infection is grossly inflamed 
whereas histology of IL-17RKO lung during the same infection is not 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, sacrificed at 48 hours and 
lung tissue was dissected and fixed in paraffin, before being sectioned and stained with H&E. 
magnification x40. . Pictures are representative of 3 individual animals per group. Data are 
representative of 1experiment. 
This suggests a role for IL-17 signalling through IL-17R at inducing inflammation 
in both the parenchyma and at the visceral pleura in S. pneumoniae infection, as 
this inflammation is absent in IL-17RKO animals. 
7.13 IL-17 and neutrophil recruitment in BAL in IL-17RKO 
animals 
Previously we have observed considerable amounts of IL-17 in the BAL during S. 
pneumoniae infection (Figure 7-9), that are significantly increased from the 
control, appearing to correlate with an influx of neutrophils in this space (Figure 
7-7C) indicating that IL-17 signalling may enhance neutrophil recruitment. 
Similar concentrations of IL-17 in the BAL were observed here during S. 
pneumoniae infection in the WT animals as we have observed before (Figure 
7-9), with no significant difference observed in absence of IL-17R (Figure 7-23). 
  211 
 
Figure 7-23 IL-17R does not regulate IL-17 concentrations in the BAL 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, and sacrificed at 48 
hours. BALs were performed and analysed for IL-17 by ELISA.. All error bars represent mean ± 
SEM from 3 individual animals per group.  Data representative of 1 experiment.  
This indicates that IL-17 signalling via IL-17R may not regulate IL-17 secretion 
from cells in the lung during S. pneumoniae infection. 
Although the two animal strains, WT and IL-17RKO, appear to secrete similar 
concentrations of IL-17 in the BAL (Figure 7-23), the cellular compositions in this 
space differ (Figure 7-24). 
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Figure 7-24 Cytospin of cells from BAL of WT and IL-17RKO lung during S. pneumoniae 
infection stained with rapid Romanowsky 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, sacrificed at 48 hours, 
and BALS were performed. Aliquots of the BAL were spun down onto slides and stained with rapid 
Romanowsky to show cellular differentiation of cell population. . Pictures are representative of 3 
individual animals per group. Data are representative of 1 experiment. 
In the WT animals neutrophils almost completely dominate the BAL during S. 
pneumoniae infection (Figure 7-24). However, during S. pneumoniae infection in 
the IL-17RKO animals although there is increased neutrophil numbers, there is 
also a definite macrophage presence (Figure 7-24). This neutrophil/macrophage 
mix may represent a less severe inflammatory cell infiltrate, which would 
correlate with reduced inflammation observed in the histology of the lungs in 
these animals (Figure 7-22). Fewer neutrophils in the BAL of IL-17RKO animals 
indicates that IL-17R signalling enhances neutrophil recruitment, further 
supporting our hypothesis that IL-17 signalling may aid in neutrophil recruitment 
in the lung during S. pneumoniae infection. However as these mice were larger 
and we are not clear of the extent of the infection due to the cfu that we have 
administered, further experiments will be required to confirm this finding. 
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7.14 IL-17 signalling via IL-17R may regulate immune 
cells in the pleural space during S. pneumoniae 
infection 
7.14.1 Increased cells in the pleural space of IL-17RKO mice 
during S. pneumoniae infection 
In S. pneumoniae infection in the WT animals an influx of cells has previously 
been observed in the pleural space as can be observed in Figure 7-11. We wished 
to investigate the cellular composition in this space during S. pneumoniae 
infection in the IL-17R KO mice, where there is a notable lack of inflammation at 
the pleural edge, thus investigating what role IL-17 and IL-17R may play at 
recruiting cells to this space during S. pneumoniae infection. 
First we observe that there appears to be many more cells in the pleural space 
of the KO mouse, than the WT mouse (Figure 7-25).  
 
Figure 7-25 Cell numbers are increased in pleural space during S. pneumoniae infection in 
IL-17RKO animals 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, and sacrificed at 48 hours 
according to animal health. Pleural washes of the animals were performed, and cells were counted 
to obtain total cell counts. All error bars represent mean ± SEM from 3 individual animals per 
group.  Data are representative of 1 experiment. 
This is of interest as there is no inflammation at the pleural edge in IL-17RKO 
animals as there is in the WT (Figure 7-22). What are these cells and why would 
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there be more cells present in this space in the IL-17RKO animals if there is no 
inflammation at this site? 
Upon analysis of cells in the pleural space by staining them use rapid 
Romanowsky, the cells in this space look to be mainly neutrophils as can be 
identified by their multi-nucleated appearance (Figure 7-26). 
 
Figure 7-26 The pleural space of IL-17RKO animals is dominated by neutrophils during S. 
pneumoniae infection 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, sacrificed at 48 hours 
Aliquots of the pleural wash from IL-17RKO animals were spun down onto slides and stained with 
rapid Romanowsky kit to show cellular differentiation of cell populations . Pictures are 
representative of 3 individual animals per group. Data are representative of 1 experiment. 
Differential counts of cells were performed and percentages of macrophages and 
neutrophils were calculated. It appears as if the cellular infiltrate in the pleural 
space during S. pneumoniae infection in IL-17RKO animals is mainly neutrophils 
(Figure 7-27).  
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Figure 7-27 Neutrophils are increased in the pleural space during S. pneumoniae infection in 
IL-17RKO animals 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, and sacrificed at 48 hours 
according to animal health. Pleural washes of the animals were performed, and cells were counted 
to obtain total cell counts. Aliquots of the pleural wash were spun down onto slides and stained with 
rapid romanowsky to show cellular differentiation of cell population, and percentages of neutrophils 
and macrophages were counted and calculated. Pleural washes of both WT and IL-17RKO animals 
show mainly neutrophils, however the total number is significantly increased in IL-17RKO animals 
compared to WT animals. All error bars represent mean ± SEM from 3 individual animals per 
group. Data representative of 1 experiment. * P < 0.05 
This observation is of interest as there is no inflammation at the visceral pleura 
during S. pneumoniae infection in IL-17RKO animals as observed by histology 
(Figure 7-22), and we believed that neutrophils would be responsible for this 
inflammation, as observed in WT animals during S. pneumoniae infection. 
Furthermore we believed that lack of IL-17R signalling would down-regulate 
recruitment of neutrophils, not increase it as has been observed here. This 
conflict of results is discussed further in the discussion. 
7.14.2 IL-17R may regulate IL-17 concentrations in pleural 
space 
We have previously observed small but significant concentrations of IL-17 in the 
pleural space during S. pneumoniae infection (Figure 7-14) and so we were 
interested to see if lack of IL-17R affected IL-17 concentrations in the pleural 
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space during this infection (Figure 7-28) as IL-17 secretion in the BAL appears to 
be IL-17R independent during S. pneumoniae infection (Figure 7-23). 
 
Figure 7-28 IL-17 is increased during S. pneumoniae infection in IL-17RKO animals 
WT and IL-17RKO animals were infected with 5x10
6
 cfu S. pneumoniae, and sacrificed at 48 
hours. Pleural washes were taken and analysed for IL-17 by ELISA. All error bars represent mean 
± SEM from 3 animals. Data representative of 1 experiment. * p< 0.05.  
From this preliminary experiment it appears that, unlike the BAL, presence of IL-
17R regulates IL-17 concentrations in the pleural space as IL-17 concentration in 
the IL-17RKO mice are significantly larger from that during the same infection in 
the WT animals. This may indicate that IL-17 negatively regulates itself via 
signalling through IL-17R, or it could be that the same concentrations of IL-17 
are produced regardless of presence or absence of IL-17R, but it is not consumed 
as it has no receptor to bind to. We did not investigate either of these theories 
and so cannot comment further. 
7.14.3 IL-17R regulation of immune cells in pleural space 
The pleural washes of these animals were analysed by flow cytometry to further 
investigate the cellular composition in this space and how it differed between 
WT and IL-17RKO animals during S. pneumoniae infection, so we may gain a 
better idea of the role of IL-17R, if any, in recruitment of cells to the pleural 
edge during this infection. 
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In the pleural space γδ T cells do not appear to differ between WT and IL-17R 
KO animals during S. pneumoniae infection (Figure 7-29A), indicating that γδ T 
cells are not regulated at this site by IL-17 signalling through IL-17R on cells. 
CD4+ cells increase from 68% in WT mice to 85% in IL-17RKO mice (Figure 7-29B). 
Increased CD4+ cells observed in IL-17R absence indicates that CD4+ recruitment 
in the pleural space in S. pneumoniae infection is regulated by IL-17 and IL-17R, 
with IL-17 signalling appearing to limit recruitment of CD4+ cells to this site. B 
cells increase from 22% in WT animals to 30% in the IL-17RKO animals, indicating 
that IL-17 presence may have a role in down-regulating B cell recruitment in the 
pleural space during S. pneumoniae infection. There is a small increase in the 
percentage of Gr-1 cells in this space in the absence of IL-17R with 28.2% Gr-1 
cells observed in the WT animals and 34.1% in the IL-17RKO (Figure 7-29C).  
However, the absolute numbers of neutrophils as assayed by direct cell counting 
did show an increase (Figure 7-27).  
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Figure 7-29 Immune populations in the pleural space of WT and IL-17RKO mice during S. 
pneumoniae infection 
Lungs of WT and IL-17RKO S. pneumoniae infected mice were dissected and digested to obtain 
single cell suspensions. Cells were stained with CD4 (A), γδ (B) Gr-1 (C) and CD19 (D) and 
analysed by flow cytometry compared to their respective isotypes. Cells gated on live cells based 
on FSC and SSC with a larger gate set for Gr-1 analysis as described in materials and methods. 
Positive gates were set on isotypes for markers on cells isolated from P. aeruginosa infected 
animals. Dot plots represent data pooled from 3 animals. Data representative of 1 experiment.  
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For reasons unknown IL-17 could not be observed by flow cytometry and so the 
sources of IL-17, and if IL-17 producing cells differ at this site between the WT 
and IL-17RKO animals during S. pneumoniae infection, is presently unknown. 
7.15 IL-17 signalling via IL-17R may regulate immune 
cells in the lung during S. pneumoniae infection 
Infiltrate of immune cells in the lungs of IL-17RKO mice is not evident from the 
histology but analysis of the cells in the digested lung by flow cytometry show 
that immune cells are increased during S. pneumoniae infection in the IL-17RKO 
animals (Figure 7-30). Lungs of the WT and IL-17RKO animals infected with S. 
pneumoniae were digested to obtain single cell suspensions and stained for IL-17 
investigate if IL-17 production differs between the WT and the IL-17RKO, and 
CD4 and γδ to indentify if these immune cells are sources of IL-17 in these 
animals. Looking at the surface markers, γδ T cells almost double (Figure 7-30A) 
and CD4+ cells appear to increase 30% in the IL-17RKO mice from WT (Figure 
7-30B) indicating that IL-17 may down-regulate these populations to an extent, 
in the lung during S. pneumoniae infection. 
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Figure 7-30 CD4 and γδ populations in WT and IL-17RKO mice during S. pneumoniae 
infection 
Lungs of WT and IL-17RKO S. pneumoniae infected mice were dissected and digested to obtain 
single cell suspensions. Cells were stained for CD4 and IL -17, and analysed by flow cytometry 
compared to their respective isotypes. Cells gated on live cells based on FSC and SSC as 
described in materials and methods. Positive gates were set on isotypes for markers on cells 
isolated from P. aeruginosa infected animals. Dot plots represent data pooled from 3 animals. Data 
representative of 1 experiment.  
The lung cells were also stained for Gr-1 to identify neutrophils, but the 
populations of Gr-1 in each animal did not greatly differ (data not shown). We 
have previously stated that Gr-1 may stain all granulocytes in the lung, and so 
use of this marker cannot give us any conclusions about neutrophil involvement 
in these infections, and so is not included in this thesis.  
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7.15.1 IL-17R negatively regulates IL-17+ cells in the lung 
during S. pneumoniae infection  
Upon investigating the IL-17+ producing cells we see that IL-17 cell populations 
increase 1.7 times during S. pneumoniae infection in the IL-17RKO animals from 
WT (Figure 7-31). 
 
Figure 7-31 IL-17 producing populations are increased in S. pneumoniae infection in the 
absence of IL-17R  
Lungs of WT and IL-17RKO S. pneumoniae infected mice were dissected and digested to obtain 
single cell suspensions. Cells were stimulated with PMA and ionomycin in the presence of brefeldin 
A for 5 hours then stained for IL-17, and analysed by flow cytometry compared to their respective 
isotypes.  Cells gated on live cells based on FSC and SSC as described in materials and methods. 
Positive gates were set on isotypes for markers on cells isolated from P. aeruginosa infected 
animals. Dot plots represent data pooled from 3 animals. Data representative of 1 experiment.  
As we observe increased IL-17+ cells in the IL-17RKO animals, compared to WT, 
we deduce that IL-17 signalling through IL-17R negatively regulates IL-17 
producing cells, indicating IL-17 acts in a negative feedback loop on the cells 
that produce it. The sources of IL-17 in S. pneumoniae infection between the WT 
and IL-17R KO mice appear to be similar (Figure 7-32) just increased in the      
IL-17RKO mice, explaining the increased IL-17+ population observed in figure 
Figure 7-31. 
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Figure 7-32 Sources of IL-17 during S. pneumoniae infection in WT and IL-17RKO mice 
Lungs of WT and IL-17RKO S. pneumoniae infected mice were dissected and digested to obtain 
single cell suspensions. Cells were stimulated with PMA and ionomycin in the presence of brefeldin 
A for 5 hours then stained for CD4, γδ, Gr -1 and IL-17,and analysed by flow cytometry compared to 
their respective isotypes.  Cells gated on live cells based on FSC and SSC as described in 
materials and methods. Positive gates were set on isotypes for markers on cells isolated from P. 
aeruginosa infected animals. Dot plots represent data pooled from 3 animals. Data representative 
of 1 experiment.  
IL-17+ γδ T cells increase from 17% of IL-17+ cells in the WT animals to 25% of IL-
17+ cells in IL-17RKO animals(Figure 7-32A). Th17 cells are responsible for 27% of 
IL-17 productions in the WT and this is increased to 34% in the IL-17RKO animals 
(Figure 7-32B). Gr-1 expressing cells were not investigated as a source of IL-17 
as, has been discussed previously, it is an unsuitable marker for lung tissue 
staining.  
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7.16 Discussion 
Pneumonia is induced in mice upon intranasal infection of both P. aeruginosa 
and S. pneumoniae.  We have observed that these infections are similar in their 
response in some ways such as inflammation and haematomas, yet they differ in 
some distinct ways such as areas where inflammation is focussed and cell types 
responsible for IL-17 secretion in these infections. 
Pneumonia has been observed as a haemorrhagic disease [240, 241] and this is 
evident in the lungs of the infected animals in our experiments. It can be 
observed by eye upon dissection and in the histology there is evidence in some 
areas, especially in the P. aeruginosa infection, of bloody infiltrate indicating 
that infection has ensued in the lungs of these animals. We therefore conclude 
that disease has developed in these animals and any following hypotheses we 
make may be genuine in reference to bacterial pneumonia infection in the lungs 
induced by these pathogens. 
In both infections there is clear inflammation in the lung as evident from the 
histology of the tissues. In comparison to the control we observe great 
inflammatory cell infiltrate in both P. aeruginosa and S. pneumoniae infections 
which appears to be mainly neutrophil based upon further magnification, as 
identified by cells with multi-lobed, densely stained nuclei. Both infections show 
large areas of neutrophil based inflammation but sites where inflammation is 
concentrated varies between infections. In the P. aeruginosa infection, the 
inflammation appears to be all encompassing, most of the tissue appears to be 
heavily infiltrated with neutrophils and the open spaces of the bronchioles can 
no longer be observed. In the S. pneumoniae infection, a somewhat less severe 
infection in our experiment as measured by clinical observations, the 
inflammation appears to be focussed around the blood vessels and at the 
visceral pleura. This was observed in every individual S. pneumoniae infected 
animal in every experiment (N=12) indicating that it is a genuine response in 
these animals to S. pneumoniae infection in the lung.  Extensive inflammation at 
the visceral pleura in S. pneumoniae infection and not P. aeruginosa infection, 
which we observed to be a clinically more severe infection, indicates a 
somewhat specific reaction to S. pneumoniae at the visceral pleura.  Although 
during P. aeruginosa infection gross inflammation is not observed at the visceral 
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pleura, many immune cells are still found in the pleural space in both infections, 
as can be observed by the approximate 2-fold increase of cells at this site during 
infections. Analysis of cytospins of cells found in this space, stained with rapid 
Romanowsky to identify macrophages, neutrophils and lymphocytes, indicates 
that there is an influx of neutrophils in this space from control in both 
infections. So it appears that there is a similar number of cells in P. aeruginosa 
infection as there is in S. pneumoniae infection in the pleural space, and they 
both look to be dominated by neutrophils, yet only infection with S. pneumoniae 
shows inflammation at the visceral pleura. Why is this?  
Upon further analysis of the cell population in the pleural space by flow 
cytometry, the percentage population of neutrophils, as identified by Gr-1 
staining, appears to be only marginally increased from that of the control during 
P. aeruginosa infection, whereas the population of neutrophils in S. pneumoniae  
infection from control increases considerably. This result indicates that 
neutrophils are increased in the pleural space during S. pneumoniae but less so 
in P. aeruginosa  infection and this would explain the gross inflammation 
observed in S. pneumoniae infection but not P. aeruginosa infection. Use of Gr-1 
as a neutrophil marker is debatable, however cytospin analysis of cells confirms 
that there are many neutrophils in the pleural space during S. pneumoniae 
infection. Although total cell numbers were similar in the two different 
infections, the percentage of neutrophils was significantly higher in the S. 
pneumioniae infection (Figure 7-13).  
During both infections the percentage of γδ T cells in the pleural space halves, 
but as there are double the amount of cells in the space during the infections, 
the total cell number of γδ T cells in the pleural space does not differ between 
uninfected control and both P. aeruginosa and S. pneumoniae infection. This 
implies that γδ T cells do not have a role in fighting P. aeruginosa and S. 
pneumoniae at this site, though they were observed to be a source of IL-17 in 
the lung tissue during P. aeruginosa infection as will be discussed later. CD4+ 
cell and B cell percentages are slightly reduced in the pleural space during the 
infections, but again as the total cell count in this space is increased 2-fold, 
even a small decrease in cell percentages still results in increased cell numbers 
of these populations in the pleural space during infection. It would thus appear 
that B cells and CD4+ cells are recruited to the pleural space during P. 
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aeruginosa and S. pneumoniae infection also, but do not play major roles as they 
do not represent major populations of cells at this site. Why is there such 
recruitment of immune cells to this site during these infections? Others in the 
research institute have observed with S. pneumoniae that there are many 
bacteria in the pleural space (unpublished data) that would correlate with the 
inflammation that we see. It is unclear how the pathogen reaches this space or 
the importance of this location in establishing infection. However, these data 
correlate closely with human lung infection with S. pneumoniae, where pleural 
involvement is common [250, 251]. 
We observed increased concentrations of IL-17 in the pleural space during both 
infections, more so in P. aeruginosa but this may just reflect the severity of this 
infection. Taking this observation of increased IL-17 concentrations during 
infection, along with the cytospin data where increased neutrophils were 
observed during both infections, one could suggest that increased IL-17 
correlates with increased neutrophils in the pleural space, indicating that IL-17 
aids in neutrophils recruitment.  
No IL-17+ producing cells were observed in the pleural space by flow cytometry. 
It is unclear if this is a technical error or if the cells no longer produce IL-17. 
Staining for IL-17 on pleural cells was only performed on one experiment and so 
must be repeated before any assumptions about IL-17+ populations in the pleural 
space can be made. However neutrophils are known to be a source of IL-17 
during airway inflammation [252, 253], and since we observe increased 
neutrophils and increased IL-17 in the pleural space during infection it is 
conceivable that a source of IL-17 may be neutrophils. 
The BALs of these animals were also analysed. Cells in the controls appear to be 
composed of a macrophage and neutrophil mix as identified by rapid 
Romanowsky staining. During S. pneumoniae infection cell number in the BAL 
does not change but appears to be mainly composed of neutrophils when the 
lungs are infected. However, during P. aeruginosa infection, not only are cells in 
the BAL mainly neutrophils but there is an increase in cell number also. This 
indicates that the cellular milieu in the BAL changes upon bacterial infection, 
and during the more severe infection with P. aeruginosa, many more neutrophils 
are recruited. IL-17 is increased in the BAL during both infections, again more so 
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during P. aeruginosa infection. Increased IL-17 concentrations in the BAL and 
increased neutrophils as observed on the cytospins implies that IL-17 may be 
responsible for neutrophil recruitment at this site.  
Looking at cells in the lung tissue, and so the site of infection, we see an 
increase in immune cell populations during both infections. γδ T cells appear to 
be increased during both infection and CD4+ cells seem to increase almost 2-fold 
during P. aeruginosa infection, but not so much during S. pneumoniae infection. 
We could not fully investigate neutrophil populations in the lung by flow 
cytometry as the selected marker for neutrophils Gr-1, which has been shown to 
be effective for identifying neutrophils in the blood by other groups, and in the 
pleural space as observed by us. However, the use of this marker as a marker for 
tissue neutrophils is flawed as all Gr-1+ cells which may contain alveolar 
monocytes/macrophages will be stained also [246]. Hence use of Gr-1 as a 
marker for neutrophils is the tissue was abandoned. Since these experiments 
were performed there has been development of a new antibody for identifying 
neutrophils by flow cytometry named 1A8. Gr-1 identifies both Ly-6G and Ly-6C, 
and thus may identify Ly-6C monocytic cells also. New clone 1A8 idenfies Ly-6G 
only which distinguishes neutrophils and thus use of this antibody is a 
consideration for furtue experiments. A further method to identify neutrophils 
are use of a myeloperoxidase (MPO) assay, which in future could be used to 
assay neutrophil accumulation in the tissue during P. aeruginosa and S. 
pneumoniae infection. 
It is evident that infection with S. pneumoniae leads to a higher IL-17+ 
population than infection with P. aeruginosa, as total percent of IL-17+ cells 
during S. pneumoniae doubles from that of uninfected, whereas IL-17+ total 
population percentage with P. aeruginosa doesn’t seem to vary from control. 
What does vary during P. aeruginosa infection is the shift in the cells that 
produce IL-17. During P. aeruginosa infection IL-17+ cells seem to shift from 
being from CD4+ cells as they are in the control, to γδ T cells, with 40% of the 
IL-17+ cells being γδ+ also. This indicates the presence of Th17 cells in the 
resting animal that can make IL-17 if stimulated. However upon P. aeruginosa 
infection, γδ T cells appear to be a predominant source of IL-17, with CD4+ IL-
17+ cells decreasing. During S. pneumoniae infection, where we see increased 
IL-17+ cells, the main source of IL-17 is still unclear. We see an increase in Th17 
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cells, yet we did not see an increase in CD4+ cells indicating another shift of IL-
17 production from control. However, it appears that the majority of IL-17+ cells 
in the lung are CD4-, γδ-, CD19- and Gr-1- (although we found use of Gr-1 to be 
dubious for tissue staining to represent neutrophils, we still show that our IL-17+ 
cells are Gr-1 and thus not neutrophils, alveolar monocytes/macrophages or any 
other Gr-1+ cell that may be in the lung). The main source of IL-17 during these 
infections thus remains unclear. We hypothesize that it must be some kind of 
memory or innate cell with the speed of response. We speculate, that IL-17 may 
be produced from lung epithelial cells, along with other pro-inflammatory 
cytokines such as IL-1β, IL-6 and TNFα [254]. 
A pitfall in our IL-17 analysis is the well documented use of polyclonal 
stimulation to induce the cells to secrete their cytokines so that they may be 
retained and analysed. This polyclonal stimulation is essentially allowing any cell 
that can and has ever been able to produce IL-17, once again produce it and be 
monitored. Thus, we will activate pre-existing IL-17 producing populations in the 
control animals. There have been suggestions of injecting the animals at the 
final stage of infection with brefeldin A, to capture cytokines intracellularly in 
the cells that are producing these cytokines during the assault, instead of non-
specifically re-stimulating them. This would give a more accurate portrayal of 
what cells are producing IL-17 during infection, but will also be harmful to the 
animals and so must be tightly regulated. This is a consideration for future work. 
The contribution of IL-17 signalling via its receptor IL-17R in controlling the 
immune response to S. pneumoniae infection in the lung was investigated during 
one experiment by use of IL-17R KO animals. These animals were deficient in IL-
17RA and thus do not allow signalling of IL-17A or IL-17F. The IL-17RKO animals 
were a lot older than the WT animals, aged 16 weeks as opposed to 8 weeks. We 
acknowledge that using animals so different in age did not make an ideal 
experimental set up, but the previous in vivo infections had been continually set 
up with mice aged at 8 weeks and so these were the animals that were 
continually ordered and made available during experiments, and so were the 
only WT animals we had available when the IL-17RKO animals were available to 
us. As stated this was not a model set up as ideally animals should be age 
matched, however we considered that as both ages of animals are regarded as 
adults, there may not be too much immunological difference in response to the 
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pathogen and so decided to carry out a preliminary investigation with whatever 
resources were available to us. We observed that the IL-17RKO animals were 
much larger in size than we expected, and were twice the weight of the WT 
animals. As the IL-17RKO animals were older than the WT mice we expected a 
size difference. However, the IL-17RKO animals were much larger than we 
expected WT animal of 16 weeks to be. The size difference between these 
animals did not appear to be the normal difference that would have been 
observed between older and younger WT animals. A consequence of this size is 
the number of pathogens given to the mice may have a lesser effect on these 
animals before immunological differences are even taken into account. The 
lungs of the larger IL-17RKO mice are proportionally bigger, and so one would 
suppose that a cfu of 2x107 would have a lesser effect in these animals as 
relatively there is a lower multiplicity of infection (MOI), compared to lungs of 
smaller animals. Using this infection of 2x107 cfu the IL-17RKO mice still 
succumbed to infection to a point and displayed clinical manifestations of 
sickness such as lethargic behaviour, staggered gait and matted coats. This 
infection was not as severe as that of the WT animals with the same S. 
pneumoniae infection where animals displayed the same symptoms that were 
more pronounced. However, we conclude that infection has ensued in the IL-
17RKO animals and therefore any observations we made were in response to S. 
pneumoniae infection. 
Upon dissection it was observed that the large IL-17RKO mice had abundant 
subcutaneous fat. Older WT animals are generally found to be larger in size but 
not fatter. Other studies have found that IL-17RKO mice are heavier and fatter 
than WT mice [249]. It appears that IL-17 down-regulates leptin [249], a 
hormone that negatively regulates body weight [255]. High levels of plasma 
leptin correlates weight gain and conversely low levels of plasma leptin 
correlate with weight loss [255]. Thus if IL-17 down-regulates leptin as the study 
claims [249], IL-17RKO animals would have higher levels of leptin, as IL-17 is not 
signalling via IL-17R and down-regulating leptin production. Higher leptin levels 
correlates with weight gain which we observe in these IL-17RKO animals. 
Another study with IL-17KO mice further confirms the regulatory qualities of IL-
17 with reference to adipose tissue formation claiming IL-17 inhibits 
adipogenesis [256]. This is further proof that IL-17 signalling, through IL-17R, 
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regulates fat deposition in mice and thus animals lacking in this signalling will be 
overweight with fatty deposits which we observe. This massive size and weight 
difference could affect the response to pathogen and so it is suggested that in 
future studies mice not be age matched but perhaps size and weight matched, 
to give a better idea of how these animals respond to S. pneumoniae and the 
contribution of IL-17 and IL-17R during this infection. An alternative would be to 
work out a model for cfu of pathogen per gram of weight to obtain similar levels 
of sickness. 
It was hypothesised that IL-17, and its interaction with IL-17R, is a key source of 
downstream neutrophil recruitment during bacterial pneumonia and thus lack of 
IL-17R would lead to lack of neutrophils at the site of infection. This can be 
observed in the histology of the IL-17RKO lung where there is greatly reduced 
inflammation in the lung and we no longer see the gross inflammation that can 
be observed at the visceral pleura in S. pneumoniae infection in WT mice, 
thereby indicating that the hypothesis may be true, as we have shown that 
neutrophils contirubte greatly to this gross inflammation. However, this lack of 
neutrophils and inflammation in the infected IL-17RKO mice is interesting as the 
animals were clinically unwell, as measured by clinical parameters, but no more 
unwell than the WT. One would perhaps predict that in a setting where there is 
a lack of neutrophils, there would be inadequate fighting of infection and 
therefore the animal would be sicker as infection develops, but we do not see 
this. We observe that IL-17RKO mice are not as sick as the WT infected mice, 
and this would suggest that there may be other immune cells present at the site 
of infection to fight pathogen and to stop the mouse succumbing to infection, 
but we do not see this in the histology. We in fact see less cellular infiltrate in 
the IL-17RKO mice. The theory that cells have compensated for the lack of 
neutrophils in fighting this infection may be backed up by the observation that 
although there is no inflammation in the lung tissue with regards to morphology, 
more immune cells can be observed in the lung tissue when it is digested as 
observed by flow cytometry. Perhaps CD4+ memory cells and γδ T cells have 
compensated here, as we see an increase in both these populations in the lungs 
of IL-17RKO animal from the WT animal during S. pneumoniae infection. What is 
notable is that we see fewer neutrophils and less inflammation in the tissue as a 
consequence in the IL-17RKO animals, as viewed by histology of the lung tissue, 
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but there appears to be more neutrophils in the pleural space of these mice 
during S. pneumoniae infection. This is observed by flow cytometric analysis of 
cells in the pleural space obtained by pleural wash, and rapid Romanowsky 
staining of these cells also. Both techniques display neutrophil influx in this 
space in the IL-17RKO animals that is not observed in the lung tissue. This 
implies that the neutrophils are still present in the pleural space, but they are 
not migrating and causing inflammation in the lungs of the IL-17RKO animals. 
This suggests that IL-17 signalling is important in migration of neutrophils into 
lung but not pleural space. The reasoning for the flux of neutrophils into this 
space is not clear. It is possible that pleural cells subsequently migrate to the 
lung, however it is not common for cells to migrate into a tissue in such a 
manner, and so the direction of neutrophil flux will need to be examined in 
further experiments. Thus the role of IL-17 signalling in neutrophil recruitment 
in the lung and surrounding areas during S. pneumoniae infection is still unclear.  
The histology and lack of neutrophils in the lung correlates with our hypothesis 
that IL-17 signalling via IL-17R may be responsible for neutrophil recruitment. 
But we also imagined these mice to be sicker which we do not witness, 
suggesting that perhaps neutrophils contribute to decline in host health with 
regards to lung function during acute infection. These conflicting results require 
further experimentation. 
In conclusion, we see that sources of IL-17 differ during P. aeruginosa and S. 
pneumoniae infection, with γδ T cells appearing to be a key source of IL-17 
during P. aeruginosa infection and CD4+ cells appearing to more important 
during S. pneumoniae infection then P. aeruginosa, although the main source of 
IL-17 during these infections seems to be γδ-, CD4- and Gr-1-.  Further 
investigation is required to see what the main source of IL-17 is during P. 
aeruginosa and S. pneumoniae infection. The sites of inflammation during these 
infections differ with inflammation of whole lung observed during P. aeruginosa 
infection, but localized inflammation at the visceral pleura during S. 
pneumoniae infection. Why these pathogens differ in their location of 
inflammation and why S. pneumoniae has such a specific effect at the pleural 
surface is unclear and will be an interesting subject of future investigations.  
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Our preliminary experiment suggests that our hypothesis that IL-17 signalling via 
IL-17R may be responsible for neutrophil recruitment in the lung during this 
infection may be true, as reduced neutrophils are observed in the lung by 
histology and analysis of the BAL. Furthermore IL-17 and IL-17R signalling looks 
as if they may regulate other immune cells such as CD4+ cells and IL-17 
production in the lung during S. pneumoniae infection. However, this must be 
fully investigated with age matched studies where the pathogen delivers a 
similar level of infection that can be directly compared, before any firm 
conclusions can be made about the role of IL-17 and IL-17R in the lung during 
this infection.  
Overall our preliminary experiments investigating in vivo infection with P. 
aeruginosa and S. pneumoniae in mice give us good cause to proceed with the 
experiments and investigate our observations further in greater depth. 
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8 General Discussion 
  233 
The main hypothesis of our research was that Th17 cells may be a major source 
of IL-17 in response to infections with the bacterial pathogens P. aeruginosa and 
S. pneumoniae, that IL-1β may influence induction of these Th17 cells during 
infection, and that IL-17 secreted by these cells may be a key attractant of 
neutrophils in the lung during bacterial pneumonia.  
The results presented in this thesis indicate that P. aeruginosa and S. 
pneumoniae infect DCs to induce cytokines that may influence production and 
maintenance of Th17 and other IL-17 producing T cells during these infections, 
such as IL-1β, with P. aeruginosa infection of DCs also leading to production of 
Th17 maintenance cytokine IL-23.  
Our primary aim with the in vitro experiments was to investigate the 
contribution of IL-1β in Th17 induction from naive CD4+ T cells. Our original 
strategy to investigate IL-1β contribution was to use 2 strains of each pathogen, 
one that allowed IL-1β secretion from DCs, and one that does not. In the case of 
P. aeruginosa, PA103 ΔUΔT is a strain that allows IL-1β secretion from DCs due 
to possesion of a fully functional T3SS that leads to activation of the 
inflammasome and IL-1β secretion. P. aeruginosa strain PA103 ΔpcrV does not 
allow IL-1β production from DCs as it lacks a functional T3SS, and so does not 
activate the inflammasome. We confirmed that these strains do and do not 
produce IL-1β from DCs respectively after 90 minutes infection before addition 
of antibiotics and incubation for 2 hours. However we found this difference in IL-
1β secretion between these strains to be time dependent, as cells allowed to 
incubate overnight after antibiotic addition to allow full up-regulation of co-
stimulatory molecules, produce IL-1β upon infection with both P. aeruginosa 
strains. So it appears that other factors, that we have not investigated, activate 
the inflammasome and lead to IL-1β release from the DCs infected with PA103 
ΔpcrV when incubated overnight after antibiotic addition. Thus these P. 
aeruginosa strains cannot be used in our experimental set up to demonstrate the 
contribution of IL-1β absence and presence. 
In the case of S. pneumoniae, we use strains D39 WT and a PLY deficient mutant 
of this D39 ΔPLY and found that, as has been suggested [37, 38], PLY is 
important at induction of significant IL-1β secretion from DCs and so the D39 
ΔPLY represents our IL-1β absence situation. The PLY deficient mutant did not 
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completely abrogate IL-1β secretion from DCs but we do see that IL-1β secretion 
during infection of DCs with the PLY competent D39 WT is significantly higher. 
Use of S. pneumoniae and the differences observed in IL-1β production from the 
DCs indicate that, upon co-culture of naive CD4+ T cells with DCs infected with 
the S. pneumoniae strains, IL-1β does not appear to make a significant 
contribution to Th17 induction from naive T cells. We confirmed this by culture 
of naive CD4+ cells with Th17 inducing cytokines TGFβ and IL-6, set up in the 
presence of absence of IL-1β. We observed Th17 populations from naive CD4+ T 
cells both in IL-1β absence and presence, further indicating that IL-1β is not 
necessary for Th17 induction from naive CD4+ T cells. However, addition of IL-1β 
does appear to increase Th17 populations, and so although not important for 
Th17 induction, appears to have roles at enhancing these populations.  
We found that an important source of IL-17 during P. aeruginosa infection was 
γδ T cells, which contaminated the MACS isolated CD4+ T cell preparation from 
mice. These cells produced IL-17 in a rapid IL-23 dependent, IL-1β independent 
manner. We found IL-23 was produced by DCs infected with P. aeruginosa but 
not S. pneumoniae in what is believed to be a TLR4 dependent manner [49], 
which may be backed up by the fact that P. aeruginosa possesses TLR4 ligand 
LPS and S. pneumoniae does not. However, S. pneumoniae toxin PLY has been 
claimed by some groups to be a TLR4 ligand [39], yet we do not see IL-23 
production from DCs infected with PLY competent D39 WT, and so this questions 
the role of PLY as a TLR4 ligand, or the TLR4 dependence of IL-23 secretion, and 
must be investigated further. 
We hypothesised that Th17 cells may be a major source of IL-17 during bacterial 
pneumonia, yet we find that the majority of IL-17+ cells during P. aeruginosa 
and S. pneumoniae infection are CD4-. Not only this, but they are mainly γδ- and 
Gr-1- indicating that the main source of IL-17 during these infections are not γδ 
T cells nor neutrophils. However, γδ T cells appear do to be a key source of IL-
17 during infection with P. aeruginosa, as we see a shift in IL-17 production 
during P. aeruginosa infection to γδ+IL-17+ cells from CD4+ Th17 cells that are 
observed in healthy control animals. We hypothesise that the main source of IL-
17 in the lung during this infection could be non-immune cells such as epithelial 
cells, as these cells may recognise antigen directly as they have PRRs on their 
surface [59] and are known to secrete other cytokines such as IL-1β, IL-6 and 
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TNFα [254]. Therefore in future experiments we believe epithelial cells should 
be investigated during bacterial pneumonia alongside immune cells and innate 
lymphoid cells. 
We observe that both P. aeruginosa and S. pneumoniae infection induce 
pneumonia that manifest itself in haematomas, inflammation and neutrophil 
influx. A key difference in the lung inflammation in these infections is that S. 
pneumoniae infection, which manifested as a less severe infection clinically, has 
gross inflammation at the edge of the visceral pleura of the lung that is not 
observed in clinically severe P. aeruginosa infection. Preliminary experiments 
suggest that this inflammation may be IL-17 dependent as during S. pneumoniae 
infection in IL-17RKO animals this gross inflammation at the pleural edge was 
absent. Upon further inspection it appears as if neutrophils may be responsible 
for this inflammation at the pleural edge as is witnessed by histology, and as this 
is absent in IL-17RKO, this suggest that neutrophil recruitment in the lung during 
S. pneumoniae infection is enhanced by IL-17 and IL-17R signalling. However, our 
preliminary experiments imply neutrophils are enhanced in IL-17RKO animals in 
the pleural space during S. pneumoniae infection. This indicates that the role of 
IL-17 signalling in neutrophil recruitment may differ at different sites during 
bacterial pneumonia, and this is of great interest to future studies. It has also 
brought attention to the pleural space as an area to investigate in studies of 
bacterial pneumonia. Usually the BAL is used as an illustration of what is going 
on inside the lung during disease. The pleural wash is a wash of the pleura that 
surrounds the lung and this space is not usually investigated during in vivo 
bacterial infection models. However, our data suggests that this area could be of 
great interest and we suggest that others in the future consider this site also.  
Taken together the results presented in this thesis indicate that IL-1β is not 
required for induction of Th17 cells during P. aeruginosa and S. pneumoniae 
infection, yet it may enhance Th17 populations during these infections in vitro. 
γδ T cells are confirmed to be a prolific source of IL-17 and produce the cytokine 
in an IL-23 dependent manner, independent of IL-1β. We show that bacterial 
pneumonia in the lungs differs with Gram-negative and Gram-positive pathogens 
in their sites of inflammation, with interest in further studying the pleural space 
in S. pneumoniae infection as this is a site of gross inflammation that has not as 
yet been thoroughly investigated. Preliminary data hints to the role of IL-17 in 
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neutrophil recruitment in the lung, but again must be investigate much more 
thoroughly before any conclusions can be made. 
While these observations of the role of IL-17 and sources of IL-17 during P. 
aeruginosa and S. pneumoniae infection are informative, they are merely a basis 
for the in depth study of IL-17 cells and their roles in respiratory pneumonia. 
Future studies must further investigate all sources of IL-17 during pneumonia 
with these pathogens and focus on the pleural space as an area of interest 
alongside the BAL and lung tissue itself, to give a better idea of what is 
occurring at this site during infection. Further studies with IL-17RKO mice must 
be performed to affirm the role of IL-17R signalling during pneumonia, with care 
and attention taken to age match and size match the animals for comparison of 
infection to infection in WT animals. Additionally it would be of interest to 
investigate the histology of lung inflammation during infection with another 
Gram-positive pathogen, such as Staphylococcus aureus another causative agent 
of bacterial pneumonia, to investigate if inflammation at the pleural edge is a 
Gram-positive pathogen quality or a sole feature of S. pneumoniae infection. It 
is also of interest to investigate the role of IL-1β during Th17 induction in vivo as 
this may be different to its role, or lack thereof, during Th17 induction in vitro. 
This could be investigated with use of IL-1β KO animals, and investigation of 
Th17 and IL-17 secretion cells responses during infection. 
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